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General Introduction
1CHAPTER
2Some decades ago, the general expectations were that infec-
tious illness would become less important in future than it had been
until then. There was optimism about the possibility to exterminate
notorious infectious diseases and trust in the action of antibiotics.
Unfortunately, nowadays resistance is a serious problem and the
micro-organisms that produce orthopaedic infections have become
more difficult to kill. This resistance to standard antibiotic regimens
makes proper antibiotic selection mandatory. Moreover it requires
a long and sometimes intensive treatment, partially due to the diffi-
culty to eradicate the causative organisms in an environment of
poor vascularisation (such as in bone sequestra or adjacent to an
endoprosthesis). Such a prolonged treatment of orthopaedic infec-
tions, in comparison with other infectious diseases, has a consider-
able physical and social impact on the patient and a relative high
economic impact. Under the influence of managed care, the cost
and effectiveness of various treatment alternatives have been ques-
tioned and efforts have been made to decrease hospitalisation and
limit parental antibiotics.
Infections in orthopaedics, because of the nature of the sub-
strate, are localised in bone and/or joints and are called
osteomyelitis and arthritis. The infectious process of the bone and
its marrow normally is caused by pyogenic micro-organisms,
although other agents (e.g. those responsible for tuberculosis, viral
or fungal infections) are possible as well. The commonest route is
the haematogenous spread from a distant focus, but it can also be
produced by extension of soft tissue infection adjacent to bone, or
it can be initiated from an open wound or fracture. Septic arthritis
can be produced by haematogenous spread to the synovium or by
the aggravation of osteomyelitis involving the epiphysis or an intra-
capsular metaphysis. Direct contamination of the joint is another
possibility.
The vascular architecture of the bone (i.e. the metaphysis) should
predispose to the establishment of infection following bacteremia.
The anatomical different patterns of vascularity between infant,
child and adult explain the difference in clinical manifestations of
the infection in children and adult. In children, the acute
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3haematogenous osteomyelitis occur more frequently than in adults,
because of the vascular anatomy of growing bones, as well as the
more frequent bacteremia and repeated traumata.
Infection reflects a complex interaction between the host, a
micro-organism, and the mutual response of each to the other. The
mere presence of bacteria in bone, whether from bacteremia or
from direct inoculation, is not sufficient to produce an orthopaedic
infection. Illness, malnutrition, trauma and inadequacy of the
immune system may be factors that trigger bone and joint infec-
tions to become manifest. Infection occurs when an adequate num-
ber of a sufficiently virulent micro-organism overcomes the host’s
natural defences. Local factors (such as the vascularity) also play an
important role in the development of infection. Besides, the rela-
tive absence of phagocytic cells in the metaphyses of bones may
explain why acute haematogenous osteomyelitis is more common
in this location.
In both the adult and paediatric population, Staphylococcus
aureus is the most common causative agent for osteomyelitis and
septic arthritis. However, depending on age, also other micro-
organisms are frequently isolated. In neonates, group B streptococci
and enterobacteriaceae are frequent causative agents; in older chil-
dren haemolytic group A streptococci are isolated relatively fre-
quently. This holds too for Haemophilus influenzae type B in chil-
dren younger than 3 years of age, before the recent introduction of
nation-wide vaccination.
Despite recent advances in diagnosis, antibiotic development and
refined surgical techniques, thus a proper management of bone and
joint infections remain a formidable challenge. It may require both
antibiotic and surgical treatment. In acute osteomyelitis only antibi-
otic treatment may be sufficient, but then the micro-organism
should be accurately identified and its antimicrobial susceptibility
should be determined preferentially. When treatment is delayed,
infection becomes chronic, resulting in pus and sequestra. In
chronic osteomyelitis surgery is usually inevitable. 
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4Orthopaedic surgery is evolving. The modern era of total
hip arthroplasty is only about forty years old. During this relatively
short period, the procedure has shown to be highly effective in
improving physical function, social interaction and the overall
health of patients. Development and improvement of these
orthopaedic devices has led to new cemented implanting tech-
niques, and cementless techniques and implants were introduced as
well.
The introduction of implants in orthopaedic surgery has resulted in
a new kind of infection, the prosthetic joint-related infections.
Because of the presence of the foreign body there appears to be a
higher susceptibility to infections, probably developing through
direct contamination during implantation. However, also a
haematogenous origin of infections has been documented, although
it is probably less frequent.
In 1969 Charnley reported an infection rate for total hip arthroplas-
ty of 9.5 per cent (Charnley 1969). In the following years, especially
because of prophylactic antibiotics, the prevalence of an infected
prosthesis was reduced considerably. As a result, in the more recent
years, infection rates of 1 to 2 per cent have been reported for pri-
mary total hip arthroplasties (Charnley 1972; Fitzgerald 1973;
Salvati 1982b; Lidwell 1986; Lidwell 1987; Maderazo 1988;
Schutzer 1988; Garvin 1995). 
Although infection rates have decreased substantially over the past
few decades, infection still is a source of considerable morbidity
because the incidence of total joint replacement is increasing
(Okhuijsen 1998). Therefore in absolute numbers, infection of a
prosthesis still constitutes a major and increasing burden to the
health care system (Sculco 1993).
As mentioned above, within the category of prosthetic joint-
related infections both the haematogenous type as well as those
caused by direct contamination have to be distinguished. One states
that haematogenous infection is more likely to occur in patients
who are immunosuppressed, such as those who have been treated
with immunosuppressive medications for inflammatory arthritis. In
fact it is not clear if this is caused by the treatment of the disease or
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5by the underlying disease itself. Recurrent bacteremia, such as
occur in patients who are repeatedly and recurrently catheterised,
dental manipulation, respiratory infection, remote periprosthetic
infection, open skin, endoscopy and contamination of the operative
site are other causes of haematogenous infections. The skin has
shown to be the most frequent source of a haematogenous infec-
tion.
Operative debridement and antibiotic therapy are the main-
stays of treatment of infection of a hip arthroplasty. The debride-
ment includes the excision of all infected and necrotic tissue and
eventually removal of the prosthesis and cement. A still unresolved
question is, whether after removal of the prosthesis, a new prosthe-
sis should be replaced immediately or in a later phase.
An increasing knowledge of mechanisms, diagnosis and
treatment of orthopaedic infections has led to a more successful
eradication of the infection for more patients than several decades
ago, however many questions still remain unanswered. Until now,
there has been a rapid increase in the use of biomaterials in
orthopaedic surgery, both with respect to the actual number of
implants as with respect to an increasing variety of implant materi-
als, all with different material (biocompatibility) characteristics. 
The author’s interest in orthopaedic infections was initiated
by the impact of these infections on patients. It stimulated to a
study, as presented in Chapter 3, of a population of children with
osteomyelitis, in which the haematogenous route is by far the most
important pathway for bone infection. In Chapters 4 and 5 clinical
aspects of prosthetic joint-related infections are described. At first,
an attempt is made to define the outcome of this difficult and het-
erogeneous population. Then, emphasising the significance of the
haematogenous route for prosthetic infections, an unusual compli-
cation of an abdominal infection, i.e. prosthetic hip infection, is
presented.  Before these clinical data, the literature is presented in
Chapter 2. In Chapter 6 a summary of the foregoing chapters 2 to 5
is given and aims for experimental studies are formulated. These
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6experimental studies are presented in Chapters 7 and 8. In Chapter
7 the question of infection susceptibility in relation with implant
surface characteristics and biocompatibility is addressed. New
implant materials have been developed during the last decade, with
the goal of increased biocompatibility, while “bacterial compatibili-
ty” did not receive much attention. Are bioactive implant surfaces
less susceptible to bacterial colonisation, as Gristina’s “race for the
surface” would suggest, or are there other aspects, which in turn
determine the clinical success of an infected implant? And what is
the influence of infection on the ingrowth of noncemented pros-
theses? Chapter 8 focuses on a further understanding of the
haematogenous route as a cause for bone or prosthesis infection by
the development of animal model in the rabbit. Finally, Chapter 9
contains a summary and discussion of this thesis.
CHAPTER 1
Review of the Literature
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82.1. Introduction
The replacement of the hip joint by a total joint arthroplasty
has been performed for almost 40 years. The procedure has proven
to be highly effective in improving physical function, social interac-
tion and over-all health of millions of patients (Laupacis 1993).
In the beginning, this total joint replacement procedure was com-
plicated by a rate of infection of almost 10 percent (Charnley 1969).
Although infection rates have decreased substantially over the past
few decades, infection still is a source of considerable morbidity.
This reduction in infection rate has been accompanied by an
increase in the incidence of total joint replacement (Okhuijsen
1998). Therefore in absolute numbers, infection of a prosthesis still
constitutes a major burden to the health care system and is a com-
plication that remains a considerable concern (Sculco 1993). In the
current chapter, various general aspects of an infected total joint
arthroplasty such as epidemiology, risk factors, classification, diag-
nostic tools, and treatment options will be described.
2.2. Epidemiology and risk factors of infection
of joint replacement
In 1969 Charnley reported an infection rate for total hip
arthroplasty of 9.5 per cent (Charnley 1969). In the following years,
various precautions such as prophylactic antibiotics, ultraclean-air
operation rooms, better operative techniques, different modes of
fixation of the implant and careful selection of patients, consider-
ably reduced the prevalence of an infected prosthesis. As a result, in
the more recent years, infection rates of 1 to 2 per cent have been
reported for primary total hip arthroplasties (Charnley 1972;
Fitzgerald 1973; Salvati 1982b; Lidwell 1986; Lidwell 1987;
Maderazo 1988; Schutzer 1988; Garvin 1995). In the Mayo Clinic,
between 1969 and 1996, the prevalence of infection of a primary
total hip prosthesis and a primary total knee prosthesis, was 1.3 per
cent and 2.0 per cent respectively (Hanssen 1999). The rate of deep
infection was influenced by previous surgery of the affected joint
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9(Fitzgerald 1977; Poss 1984; Wilson 1990). For revision operations,
the rate of infection was 3.2 per cent and 5.6 per cent for hip and
knee arthroplasty respectively (Hanssen 1999).
The infection rate of a total joint arthroplasty is higher in patients
with rheumatoid arthritis than with osteoarthritis (Charnley 1972;
Ahlberg 1978; Stinchfield 1980; Glynn 1983; Ainscow 1984; Poss
1984; Bengtson 1987; Maderazo 1988; Wilson 1990). Also patients
suffering from diabetes mellitus are at an increased risk for a deep
total joint infection (England 1990; Papagelopoulos 1996).
However, Moeckel et al. did not find a higher rate of infection of
total hip arthroplasties in patients with diabetes mellitus (Moeckel
1993). 
Another factor influencing infection is poor nutrition. Wound
complications occurred more frequently in patients with malnutri-
tion as indicated by a serum albumin level of less than 35 grams per
litre (Jensen 1982; Greene 1991; Smith 1991). Other risk factors for
wound complications and deep infection are for instance obesity,
recurrent urinary-tract infection, oral use of steroids (Wilson 1990)
and psoriasis (Stern 1989).
Prolonged preoperative hospital stay is another potential factor that
increases the rate of infection of an arthroplasty. According to
Cruse and Foord, the rate of infection was 1.1 per cent for patients
who had been admitted to the hospital on the day of operation
compared with 4.3 per cent for those who had been hospitalised for
two weeks before the operation (Cruse 1973).
Other factors that are associated with an increased infection rate are
the presence of structural bone graft (Schutzer 1988), the use of
metal-metal prosthesis (Poss 1984), and the use of constrained pros-
theses (Poss 1984; Bengtson 1987).
A specific group are the haematogenous infections. This type of
infections is likely to occur in patients who are immunosuppressed,
such as those who have had a renal transplant or who have been
treated with immunosuppressive medications for inflammatory
arthritis, and those who have recurrent bacteremia, such as drug
abusers and patients who are repeatedly and recurrently catheterised
(Irvine 1974; Hughes 1979). Also responsible for a haematogenous
infection may be dental manipulation (Rubin 1976; Hunter 1977;
REVIEW OF THE LITERATURE
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Hughes 1979; Stinchfield 1980), respiratory infection (Hunter
1977), remote periprosthetic infection (Hunter 1977), open skin
(Ainscow 1984; Maderazo 1988; Deacon 1996), endoscopy
(Vanderhooft 1994) and contamination of the operative site
(Hughes 1979). It is usually not possible to trace the primary focus
of infection, but in a literature review Deacon reported on 180
cases of suspected haematogenous infections of a prosthetic joint
(Deacon 1996). The skin was the most frequent source, and other
frequently found foci were the genito-urinary tract, the mouth and
the respiratory tract.
The cost of treatment of a total hip prosthesis infection was at least
50,000 dollars per patient in 1986 in the United States (Maderazo
1988), and currently these costs may very well be higher. The costs
per year to treat the total of 3,500 to 4,000 total hip infections was
estimated between 150 and 200 million dollars (Sculco 1993). These
costs are considerably higher after revision procedures. 
2.3. Classification of prosthesis-related
infections of the hip
A classification system of infection of orthopaedic implants
was proposed by Coventry (Coventry 1975) and later amended by
Fitzgerald et al. (Fitzgerald 1977) (Table 2.1). This three-stage sys-
tem is based on the mode or timing of the presentation of infection.
Stage-I infections occur in the immediate postoperative period as
an acute fulminating infection. The infection is caused by contami-
nation at the time of the operation or by infected haematomas or
superficial wound infections. This type of infection present within
the first 3 months, usually becomes manifest within 4 weeks after
the operation. The diagnostic challenge is to determine whether or
not a superficial infection has penetrated deep into the fascia. Stage-
II infections are believed to originate also at the time of the opera-
tion. Because of a small inoculum or the low virulence of the
organism, the onset of the symptoms is delayed. Mostly the infec-
tion presents itself in the form of an indolent, chronic low-grade
infection. Pain is often present from the beginning of the original
CHAPTER 2
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procedure. The patient is usually seen between 6 weeks and 24
months after the operative procedure. This type of infection repre-
sents a diagnostic challenge, because the findings on examination of
the hip in a patient who has a stage-II infection usually are not spe-
cific and are similar to those associated with aseptic loosening.
Stage-III infections are thought to be caused by haematogenous
spread from a distant focus to a previously asymptomatic hip. This
type of infection appears usually 2 years or more after the operative
procedure. Early diagnosis may allow salvage of the joint by means
of complete debridement. A delay in the diagnosis may necessitate a
one- or two-stage exchange procedure.
To facilitate the management of the patients with an infected hip
arthroplasty, Estrada described a new classification that comprises
four categories (Table 2.1), and he also makes general suggestions
for treatment (Estrada 1993). In the first category, peroperative
unexpected “positive intraoperative cultures” are present. Infection
is diagnosed after two or more positive specimens, obtained intra-
operatively from different sites of the hip. The cultures must be
positive for the same organism. He suggests that the infection
should be treated by intravenous antibiotics without operative
intervention. The second category includes patients with an “early
postoperative infection”, apparent within one month after opera-
tion, and debridement with intravenous administration of antibi-
otics are the treatment suggestions. More than one month after
operation, the infection is classified as “late chronic” and is charac-
terised by an insidious clinical onset. As treatment suggestions for
this stage, removal of the components and intravenous antibiotics
are mentioned, followed by various other options. The last catego-
ry is the “acute haematogenous infection”, characterised by an
acute onset of clinical symptoms in a previously well functioning
hip. If the prosthesis is well fixed, treatment is suggested according
to the “early postoperative infection”, and if the prosthesis is found
to be loose, the treatment should be similar to that for a “late
chronic infection”.
REVIEW OF THE LITERATURE
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2.4. Causative organisms
From the majority of the patients with an infected hip
arthroplasty, Gram-positive micro-organisms are isolated (Table
2.2). More than 50 percent of the Gram-positive isolates are staphy-
lococci. Coagulase-negative staphylococci (CNS) and Staphylococcus
aureus are isolated in almost equal numbers. During surgical
debridement of an infected arthroplasty, Gram-negative bacilli are
isolated from only 18 per cent of the cultured micro-organisms.
Gram-negative bacilli have rarely been cultured from wounds that
were closed and did not have sinus tract drainage at some time dur-
ing the postoperative course. Because Gram-negative bacilli are
usually isolated from mixed infections, it seems that the Gram-neg-
CHAPTER 2
Table 2.1. 
Classification of 
prosthetic-related 
infections according to
Fitzgerald and Estrada.
Classification
Category Definition
Fitzgerald et al. (Fitzgerald 1977):
Stage-I (acute fulminating infection) Developed within 3 months after surgery,
usually within the first month 
Stage-II (delayed sepsis) Developed as a creeping, indolent infection
within the first 24 months
Stage-III (late haematogenous infection) Caused by a haematogenous spread to a
previously asymptomatic hip, usually 2 years
or more after the arthroplasty 
Estrada et al. (Estrada 1993):
Positive intraoperative culture Two or more intraoperative specimens
positive for the same organisms
Early postoperative infection Apparent within 1 month of surgery
Late chronic infection Presenting >1 month after surgery, with an
insidious clinical onset
Acute haematogenous infection Acute onset of clinical symptoms in a
previously well-functioning joint
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ative bacilli are usually secondary invaders of open, draining
wounds in patients with deep sepsis of an arthroplasty of the hip
(Lotke 1992). Anaerobic micro-organisms are isolated in 10 per
cent of the positive cultures.
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Table 2.2. 
Overview of causative micro-organisms of prosthetic infections as reported to the literature between 1973 and 1998.
Reference CNS S. aureus Strepto- other Gram anaerobes other no. of 
cocci Gram pos. neg. isolates
% % % % % % %
Murray 1973 27 33 7 - 33 - - 15
Fitzgerald 1977 16 20 18 - 24 20 - 49
Carlsson 1978 29 28 12 2 6 23 - 102
Hughes 1979 70 10 3 3 3 7 3 30
Buchholz 1981 5 40 8 11 23 12 2 695
Inman 1984 38 18 23 3 11 8 - 66
Fitzgerald 1985 32 27 12 6 17 6 - 142
Antti-Poika 1989 8 35 28 - 30 - - 40
McDonald 1989 34 17 17 8 16 7 - 110
Schmalzried 1992 12 33 10 4 37 4 - 51
Garvin 1993 38 19 13 6 11 13 1 96
Garvin 1994a 30 19 16 9 19 7 - 43
Raut 1994 33 21 15 17 10 2 2 52
Nestor 1994 42 18 13 - 16 11 - 45
Lieberman 1995 29 16 21 - 29 4 - 68
Raut 1995 52 9 10 22 6 1 - 162
Lai 1996 26 42 2 5 21 - 5 43
Lachiewicz 1996 38 29 10 - 14 10 - 21
Tsukayama 1996 38 22 14 - 14 8 3 147
Ure 1998 41 23 23 5 - 9 - 22
Ostendorf 1998 38 18 16 2 16 10 - 209
Total 26 27 12 7 18 9 1 2208
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There is a shift in the types of bacteria found in peroperative cul-
tures during the last two decades. More infections with
Staphylococcus epidermidis are seen nowadays (Ostendorf 1998), while
for instance less anaerobic micro-organisms were isolated from
patients with infected arthroplasties (Fitzgerald 1973; Ostendorf
1998). Peptococcus species are the most frequent anaerobic isolates
recovered.
One of the main items in the successful management of the infect-
ed arthroplasty is the virulence of the causal organism. McDonald
et al. (McDonald 1989) demonstrated that patients from whom a
causal organism of low virulence was isolated, had a lower inci-
dence of recurrent sepsis than those patients from which a more
virulent organism was isolated. The less virulent organisms included
CNS, anaerobic cocci, and streptococci other than group D strep-
tococci. The virulent causal organisms included methicillin-resistant
staphylococci, gram-negative bacilli, group D streptococci and
enterococci. Especially, organisms that secrete glycocalyx should be
considered to be more virulent causal organisms (McDonald 1989).
2.5. Diagnosis of infection
An outline of the various data and investigations on which
the diagnosis orthopaedic implant infection may be based, is pre-
sented in Table 2.3. This includes clinical data, laboratory investiga-
tions and imaging studies. Each of these will be discussed briefly.
2.5.1. Clinical Presentation
Pain is the major presenting symptom of most patients with
a deep infection. Systemic signs of infection, such as fever, chills
and sweating may also be present. The region of the hip may be
erythematous, swollen, fluctuant and tender. Sometimes wound
drainage is present, usually purulent. However, these symptoms are
not always present, so it is not always possible to establish a clear
conclusive diagnosis. A history of persisting pain or prolonged
drainage after the operation and a careful physical examination can
help to guide the appropriate investigations.
CHAPTER 2
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2.5.2. Laboratory examinations
White blood-cell count (WBC)
White blood-cell count is rarely elevated in patients who
have an infection following a total hip arthroplasty and is therefore
not helpful for diagnosing an infection of an arthroplasty (Eftekhar
1984; Spangehl 1999). Considering white blood-cell count to be
elevated when it is more than 11.0x109 per litre, sensitivity is only
0.20 and specificity 0.96 (Spangehl 1999). When the white blood-
cell count is increased, a systemic manifestation of infection is usu-
ally clinically obvious.
REVIEW OF THE LITERATURE
Table 2.3.
Overview of various investigations that may lead to the diagnosis of infection.
Diagnosis of infection
Preoperative investigations
History and examination Fever, local pain and erythema
Haematological investigations ESR >30 mm/hr
CRP >10 mg/l
WBC >11.0x109/l
Radiography Radiographs Osteolysis, periosteal reaction
Arthrographs Loosening
Radionuclide imaging Technetium-99m bone Increased uptake
Gallium-67 citrate Increased uptake
Indium-111-labeled leukocytes Increased uptake
Indium-111-labeled Ig-G Increased uptake
Preoperative aspiration Gram-staining Presence of bacteria
Culture Positive culture
Peroperative investigations
Surgical judgement Pus
Peroperative sampling Gram-staining Presence of bacteria
Culture More than one-third of cultures are positive
Polymerase chain reaction Presence of bacterial DNA
Frozen section More than 5 polymorphonuclear leukocytes 
per high-power field
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Erythrocyte sedimentation rate (ESR)
The erythrocyte sedimentation rate is a non-specific haema-
tological test. Responsible for an elevation of the erythrocyte sedi-
mentation rate are acute-phase reactants. These positively charged
macromolecules are produced in the liver as a response to a variety
of conditions such as inflammatory diseases, infection and neoplas-
tic processes (Covey 1987). The discriminating value chosen to dif-
ferentiate between septic and aseptic conditions has been described
to be above 30 to 35 millimetres per hour (Sanzen 1989; Thoren
1991; Roberts 1992). A specificity of 0.85 for an elevated erythro-
cyte sedimentation rate was reported, and a sensitivity of 0.82
(Spangehl 1999). The erythrocyte sedimentation rate may remain
elevated for months after an uncomplicated total hip replacement
(Shih 1987).
C-reactive protein level (CRP)
Another acute-phase reactant, C-reactive protein, is synthe-
sised in the liver. Under normal conditions, it is found in trace
amounts (Sanzen 1989). Also C-reactive protein increases in a non-
specific manner as a result of infection, inflammatory disease neo-
plastic disorder and surgery. The C-reactive protein level elevates to
maximum values within 48 hours after an operation and returns to
normal trace amounts in approximately 2 to 3 weeks (Aalto 1984;
Shih 1987; Niskanen 1996). Because of this ability to return to a
normal value much faster then the erythrocyte sedimentation rate, it
is a more sensitive indicator of infection, especially in the early post-
operative period (White 1998; Spangehl 1999). A C-reactive protein
value higher than 10 milligrams per litre should be considered to be
suggestive of infection. For this parameter, a sensitivity of 0.96 and a
specificity of 0.92 were reported (Spangehl 1999).
2.5.3. Imaging techniques
Radiography
Plain radiographs are of limited value for the diagnosis of
infection of an orthopaedic implant, particularly in differentiating
between aseptic loosening and infection. Many radiographic find-
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ings, such as loosening, osteolysis (Huddleston 1988; Barrack 1993)
and endosteal scalloping (Lyons 1985) are common in both septic
and aseptic failure (Figure 2.1).
Periostal new-bone formation has been considered by some to be
pathognomonic of deep infection (Fitzgerald 1992).
Most patients who have an early postoperative or an acute
haematogenous infection show no signs of loosening. In cemented
prosthesis, loosening is categorised as possible, probable and definite
loosening (Harris 1982). Possible loosening is defined as a radiolu-
cent line, occupying 50 to 100 per cent of the bone-cement inter-
face which was not visible on the radiographs taken immediately
postoperatively. Probable loosening is defined as a continuous radi-
olucent line surrounding the entire cement mantle. Definite loose-
ning is defined as a radiolucent line at the stem-cement interface,
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Figure 2.1 
X-ray of a patient with
an infected total hip pros-
thesis. There is obvious
osteolysis around the
femoral component.
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fracture of the cement mantle or migration of the prosthesis.
However, the clinical significance of a radiolucent line on radi-
ographs has been questioned (Jasty 1991; Kwong 1992). On the
acetabular side definitive loosening is defined by migration of the
socket or cement mantle, protrusio acetabuli or acetabular fracture
(Lyons 1985). Loosening is often subtle and easier to distinguish if
old radiographs are reviewed. Arthrography can improve the accu-
racy of radiographs in the diagnosis of loosening (O’Neill 1984;
Harris 1986). Arthrography does not have notable advantages com-
pared with plain radiography when used for the diagnosis of loose-
ning of the femoral component. It is of more benefit when used for
the assessment of loosening of a cemented socket (O’Neill 1984).
Radionuclide imaging
Technetium-99m bone scintigraphy is highly sensitive, but
not specific for the diagnosis of infection after a hip arthroplasty
(Nijhof 1997b). Multiple conditions, such as fractures, tumours,
heterotopic ossification and inflammatory disorders can also result
in an increased uptake. 
Focal uptake can be present for as long as one year after an uncom-
plicated hip replacement and for more than two years after inser-
tion of a cementless implant (Oswald 1989).
Gallium-67 citrate is an isotope that accumulates in areas of inflam-
mation. Because any inflammation may cause an increased uptake,
it is not specific (Wegener 1991). Although more accurate than sin-
gle isotope scans, sequential technetium-gallium scintigraphy still
lacks sufficient accuracy to be clinically useful for diagnosing a pros-
thetic infection. Merkel et al. and Kraemer et al. reported a sensi-
tivity of 0.50 and 0.38 and a specificity of 0.78 and 1.00 (Merkel
1985; Kraemer 1993).
Indium-111-labeled leukocytes are useful for the diagnosis of
increased vascularity and leukocyte accumulation. The sensitivity
for diagnosing an infection after hip replacement is high, but the
specificity is poor (1.00 and 0.41-0.50, respectively) (Wukich 1987;
Johnson 1988). In an attempt to increase its ability to aid in the
diagnosis of infection, indium-111-labeled leukocyte scanning was,
in a sequential protocol, combined with technetium scanning. The
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combined scans generally had higher sensitivities and specificities
(0.89-1.00 and 0.95-0.98, respectively) (Johnson 1988; Palestro
1990).
In Indium-111-labeled immunoglobulin-G scintigraphy, the radio-
pharmaceutical agent is labelled to a carrier that targets areas of
acute inflammation. The advantage of this method compared with
indium-111-labeled leukocyte scintigraphy is that the lengthy labo-
ratory preparation and handling of possible infected blood can be
avoided. The first studies prospectively compared results of indium-
111-labeled immunoglobulin-G scintigraphy with standard three-
phase technetium-99m scintigraphy, with promising results (sensi-
tivity 0.92, specificity 0.88) (Oyen 1992). Additional studies showed
that Indium-111-labeled immunoglobulin-G scintigraphy is a very
sensitive tool for detection of infectious bone and joint disease and
is a highly sensitive (1.00) and fairly specific tool for detecting late
infection of total hip and total knee arthroplasties (0.82 and 0.50,
respectively) (Nijhof 1997b; Nijhof 1997c).
2.5.4. Microbiological examinations
The role of aspiration to obtain material for culturing has
generated considerable debate. By some authors aspiration was
advocated for all patients who had a failed hip replacement
(Fitzgerald 1977; Roberts 1992). More recently however, other
authors favour a more limited role, with aspiration being used to
confirm a clinical suspicion of infection or to support (or to reject)
the findings of other preoperative investigations (Barrack 1993;
Tigges 1993; Fehring 1996; Lachiewicz 1996; Mulcahy 1996). A
great benefit of aspiration at suspected infection is the ability to
identify the organism and its antibiotic sensitivity profile, which
may influence the preoperative planning as well as the type of
antibiotics chosen for therapy. Investigations reported a wide range
of sensitivity (0.50-0.93) and specificity (0.82-0.97) for aspiration
(Roberts 1992; Barrack 1993; Kraemer 1993; Tigges 1993; Fehring
1996; Lachiewicz 1996; Mulcahy 1996; Spangehl 1999). The wide
variation in positive results may be due in part to the technique of
aspiration (Spangehl 1999). To reduce the number of false-positive
results, and thereby improve accuracy, a standard protocol should
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be established. To reduce the number of false-negative results, all
antibiotics must be discontinued for 2 to 3 weeks before aspiration.
Local anaesthetics should be used only in the skin and not in the
joint as they may be bacteriostatic. If not enough fluid is obtained,
the joint can be irrigated with saline solution and reaspirated. A
needle biopsy of synovial tissue also should be performed at the
time of the aspiration (Spangehl 1998).
A Gram stain is a simple investigation to establish the presence or
absence of bacteria. The Gram stain may be specific, but it lacks any
acceptable level of sensitivity (0-0.23) (Kraemer 1993; Feldman
1995; Chimento 1996; Della Valle 1999b; Spangehl 1999).
Therefore the Gram stain is not reliable for determining the pres-
ence of an infection in patients who undergo a reoperation after a
hip arthroplasty.
Peroperative cultures are often used as the standard for the diagnosis
of infection after an arthroplasty. However, the results are not 100
per cent accurate. A recent study reported a rate of peroperative
false-positive cultures of 3 per cent for patients who had a revision
hip replacement (Spangehl 1999). Several other investigators have
reported rates of false-positive cultures as high as 29 percent in asso-
ciation with total hip arthroplasty (Murray 1973; Tietjen 1977). To
avoid false results, a careful sample acquisition protocol is impor-
tant. Preoperative antibiotics should be withheld until samples for
cultures have been taken. Clean instruments should be used. The
samples should be taken from an area that has not been cauterised
and prior to irrigation of the woundbed. To decrease the chance of
colonisation and to allow for subsequent administration of antibi-
otics the samples are taken immediately after the pseudocapsule has
been opened. A minimum of 3 samples should be obtained from
close to the surface of the prosthesis and from inflamed tissue and
sent immediately to the microbiology laboratory for processing
(Spangehl 1998). Cultures should not be considered negative until
the final results of the broth subcultures are available. These final
results should be interpreted in the context of all preoperative and
perioperative findings (Spangehl 1998).
New molecular biological technology can be used to determine the
presence of bacterial DNA and RNA. Polymerase chain reaction
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enables the production of large amounts of specific sequences of
target DNA from small quantities of starting material. Next, the
DNA can be identified by several techniques (Clarke 1992; Rapley
1992; Garvin 1995; Mariani 1998). The disadvantage of the tech-
nique of polymerase chain reaction is susceptibility to contamina-
tion. Whether this technique is too sensitive, leading to a high rate
of false-positive results, remains to be determined (Nijhof 1998). 
2.5.5. Peroperative judgement of infection
Even though preoperative investigations have been normal,
some arthroplasties may appear to be infected to the surgeon during
the operative procedure. Formation of an abscess and pus are the
most obvious signs of infection. Signs such as a diffuse synovitis,
turbid joint fluid and formation of slime are all suspicious. Keeping
in mind that preoperative investigations are not 100 per cent accu-
rate, the appearance of the joint is occasionally so clearly suspicious
for infection that the surgeon will not proceed with a normal sin-
gle-stage exchange procedure. However false impressions do occur.
For example, severe accumulations of wear debris can induce a
reaction that is similar in macroscopical appearance to that of an
infection.
There are various options for patients in whom the macroscopic
appearance looks like an infection, despite negative findings of pre-
operative investigations. The first option is to remove the prosthe-
sis, obtaining multiple cultures and performing a radical debride-
ment. The postoperative clinical situation of the patient and the
results of the cultures should then either lead to the decision to cre-
ate a definitive Girdlestone situation or to do a two-stage exchange.
A second option is to leave the prosthesis in place, obtain multiple
specimens for culture and reoperate at a later date after the results of
the cultures are available. The last option is to perform a one-stage
exchange procedure after a radical debridement. The results of the
peroperative cultures should direct decisions as to the necessity of
further antibiotic treatment (Spangehl 1998).
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2.5.6. Histological examination
For diagnosing infection, peroperative frozen sections of
periprosthetic tissue have become a valuable tool. Mirra et al. stated
that five polymorphonucleair leukocytes per high-power field is
conclusive for the diagnosis of infection and that lack of polymor-
phonucleair leukocytes is conclusive for absence of infection (Mirra
1976). Various investigators reported a sensitivity of more than 0.80
and a specificity of more than 0.90 (Athanasou 1995; Feldman 1995;
Lonner 1996; Spangehl 1999). However, Fehring reported a much
lower sensitivity for the use of frozen sections in the diagnosis of
infection (Fehring 1994; Fehring 1996). It is important that tissue
samples should be taken from the areas that appear to be actually
infected. In addition, as a result of substantial interobserver varia-
tions, the pathologist should be experienced in preparation and
interpretation of the specimens (Spangehl 1998). The sensitivity of
frozen sections at the time of reoperation, for the detection of per-
sistent infection after resection arthroplasty and treatment with
antibiotics, is however poor (Della Valle 1999a).
2.6. Treatment of the infected prosthesis 
(Table 2.4)
2.6.1. Antibiotics without surgical treatment
Antibiotic treatment without operative intervention is most
commonly used in an attempt to achieve chronic suppression of a
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Table 2.4. 
Overview of the various
options for treatment of
an infected arthroplasty.
Antibiotics are always
indicated.
Treatment options
Antibiotics No surgical treatment
Debridement Prosthesis remains in situ
One-stage revision Surgical debridement plus exchange arthroplasty
Two-stage revision Removal of the prosthesis, surgical debridement and exchange
in a second stage
Resection arthroplasty Removal of the prosthesis and surgical debridement
Disarticulation Separation of the leg
Arthrodesis Fusion of the hip
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prosthetic infection. This treatment is used in patients who are
medically unfit to undergo a major operation or when they refuse
an operative treatment (Goulet 1988; Segreti 1998). The infection is
suppressed so that the symptoms are minimised, but it is not eradi-
cated. The infecting organism must be known and must be sensi-
tive for the used antibiotics. The selected antibiotics should be
effective orally and should be well tolerated by the patient. Side
effects such as diarrhoea and the emergence of resistant strains are
the most common causes of failure of this treatment.
2.6.2. Debridement without removal of the prosthesis
Direct postoperative and acute late haematogenous infec-
tions can be treated with adequate debridement and appropriate
systemic antibiotics. Tsukayama et al. (Tsukayama 1996) emphasised
the importance of limiting this method of treatment to early post-
operative infections that had developed less then one month post-
operatively. Seventy-one per cent of the infections that developed
less than one month after the operation were eradicated by debride-
ment and intravenous administration of antibiotics.
The primary difficulty appears to be the lack of accuracy with
which acute infections can be distinguished from the chronic ones.
Patients in whom the distinction between acute and chronic infec-
tion cannot be made with confidence should be managed as if they
have a chronic infection (Masterson 1998).
2.6.3. One-stage exchange arthroplasty
The one-stage exchange procedure was introduced by
Buchholz and Gartman in 1972. This treatments consist of excision
of the infected components, surgical debridement, and an immedi-
ate reconstruction with a cemented arthroplasty (Buchholz 1972). 
A one-stage procedure could be desirable because of the avoidance
of additional operative procedures. This is particularly important for
patients who have several major medical problems, for whom the
risks of additional procedures are high. However, the potential
advantages must be weighted against the slightly lower rates of
eradication of infection that are observed after one-stage compared
with two-stage procedures. The difficulty of removing a solidly
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fixed cemented prosthesis without destroying the remaining bone
stock can be a problem. Especially when bone stock is deficient, the
insertion of an implant with cement is not appropriate in many
revision procedures (Masterson 1998).
Garvin and Hansen summarised results of one-stage exchange
arthroplasties (Garvin 1995). They found that the cumulative suc-
cess rate from sixteen reports of these procedures performed with
antibiotic-impregnated cement was 82 per cent. The cumulative
success rate from four reports of one-stage exchange arthroplasty
performed without local delivery of antibiotics was 58 per cent.
2.6.4. Two-stage exchange arthroplasty
The main aspects of a two-stage exchange arthroplasty
include removal of the implant including all cement, and dead or
necrotic tissue. Usually, antibiotic loaded bone cement (beads or a
cement spacer) is left behind. Intravenous antibiotics are adminis-
tered postoperatively. In a second stage a new prosthesis is
implanted.
The success of eradication of infection after a two-stage procedure
is higher as compared with a one-stage exchange procedure. Garvin
and Hanssen (Garvin 1995) reported the cumulative rate of eradica-
tion of infection to be 91 per cent in a review of twelve reports of
two-stage exchange procedures in which antibiotic-impregnated
cement was used. As mentioned in the previous paragraph, the suc-
cess rate from sixteen studies of one-stage procedures with antibio-
tic-impregnated cement was 82 per cent.
There is no consensus on duration and the route of administration
of antibiotic therapy. Some evidence exists that the use of intra-
venous therapy for less than four weeks is associated with a higher
rate of recurrence when the infection is caused by highly virulent
organisms, such as gram-negative bacilli and group-D streptococci
(McDonald 1989). Most protocols have included six weeks of intra-
venous administration of antibiotics (Tsukayama 1996), which is
considered to be more reliable than oral administration.
There is also no consensus on the interval between the first and the
second stage. This is, of course, also dependent upon various clini-
cal and bacteriological parameters. This interval is reported to vary
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widely, from 6 days to more than 6 years postoperatively
(McDonald 1989).
The use of bone allograft for reconstruction after an infection is
associated with a higher rate of recurrent infection because the allo-
graft might act as a sequestrum. Therefore major bone loss has been
regarded by some authors as a contraindication for reimplantation
after an infection (Salvati 1982a).
Most centres described results of reimplantation using components
inserted with cement. Nestor et al. (Nestor 1994) and Lai et al. (Lai
1996) described results of two-stage exchange procedures that were
performed with a cementless prosthesis. In these studies, infection
recurred in 18 per cent and 13 per cent, respectively.
2.6.5. Resection arthroplasty
Resection arthroplasty or Girdlestone procedure may be the
most appropriate definitive treatment for patients who are psycho-
logically or medically unfit to have an additional reconstructive
procedure and those who are mentally unable to cooperate with
the postoperative restrictions and rehabilitation protocols after a
complex reconstruction. Also a severe deficiency of bone stock and
poor quality of local soft tissue are indications for an excision
arthroplasty (de Laat 1991; Lieberman 1994).
This procedure is highly effective in controlling the infection and
reducing pain (Bourne 1984; McElwaine 1984; Grauer 1989;
Forgon 1990; de Laat 1991; Castellanos 1998). However, it is also
associated with a considerable loss of function. After an excision
arthroplasty patients walk poorly, with a frequent need for walking
aids (Ahlgren 1980; Bittar 1982; Bourne 1984; McElwaine 1984;
Grauer 1989). Patients have a prominent lurching gait, velocity and
cadence are reduced, and their energy expenditure is increased
(Waters 1987). In addition, patients need external shoe-lifts because
of limb-shortening, varying from 3 to 11 centimetres (Ahlgren
1980; Bourne 1984; Grauer 1989; Castellanos 1998). In summary,
the Girdlestone procedure is a reasonable salvage operation for
some complications following hip surgery, but as a result of the
considerable impairment of function, reimplantation of a total hip
prosthesis is recommended whenever possible (Schroder 1998).
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2.6.6. Other options
Arthrodesis of the hip after a periprosthetic infection has been
reported by Kostuik and Alexander (Kostuik 1984). Indications for
the procedure were a relative absence of bone and poor quality of
the local soft tissues. This treatment was chosen in seven, relatively
young male persons with strenuous functional demands. All hips
fused. Although they had a mean leg-length discrepancy of 4.6 cen-
timetres, all patients were able to walk.
Disarticulation at the hip or amputation also has been reported, but
fortunately it is rarely performed. Indications are life-threatening
infection, severe loss of soft tissue and bone stock and vascular injury
(Fenelon 1980).
2.6.7. Future treatments
Improvement of antimicrobal therapy by new systems for the
local delivery of antibiotics is one of the areas of development. The
goal is to achieve local therapeutic bactericidal concentrations of the
drugs (Garvin 1994b). The advantages are that clinical parental thera-
py is not necessary and patients can be discharged from hospital soon-
er. One-stage therapy may be facilitated with the use of this tech-
nique. Also the local therapy would minimise the risk of systemic
toxicity which is associated with long-term intravenous therapy
(Callaghan 1985; Garvin 1994b).
Another area of improvement includes the possibility to amplify cell-
mediated immune responses against infection (Myrvik 1993). Patients
may be managed prophylactically by activation of a natural initiating
mechanism for amplification of the cell-mediated immune response.
Research will determine the effectiveness of priming of macrophages
as an immune augmentation against pathogens that are most likely to
be encountered at the time of hip arthroplasty (Myrvik 1993).
2.7. Microbiological aspects of implant related
infections
In the pathogenesis of infection, adhesion of bacteria to the
surface of human tissue or an implanted biomaterial surface is an
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important step (Gristina 1983; Fitzgerald 1989; Sugarman 1989; An
1996a). However, the exact mechanisms by which such infections
occur still remain unclear. It is well known that after adherence of
certain strains of bacteria to an implant surface, a layer of slime can
be secreted, which makes bacteria less accessible to the host defence
system (Gray 1984; An 1996a) and decreases antibiotic susceptibility
significantly (Sheth 1985; Gristina 1987b; Gristina 1989; Naylor
1990). These bacteria can remain “quietly” on the surface of a
material for a long period of time. However, when environmental
influences, such as a decreased host immune function or poor tissue
ingrowth around a prosthesis, change, these bacteria can result in a
manifest clinical infection. The adhesion of bacteria is a very com-
plicated process. Besides the characteristics of the bacteria itself, sur-
face factors of the target material and environmental factors affect
this process. In the following paragraphs, various aspects related to
bacterial adhesion and colonisation in relationship with
(orthopaedic) implants will be described.
2.7.1. Bacterial characteristics
Bacterial capsules
Bacterial capsules are firmly adherent as a discrete covering
layer with a distinct margin on the bacterial cells at the outside of
the cell wall. They can be seen as a clear zone surrounding the bac-
terial cell and are separated from extracellular slime. Most capsules
are composed of polysaccharides and proteins (Sutherland 1983).
According to a number of studies, cell surface polysaccharides and
proteins act as bacterial adhesins (Hogt 1986; Kroncke 1990).
Surface hydrophobicity of different encapsulated coagulase-nega-
tive staphylococci (CNS) differs. The presence of a more
hydrophilic capsule reduces adhesion (Hogt 1983). Several studies
have suggested that the capsules of Staphylococcus aureus and
Staphylococcus epidermidis are both important factors in the pathogen-
esis of infection with these bacteria (Smith 1977; Ichiman 1981).
Bacterial surface structures
Surface structures of bacteria are distinguished in flagella, sex
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pili, fimbriae and fibrillae.
Flagella are long helical filaments extending from the cell surface,
which generate propulsive forces and enable bacteria to move in
their environment. Their diameter is 15-20 nm and they may be as
long as many times the length of the bacterial cell. Flagella are com-
posed of many polypeptides that form a filamentous hook and a
complex basal body that interacts with both outer and inner mem-
branes (Beveridge 1981).
Fimbriae (or pili) are a group of rigid, straight, filamentous
appendages on a bacterial surface. (Figure 2.2) They are 3-8 nm in
diameter and may be as long as 15-20 µm. There are generally sev-
eral hundred fimbriae over the entire surface of the bacterial cell.
Fimbriae arise from proteins in the outer surface of the outer mem-
brane and may stretch out for large distances beyond the outer
membrane (Brinton 1965). Bacterial fimbriae are polymers consist-
ing of identical protein subunits (Jones 1983). They are best charac-
terised in Gram-negative bacteria and are accepted as a major adhe-
sive structure on the bacterial surface. Those who are responsible
for adhesion to other bacteria are called ‘sex pili’. These fimbriae
contain structures, which are responsible for adhesive activities
(adhesins). These adhesions or adhesive submits may mediate bacte-
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Figure 2.2 
Transmission electron
micrograph, showing the
surface structure of a
Staphylococcus epidermi-
dis cell, clearly demon-
strating filamentous
“fimbriae-like” surface
appendices. Black dots
depict immuno-gold
labelling of an adhesin for
polymer(polysterene) sur-
face. Bar = 0.1 µm.
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rial adhesion (de Graaf 1988; Hoschutzky 1989). Fimbriated bacte-
ria are also often more hydrophobic than non-fimbriated ones.
Hydrophobicity is also dependent on the type of fimbriae (Lindahl
1981), and adhesion is mediated by fimbriae-dependent surface
hydrophobicity. In summary, it is believed that bacterial fimbriae
are related to virulence, and bacteria that possess fimbriae are more
infectious than their non-fimbriated variants (Klemm 1985).
Fibrillae are more amorphous surface adhesive structures. They
have not the regular filamentous forms of fimbriae. Fibrillae are
seen at the surface of various streptococci and they are thought to
provide a better adhesion onto hydroxyapatite substrata (Phillips
1981). 
Slime and glycocalyx
The extracellular substance produced by the bacteria is
defined as “slime” (Figure 2.3). Capsules and slime are both sub-
classes of extracellular polymeric substances and are usually polysac-
charides. A glycocalyx is defined as the accumulated biomass of
bacteria and their extracellular substances (slime) on a solid surface
(An 1998). In addition to adhesion, slime production of bacteria
appears to play a primary role in the pathogenesis of most prosthesis
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Figure 2.3 
Scanning electron micro-
graph, showing slime
layer produced by 
coagulase-negative
staphylococci on the sur-
face of a polyethylene
catheter. 
Bar = 4 µm (From
Peters 1982, reprinted
with permission)
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infections (Dougherty 1989; Tsai 1992). Bacterial strains that do not
produce slime are less adherent and less pathogenic (Christensen
1982; Christensen 1983; Davenport 1986). Slime is thought to be
important for intercellular connection during surface colonisation.
The current concept is that the production of slime will be espe-
cially important for events after the initial phase of adhesion, which
include colonisation of various surfaces, protection against phago-
cytosis, interference with the cellular immune response (Buret
1991), and protection against antibiotics (An 1998).
Physicochemical characteristics of bacteria
The adherence characteristics of a specific bacterial strain are
dependent upon the specific physicochemical characteristics of the
substrate (material surface) and the bacteria. These physicochemical
characteristics of bacteria, such as hydrophobicity and surface
charge, differ for various species and strains.
Hydrophobicity of bacterial surface
Hydrophobicity of the bacterial surface is an important physical fac-
tor for adhesion. This is particularly the case when surfaces of the
materials are either hydrophilic or hydrophobic. Growth medium,
bacterial growth phase, and bacterial surface structure influence the
hydrophobicity. In general, it can be said that bacteria with
hydrophobic surface properties adhere preferentially on hydropho-
bic material surfaces; the ones with hydrophilic characteristics
adhere preferentially on hydrophilic surfaces (Hogt 1983; Satou
1988a; Satou 1988b). Usually, hydrophobic bacteria adhere to a
greater extent than hydrophilic bacteria (van Loosdrecht 1987b).
Surface charge of bacteria
Another physical factor for bacterial adhesion is the bacterial surface
charge (Hogt 1985). Most particles acquire an electric charge in
aqueous environment due to the ionisation of their surface mole-
cules/groups. The surface charge attracts ions of opposite charge in
the medium and results in the formation of an electric double layer.
A high surface charge is accompanied by a hydrophilic characteris-
tic of the bacteria, but a hydrophobic bacterium may still have a
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rather high surface charge (Hogt 1985). The surface charge of bac-
teria is influenced by growth medium, bacterial growth phase and
bacterial surface structure and varies between bacterial species.
Long-range electrostatic forces may influence the initial attachment
of bacteria onto solid surfaces. However, several studies of bacterial
adhesion have shown that adhesion of many bacteria to different
surfaces was not significantly affected by the relative surface charge
of the bacteria (Abbott 1983; Hogt 1985; Harkes 1991). This in
contradiction to several other studies, which showed that bacterial
surface charge does affect adhesion of bacteria to different surfaces
(van Loosdrecht 1987a; Gilbert 1991).
2.7.2. Material characteristics
In addition to the characteristics of the bacterial surface, the
surface of the substrate or material is a determining factor in bacter-
ial adhesion and colonisation. Such material surface parameters
include chemical composition of the material, surface roughness or
physical configuration, surface charge, and hydrophobicity. Also,
surface energy, empty binding sites and hydrophobic and
hydrophilic characteristics can be quickly altered by either the
absorption or binding of serum proteins and formation of biofilms
(Gristina 1987a).
Chemical composition of the material
Several experiments have been performed in vitro and in vivo
to investigate the role of chemical composition and the adherence
of bacteria. Polymethylmethacrylate (PMMA) usually appears as the
material most prone to infection. Metals, such as titanium and
cobalt-chromium are the materials most resistant to infection. The
number of adherent bacteria that bind to the surface of a certain
material is dependent upon the strain of the bacteria. According to
most studies, Staphylococcus epidermidis preferably adheres to poly-
mers and Staphylococcus aureus to metals.
Petty et al. (Petty 1985) studied in a dog model infection by perop-
erative contamination with Staphylococcus epidermidis, Staphylococcus
aureus, or Escherichia coli of stainless steel, cobalt-chromium alloys,
high-density polyethylene or PMMA. PMMA was found to be
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infected easier than all other implants with Escherichia coli and
Staphylococcus epidermidis. All other implants were significantly more
likely to be infected with Staphylococcus aureus. Oga et al. (Oga
1988) demonstrated in an in vitro study that PMMA was colonised
by Staphylococcus epidermidis in higher numbers as compared to stain-
less steel and alumina ceramic. Barth et al. (Barth 1989) investigated
in vitro and in vivo in a subcutaneous rabbit model the susceptibility
to infection of PMMA, ultra-high molecular weight polyethylene
(UHMWP) and a titanium alloy (Ti6Al4V). Staphylococcus epider-
midis preferentially colonised pure polymers (PMMA), while
Staphylococcus aureus preferentially colonised titanium alloy.
According to Oga et al. (Oga 1993), in vitro adherence of
Staphylococcus epidermidis was higher to sintered hydroxyapatite than
to stainless steel, Ti6Al4V and hydroxyapatite coated Ti6Al4V.
Adherence to the HA-coated Ti6Al4V was slightly higher as com-
pared to stainless steel or titanium alloy. Verheyen et al. (Verheyen
1993) evaluated in an in vitro study bacterial adherence on stainless
steel, a polymer poly(L-lactide) (PLLA) and a composite hydroxy-
apatite/poly(L-lactide) (HA-PLLA), both as smooth and sandblasted
specimens. All materials were challenged with Staphylococcus aureus
or Staphylococcus epidermidis (Figure 2.4). Staphylococcus aureus
showed a preference for the stainless steel and HA-PLLA. For
Staphylococcus epidermidis no clear preference was found for one of
the investigated materials. However, Chang and Merritt found in a
comparative study that the in vitro adherence of Staphylococcus epider-
midis was highest for stainless steel, followed by PMMA and pure
titanium. In in vivo studies of subcutaneous implantation in Syrian
hamsters, the same pattern was found (Chang 1994). Arens et al.
(Arens 1996) investigated in vivo the susceptibility to infection of
plates of either stainless steel or titanium in rabbit tibiae. A strain of
Staphylococcus aureus was inoculated percutaneously. The rate of
infection for steel plates was significantly higher than that for titani-
um plates. Cordero performed various in vivo experiments on
implant infections using rabbits. In one study, he demonstrated that
polished-surface cobalt-chrome cylinders required slightly less bac-
teria to become infected than polished-surface Ti6Al4V cylinders
(Cordero 1994). Gracia et al (Gracia 1997) tested in an in vitro study
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the adherence of Staphylococcus aureus to PMMA, fresh bone, stain-
less steel and titanium alloys. The lowest overall adherence was
found to PMMA and bone, and the highest to stainless steel and
titanium alloy. No differences were found between adherence of
Staphylococcus aureus to stainless steel and titanium alloy. Hauke et al.
(Hauke 1997) observed the rate of infection in a rabbit model
where solid nails of stainless steel or titanium were implanted in the
medullary cavity of the tibia and contaminated with Staphylococcus
aureus. In contradiction to the findings of Gracia et al. (Gracia
1997), they found a difference of infection rate between stainless
steel and titanium: the rate was higher for stainless steel than for
titanium.
Roughness of the material
Surface roughness is determined by measurement of the dis-
tance between peak and valley part on a material surface, and it
should be realised that it does not represent the actual morphology
of the surface. Several studies indicate that increased surface rough-
ness promotes bacterial adhesion (McAllister 1993; Quirynen 1993;
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Figure 2.4 
Scanning electron micro-
graph, showing a
hydroxyapatite coating
covered with Staphylo-
coccus epidermidis. 
Bar = 10 µm.
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Verheyen 1993; Cordero 1994). One of the explanations for this
phenomenon is that a rougher surface has a higher surface area and
the depressions in the roughened surfaces provide more favourable
sites for colonisation.
Porosity of the material
The physical configuration or porosity of a material surface is
considered as a morphological description of the pattern of a mate-
rial surface. It can be evaluated by scanning electron microscopy.
Merrit et al. (Merritt 1979) and Locci et al. (Locci 1981) found that
implant site infection rates are obviously different between porous
and dense dental materials and are much higher for porous materi-
als. This implies bacteria adhere and colonise the porous surface
preferentially. This can be explained by the much greater surface
that the porous-coated implants offer for bacterial adherence, but
also by a lower accessibility for host defence systems.
Physicochemical characteristics of material: surface
hydrophobicity or wettability
Polymers such as UHMWP or Teflon have a low surface
energy and are less electrostatically charged and hydrophobic. Metal
surfaces have a high surface energy, are negatively charged and
hydrophilic (An 1993). Bacteria adhere differently to materials with
different hydrophobicities, depending on the hydrophobicity of
bacteria as well as material surfaces (Hogt 1983; Satou 1988b).
Hydrophobic materials are more prone to bacterial adhesion than
hydrophilic materials (Hogt 1983; Ludwicka 1984; Pringle 1986).
Coating substrata surfaces with proteins, such as bovine serum albu-
min (BSA), bovine glycoprotein, or fatty-acid free BSA decrease
surface hydrophobicity, leading to a decrease in bacterial adhesion
to the surfaces (Fletcher 1982).
2.7.3. Environmental aspects
General environment
Several factors in the general environment, such as tempera-
ture, duration of exposure, bacterial concentration (“load”), chemi-
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cal treatment, and the presence of antibiotics, have shown to affect
bacterial adhesion.
It was found that adhesion of Streptococcus faecium increased with
increasing temperature (up to 50°C) (Orstavik 1977). The number
of bacteria adhering to a material increased with time until they
reached a saturation level which was specific for that type of mater-
ial (Orstavik 1977; Satou 1988b). Adhesion of bacteria increases
with increasing cell concentration (Orstavik 1977). Hogt et al.
found that treatment of Staphylococcus epidermidis with pepsin or
extraction with aqueous phenol resulted in a decreased adhesion on
fluorinated poly(ethylenepropylene), a biomaterial used in various
biomedical applications (Hogt 1983). A culture of Staphylococcus epi-
dermidis in subinhibitory concentrations of cephalothin, clin-
damycin and vancomycin resulted in a 30 to 80 per cent reduction
in adhesion (Pascual 1986). 
Electrolyte concentration (Orstavik 1977; Abbott 1983), CO2
(Denyer 1990) and changes in pH value (Orstavik 1977; Gordon
1981) influence the nature of the bacterial surface and with that the
process of bacterial adhesion. All of these factors may influence bac-
terial adhesion by changing surface characteristics of bacteria or
materials. 
Serum or tissue proteins
Several investigations have been performed to study the
effect of serum and tissue proteins, such as albumin, fibronectin,
laminin and denatured collagen, on bacterial adhesion to material
surfaces (Fletcher 1976; Vaudaux 1984a; Vaudaux 1984b; Kuusela
1985; Pratt-Terpstra 1987; Muller 1991; McDowell 1995; An
1996a). Adhesion of bacteria is promoted or inhibited by serum and
tissue proteins, either by binding to material surfaces, binding to the
bacterial surface, or being present in the surrounding medium dur-
ing the adhesion process. When present in surrounding medium,
most proteins inhibit bacterial adhesion (Fletcher 1976; Brokke
1991), possibly affecting bacterial adhesion by their association with
bacterial cell surface, the material surface, or both. Most of the asso-
ciations between bacteria and proteins are specific ligand- and
receptor-like interactions. Also the adherent behaviour of bacteria
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may be changed by these proteins, by changing bacterial surface
physicochemical characteristics (Miorner 1980; Reynolds 1983;
Pascual 1986).
Whole serum
The adhesion of various CNS onto plasma coated fluorinated
poly(ethylenepropylene) (FEP) was studied by Hogt et al. (Hogt
1985). The adhesion of all strains onto plasma coated FEP appeared
to be much lower than onto the untreated control surface. Pascual
et al. found that preincubation of Teflon catheters in human serum
caused an 80 to 90 per cent reduction of adhesion of Staphylococcus
epidermidis (Pascual 1986). Preincubation of Staphylococcus epidermidis
in serum similarly decreased adhesion. This effect of serum was
mainly due to albumin, while IgG and fibronectin were less effec-
tive (Pascual 1986). Similar effects were also found when polymers
were preincubated with plasma or albumin (Paulsson 1993).
Fibronectin
Fibronectin is a glycoprotein found in human sera and extracellular
matrix. In addition to its ability to mediate surface adhesion of
eukaryotic cells, it has also been shown to bind to Staphylococcus
aureus (Kuusela 1978). Staphylococci can be saturated with
fibronectin to a level that suggests the presence of specific receptors
(staphylococcal fibronectin-binding molecules) on bacterial cells
(Espersen 1982; Ryden 1983; Maxe 1986). A Staphylococcus aureus
binding domain of fibronectin was indeed found in the fibronectin
molecule (Mosher 1980; Bozzini 1992). Therefore, fibronectin
clearly promotes Staphylococcus aureus adhesion to the substratum
surface (Vaudaux 1984a; Vaudaux 1984b; Kuusela 1985; Maxe
1986) and plays an important role in foreign body infections
(Vaudaux 1984a). Although strain specific, adherence of clinical
staphylococcal isolates to intravenous device (Herrmann 1988) or
orthopaedic biomaterial (Delmi 1994) was significantly increased by
fibronectin, suggesting the possible contribution to infection.
However there are controversies regarding the fibronectin effect on
Staphylococcus epidermidis adhesion to material surfaces. Herrmann et
al. found that fibronectin promoted the adherence of all
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Staphylococcus aureus strains, but only in 4 out of 19 strains of
Staphylococcus epidermidis (Herrmann 1988), while Naylor and col-
leagues found that fibronectin can inhibit Staphylococcus epidermidis
adherence to cobalt-chrome alloy and PMMA surface with 90 per
cent (Naylor 1989b).
Albumin
Albumin adsorbed on surfaces of polymer (Hogt 1985; Pascual 1986;
Paulsson 1993), ceramic (Gibbons 1983) and metal (McDowell
1995; An 1996a; An 1996b) showed inhibition of bacterial adhesion.
It is thought that most of the proteins reduce adhesion through
adsorption to the substrata surface, while serum albumin also inhibits
the adhesion by means of binding to the bacterial cells (Brokke
1991). The mechanism of the inhibiting effect of albumin bound to
either surface is not clear. Bacterial adhesion may be reduced by
albumin by changing substratum surface hydrophobicity, because in
the presence of dissolved and absorbed bovine serum albumin, the
substrata surface became much less hydrophobic (Reynolds 1983). 
An et al., reported that a cross-linked albumin coating applied to
commercially pure titanium implants reduced the prosthetic infec-
tion rate in rabbits. It was concluded that a crosslinked albumin
coated prosthesis may represent a new method for preventing pros-
thetic infection (An 1997).
Fibrinogen
Fibrinogen also mediates bacterial adhesion onto biomaterials and
host tissues. Most studies showed that especially for staphylococci,
adsorbed fibrinogen promotes adherence to biomaterials (Herrmann
1988; Flemming 1993). However, fibrinogen markedly promotes
adherence of all Staphylococcus aureus strains but only a few coagu-
lase-negative strains (Herrmann 1988). According to Vaudaux et al.
fibrinogen is less active in promoting Staphylococcus aureus adherence
to intravascular catheters than fibronectin (Vaudaux 1993).
Laminin
Laminin is a major component of basement membranes. It was
shown to bind to some strains of Streptococcus pyogenes (Switalski
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1984). Laminin has a promoting effect on the adhesion of
Staphylococcus aureus and coagulase-negative strains to PMMA cov-
erslips but to a lesser extent compared to the effects of fibronectin
and fibrinogen (Herrmann 1988).
Other proteins or factors
Other proteins that influence attachment or adhesion of bacteria to
a material surface are gelatin (Fletcher 1976) and pepsin (Fletcher
1976; Pascual 1986). They impaired the adherence of bacteria. Basic
proteins such as histone and poly-L-lysin facilitate adherence of
Streptococcus mutans, whereas acidic proteins such as, phosvitin, b-
lactoglobulin and poly-L-glutamate have been shown to inhibit
adhesion (Reynolds 1983).
Specific adhesion by bacterial adhesins to host receptors
The selective binding between bacterial adhesins (a specific
molecular component on the bacterial surface) and the substratum
receptor (a specific component on the material surface) is defined as
specific adhesion. It is less affected by many common environmental
factors such as electrolytes, pH, or temperature. Specific adhesion of
bacteria by polysaccharide adhesins (Tojo 1988), proteinaceous
adhesins (Timmerman 1991) and hemagglutinins (Rupp 1992) is
believed to play a major role in the pathogenesis of prosthetic infec-
tions.
A capsular polysaccharide adhesin from Staphylococcus epidermidis
(strain RP-62A) was isolated by Tojo et al. (Tojo 1988).
Timmerman et al. found a proteinaceous adhesin of a strain of
Staphylococcus epidermidis (strain 354) that mediated the adhesion of
this bacterium to polystyrene (Timmerman 1991). Rupp and Archer
showed that hemagglutinins either play a direct role in adherence to
polymers and thus prosthetic-device infection or serve as an easily
demonstrable marker for adherence-prone isolates (Rupp 1992).
Morris and McBride demonstrated that saliva-coated hydroxyapatite
has two specific receptors for Streptococcus sanguis (Morris 1984).
Specific adhesion was also demonstrated by Bayer et al. in 1983 by
studying the process of Clostridium thermocellum adhesion to cellulose
(Bayer 1983).
CHAPTER 2
39
2.7.4. The process of bacterial adhesion
Bacteria as well as tissue cells prefer to grow on available sur-
faces rather than in the surrounding aqueous phase. Adhesion of
bacteria to the surface of a material can be distinguished in two
phases (Figure 2.5): firstly an immediate and reversible phase of
physicochemical interaction between bacteria and material, and
secondly a time dependent and irreversible phase of molecular and
cellular interactions between bacteria and material surfaces (Gristina
1987a).
Physicochemical interaction between bacteria and
material
Physical forces, such as Brownian motion, van der Waals
attraction forces, gravitational forces, the effect of surface electrosta-
tic charge and hydrophobic interactions are responsible for the
movement of bacteria to the surface of a material. Based upon the
distance between the micro-organism and the substrate, these phys-
ical interactions are classified, as long-range interactions and short-
range interactions (An 1998).
The long-range interactions are non-specific and described by
mutual forces, which are a function of the distance and free energy.
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Figure 2.5 
Molecular sequences in
bacterial (B) attachment,
adhesion and aggregation
to substratum (From
Coombs 1989, reprinted
with permission).
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Short-range interactions can be separated into chemical bonds (such
as hydrogen bonding), ionic and dipole interactions and hydropho-
bic interactions. In the first phase of bacterial adhesion, transport of
the bacteria by long-range interactions leads to attachment to the
surface. When bacteria and material surface come in closer contact,
short-range interactions become more important. The initial
attachment of bacteria to material surfaces is the first point of the
process of adhesion and makes the subsequent molecular or cellular
second phase of adhesion possible.
Molecular and cellular interaction between bacteria and
material
In the second phase of adhesion, molecular reactions
between bacterial surface and substratum surface become predomi-
nant. Bacterial surface polymeric structures, such as capsules, fim-
briae and fibrillae, result in a firmer adhesion of bacteria to a sur-
face. In fact, the functional part of these structures are the adhesins
that are parts of these structures, especially when the substrata are
host tissues (An 1998).
2.8. Closing remarks
Despite preventive measurements, because of an ageing pop-
ulation and a steady increase in the frequency of total joint replace-
ment operations, infection of an orthopaedic implant still is a source
of considerable morbidity.
It can be difficult to make the correct diagnosis of infected joint
arthroplasty with reasonable certainty, and such a diagnosis can be
reached with an acceptable certainty only by combining investiga-
tions. In most cases, an infection can be diagnosed or excluded on
the basis of a carefully obtained clinical history and the measure-
ment of the sedimentation rate and the C-reactive protein level.
Other preoperative investigations, such as radiography, arthrogra-
phy, radionuclide imaging and aspiration of the joint, and peropera-
tive investigations, such as frozen sections, gram stains and cultures,
may provide additional evidence. Peroperative cultures are most
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accurate; however, their usefulness is offset by false-positive and
false-negative results.
The choice of treatment is dependent on the health of the patient,
bone stock, quality of the soft tissues, virulence of the infecting
micro-organism and the mental state of the patient. Beside the
antibiotic treatment, other treatment options are debridement
without removal of the prosthesis, one-stage exchange arthroplasty,
two-stage exchange arthroplasty and the excision arthroplasty. Less
frequently used treatments are arthrodesis or disarticulation. 
Adhesion between cell and surfaces of materials, which involve
both bacteria and tissue cells, are critical, interrelated and based on
similar molecular mechanisms. Biomaterial surfaces represent avail-
able, unbonded energy sites or potential receptor sites for colonisa-
tion by bacteria or by normal tissue. At the moment of implanta-
tion, a biomaterial or allograft surface presents the available free
energy sites which await physical or chemical bonding, first from
ambient protein molecules and subsequently, or concomitantly,
from available cells.
The theory of the “race for the surface” suggests competition
between tissue and bacterial cells for implant material surfaces
(Gristina 1988). Successful colonisation by one cell type favours
dominance and exclusion of later arrivals. If tissue cells arrive first at
a biomaterial surface and a secure bond is established, bacteria will
be confronted by living, integrated cells. If not traumatised or
altered, an integrated tissue cell is resistant to bacterial colonisation
by virtue of its viability, intact cell membranes, extramembranous
polysaccharides and host defence mechanisms. If however, bacteria
arrive at the surface first and colonise the biomaterial, an infection
will develop. Such biomaterial infections almost always prevent
successful integration of the implant.
Biomaterials are susceptible to infection because they are not well
integrated for the most part. Well-integrated devices are infre-
quently infected unless an unfavourable situation is created by per-
turbed host defences, trauma or exposure to massive infecting ino-
culi.
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CHAPTER 2
The Outcome of Therapy of
Osteomyelitis in Children.
A Retrospective Study of
28 Patients
3CHAPTER
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3.1. Introduction
Osteomyelitis is a serious disease, seen in patients of every
age. The bone is infected by bacteria either directly or, more fre-
quently, via haematogenous contamination. Staphylococcus aureus is
the primary pathogen, responsible for most cases. Any bone can be
involved, although it is most frequently seen in the distal femur and
proximal tibia. Deterioration to chronic osteomyelitis is usually
associated with a delay in treatment. Spontaneous evacuation of pus
to an adjacent joint may lead to a septic arthritis, with serious dam-
age of this joint as result. Also local extension into subcutaneous tis-
sue, sometimes with spontaneous discharge of pus through the skin,
may occur. The process of bone destruction may lead to weakening
of the bone and a pathologic fracture. Disturbances of growth can
be expected when the growth plate is involved.
Clinically, osteomyelitis is suggested by the history and symptoms
of the patient. In children, there is usually an acute presentation
with high fever and local signs of inflammation, three weeks or less
in duration. The affected area is painful, warm, red, swollen and
frequently there is diminished function. Infection parameters such
as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)
and white blood-cell count (WBC) are usually increased.
However, in up to 50 percent of children the presentation is
reported to be more chronic, with vague complaints, for example
limb pain of 1 to 3 months in duration. In contrast to children, in
adults the presentation is usually more chronic. Both in adults and
children with chronic osteomyelitis, clinical signs are less pro-
nounced and the infection parameters may be normal.
Radiographs may show swelling of the soft tissues at an early stage
of osteomyelitis, but it usually takes 2 to 3 weeks after the clinical
onset of disease for typical radiographic changes, such as bone
destruction and subperiostal bone formation, to appear. If the diag-
nosis is unclear, bone scintigraphy, CT-scan and especially MRI
may be helpful.
There is no consensus in the literature about the optimal treatment
of osteomyelitis, especially with respect to the decision on surgical
intervention. Some do not advocate surgical treatment in an early
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stage. According to our protocol we perform surgery in every
child, including drainage and obtaining samples for microbiologic
determination. The range of duration of antibiotic therapy as rec-
ommended in the literature is fairly wide, namely 2 to 12 weeks,
but is usually 4 to 6 weeks. In our hospital we adhere to a protocol
of 2 to 3 weeks intravenous therapy followed by 3 weeks oral
antibiotics.
The purpose of this retrospective study was the evaluation of the
outcome of therapy in children with osteomyelitis. Special empha-
sis was given to cure and to recurrence.
3.2. Materials and Methods
We reviewed patient records of children admitted to the
Wilhelmina Children’s Hospital between 1985 and 1995 with the
diagnosis of osteomyelitis. Children who were primarily treated in
other hospitals were not included in this study. Also, the children
diagnosed with spondylitis or with concomitant septic arthritis were
not included. Consequently a total of 28 children were reviewed.
The records were screened for history, clinical presentation and
diagnostic work-up. According to definitions proposed in the
orthopaedic literature (Crenshaw 1992), patients were separated as
having either an acute or chronic haematogenous osteomyelitis and
this separation was primarily based on clinical criteria as defined in
Table 3.1. Subsequently, treatment and outcome were evaluated.
THE OUTCOME OF THERAPY OF OSTEOMYELITIS IN CHILDREN
Table 3.1. 
Diagnosis of acute and
chronic osteomyelitis.
WBC = white blood-cell
count; ESR = erythro-
cyte sedimentation rate.
Acute Osteomyelitis Chronic Osteomyelitis
Pain Severe Mild
Illness Fever, malaise No
Loss of Function Marked None or minimal
Prior Antibiotics Occasional 30-40%
Initial X-ray Bone normal Frequently abnormal
WBC Frequently elevated Frequently normal
ESR Frequently elevated Frequently elevated
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3.3. Results
The main results of our retrospective study are described in
Table 3.2. Twenty-eight children with a haematogenous
osteomyelitis were identified. We distinguished 12 patients with an
acute and 16 patients with a chronic osteomyelitis. In both groups,
the sexes were almost equally represented. The mean age of the
children with an acute osteomyelitis was 5.5 (range: 1.2-16.3) years
and with a chronic osteomyelitis 5.9 (0.8-13.6) years. The mean
duration from onset of symptoms until surgery was 8 (2-28) days for
the acute patients. For the chronic osteomyelitis patients this mean
duration was 128 (14-640) days.
In 13 children the osteomyelitis was located in the femur (n=7) and
tibia (n=6). In 6 children the infection was located in the calcaneus.
Other localisations were fibula, talus, scapula, rib, humerus, radius,
ulna and in a finger.
At admission, the mean temperature in the patients with an acute
osteomyelitis was 38.4°C and in those with a chronic osteomyelitis
37.3°C. In spite of the acute onset of symptoms in acute
osteomyelitis there were 3 patients with a temperature below 38°C,
5 patients with a temperature between 38°C and 39°C and 3
patients with a temperature above 39°C. In the group of chronic
osteomyelitis all but one patients had a body temperature below
38°C.
The laboratory values in the patients with an acute osteomyelitis
differed substantially from those with a chronic osteomyelitis. The
mean ESR, CRP and WBC in patients with an acute osteomyelitis
were 49 mm/h, 111 mg/l and 16.2x109/l, respectively. In patients
with a chronic osteomyelitis these values were 24 mm/h, 33 mg/l
and 10.0x109/l, respectively. In this last group of patients the mean
CRP was biased by a patient who also suffered from chronic renal
insufficiency needing dialysis. If we exclude this patient the mean
value of the CRP is decreased from 33 to 12 mg/l.
On plain radiographs of the affected bone no abnormalities were
seen in the patients with acute osteomyelitis, but in 50 per cent of
these cases a high density of the soft tissue was visible.
Abnormalities of the bone were seen in all patients with a chronic
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osteomyelitis. A bone scintigram was performed in 4 patients with
an acute osteomyelitis and was positive in all cases. Seven out of 9
bone scintigrams were positive in the chronic cases.
Despite examinations such as radiographs and nuclear bone scinti-
graphy, differentiation between an osteomyelitis and a bone tumour
was sometimes difficult. In these cases a CT-scan or MRI was help-
ful. (Figures 3.1 and 3.2)
Only 3 out of 16 chronic osteomyelitis cases reported clinical signs
of a previous acute osteomyelitis. Delay in diagnosis and inadequate
treatment presumably had resulted in a chronic osteomyelitis. The 
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Figure 3.1. 
X-ray and MRI of a 13
years old girl that pre-
sented with pain and
swelling of her right leg
since 14 days, just above
the knee. She was ill and
had fever. ESR and
WBC were increased. 
a. X-ray with radiolu-
cency of the metaphysis
(arrow).
b. MRI showing oedema
of the soft tissue and
bone. a
b
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remaining chronic osteomyelitis patients, including all patients with
an osteomyelitis of the calcaneus, initially presented with less pro-
nounced signs, suggesting that the osteomyelitis was chronic from
the beginning.
According to protocol all patients underwent surgical treatment. In
the patients with acute osteomyelitis decompression was achieved
by drilling holes or making a small window in the bone at the most
painful site. Samples for microbiologic examination were obtained.
In the patients with a chronic osteomyelitis, the bone was opened,
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Figure 3.2. 
X-ray and CT-scan of a
2 years old girl. She did
not use her right leg for
several months. At
examination she was not
ill, there was a local
swelling just above the
knee. 
a. X-ray showing a cyst
in the distal metaphysis
of the femur (arrow). 
b. CT-scan with a cyst
in the cortex of the bone
indicative for a Brodies
abscess (arrow).a
b
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followed by saucerisation of the bone and excision of sequestra and
abnormal tissue. After obtaining samples for microbiologic exami-
nation, in 9 out of 16 cases gentamicin beads were left. Systemic
antibiotic treatment was started immediately after obtaining the
samples.
Nine out of 12 patients with an acute osteomyelitis had positive
cultures, whereas 7 out of 16 positive cultures were seen in the
chronic osteomyelitis patients. Only 2 out of 7 blood cultures were
positive in patients diagnosed as acute osteomyelitis. Eight times
Staphylococcus aureus was cultured: 4 times in both acute
osteomyelitis and chronic osteomyelitis patients. The remaining
positive cultures in the patients with an acute osteomyelitis patients
were group A streptococci (n=2), Haemophilus influenzae (n=2) and
Fusobacterium (n=1). In the patients with a chronic osteomyelitis we
cultured also Staphylococcus epidermidis (n=2) and Propionibacterium
(n=1).
Four patients had received antibiotics prior to obtaining material
for culture in the acute osteomyelitis group and this was also the
case in 8 patients with chronic osteomyelitis. The average time of
use was 4 (1-7) and 27 (4-56) days, respectively.
The duration of treatment with intravenous antibiotics varied
between 14 and 30 days (mean 20) for patients with acute
osteomyelitis; and between 8 and 32 days (mean 20) for patients
with chronic osteomyelitis. Subsequently, oral antibiotics were pre-
scribed for an average of 22 (21-28) days in patients with acute
osteomyelitis and 25 (21-45) days for patients with chronic
osteomyelitis.
In the majority of the patients intravenous antibiotic therapy was
started with flucloxacilin and gentamicin. The definitive results of
the cultures sometimes obliged a change in the choice of antibi-
otics. The main oral antibiotics prescribed were flucloxacillin, clin-
damycin or amoxycillin/clavulanate.
There was no difference in hospital stay between the two groups.
The children with acute osteomyelitis stayed 14 to 32 days (mean
23) and with chronic osteomyelitis 12 to 32 (mean 23) days in hos-
pital.
The mean follow-up of the patients with acute osteomyelitis was
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3.7 (0.7-8.3) years. In this group no patients had a recurrence. In
two patients decreased function was observed, one patient with
osteomyelitis of the proximal phalanx of a finger and a second with
osteomyelitis of the proximal radius. The mean follow-up of the
patients with chronic osteomyelitis was 2.7 (0.4-7.6) years. One
patient, with known renal insufficiency and multiple other related
problems, had a recurrence of osteomyelitis in different other parts
of the body. One patient with an infection of the calcaneus devel-
oped a subtalair ankylosis.
3.4. Discussion
There is no universally accepted classification system for
osteomyelitis (Levine 1993). In this study the 28 children were
grouped as having either an acute (n=12) or a chronic (n=16)
osteomyelitis according to the clinical criteria as mentioned in
Table 3.1. We realise that such a classification is entirely arbitrary,
but other classifications, for example based on the time elapsed
between onset of symptoms and diagnosis, are similarly inconclu-
sive. Moreover, not every patient has the typical symptoms of an
acute or a chronic osteomyelitis, which may further complicate
classification (Dich 1975; Wedgewood 1982). It should be noted,
however, that our finding that about half of the patients present
with a more chronic picture is in agreement with some other data
from the literature (Mader 1995).
At examination, the clinical symptoms were more prominent in
patients with an acute osteomyelitis compared to patients with a
chronic osteomyelitis. Also, the infectious parameters, such as ESR,
CRP and WBC, were markedly increased in the acute osteomyeltis
group. In the chronic osteomyelitis group, the mean CRP was
biased by a patient who also suffered from a chronic renal insuffi-
ciency needing dialysis.
Despite history, clinical examination, radiographs and laboratory
findings, the diagnosis of osteomyelitis can be difficult. In such situ-
ations a technetium bone scintigram may be a useful investigation
(Gillday 1975; Howie 1983; Schauwecker 1992). Also in our study,
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the technetium bone scintigram proved to be a reliable instrument.
In 13 patients in our study bone scintigraphy was performed when
the diagnosis osteomyelitis was not clear at fist sight. The 4 bone
scintigrams in patients with an acute osteomyeltis were all positive.
In the group of chronic osteomyelitis 7 out of 9 bone scintigrams
were positive.
In 6 out of 16 patients with a chronic infection, an osteomyelitis of
the calcaneus was diagnosed. As Wang et al. described, the clinical
symptoms in these cases are less dramatic compared to the symp-
toms of an osteomyelitis of the long bones (Wang 1992). This is in
accordance with our study. Heel pain and swelling were the symp-
toms in all cases. Bone cultures were positive in only 50 per cent.
In the remaining cases the diagnosis of osteomyelitis was made by
the pathologist. All children in our study with an osteomyelitis of
the calcaneus recovered completely.
At surgery, samples were obtained for microbiological examination
by Gram stain and culture. As expected, in most positive samples
Staphylococcus aureus was cultured. In 9 patients of the acute
osteomyelitis group and 7 patients of the chronic osteomyeltis
group the cultures were positive. To eight of these 16 culture-posi-
tive patients antibiotics had been administered previously. These
data are in contradiction to the suggestion by Morrey et al. that
pre-administration of antibiotics affect the organism retrieval rates
(Morrey 1975).
Especially in acute osteomyelitis, the role of surgery has always
been controversial (Nade 1983; Dagan 1993). With Scott et al., we
believe that early decompression, by drilling holes in the bone cor-
tex, contributes to the healing of the osteomyelitis (Scott 1990). It
may interrupt progression of the infection-pressure-necrosis chain
of events. Also samples for Gram stain and culture can be taken and
in chronic osteomyelitis cases, gentamicin beads can be left behind.
The duration of antibiotic therapy is controversial. There is a great
variability in managing osteomyelitis according to different experts
(Ross 1985; Scott 1990; Dagan 1993; Frederiksen 1993; Mader
1993). There are no controlled studies that have critically assessed
the type of administration and duration of antibiotic treatment of
osteomyelitis. Our results suggest that there is no need for extend-
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ing antibiotic therapy in either group beyond 6 weeks. Currently
we start treatment by administering antibiotics intravenously for at
least 7 days. If the clinical signs improve sufficiently rapidly, i.e.
within one week, and the infectious parameters have returned to
normal values within the same period, we switch to oral antibiotic
therapy, given for another 3 weeks.
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Hip Prosthesis Infections.
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47 Patients
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4.1. Introduction
A deep infection of a total joint replacement is a devastating
complication that often results in severe morbidity and may occa-
sionally be fatal. In addition, it may have disastrous consequences
for the patient, i.e. causing disruption of his or her social life. One
to 5 percent of prosthetic joints become infected, causing tremen-
dous health care costs, due to the time-consuming and intensive
treatment that is necessary. It will be evident that it has a particular-
ly large economic impact for hospitals that treat these patients
(Sculco 1993; Barrack 1995). 
Diagnosis of infection following a total hip arthroplasty is a consid-
erable challenge. No test is 100 per cent sensitive or specific. The
diagnosis relies on the judgement of the surgeon of the clinical pre-
sentation, the findings on physical examination and the interpreta-
tion of the results of investigations (Spangehl 1998). Only recently
an attempt was made to formulate criteria for the microbiologic
diagnosis of these infections (Atkins 1998).
Depending on the mode of infection of the prosthesis, sometimes
the infection can successfully be eradicated by a debridement only.
However in most cases the prosthesis has to be removed. A new
prosthesis can be inserted immediately or later. However, more
than once a replacement cannot be performed and it is decided to
leave a Girdlestone resection arthroplasty. Always additional antibi-
otic treatment is necessary (Antti-Poika 1990; Masterson 1998).
We investigated retrospectively a population of patients who were
admitted to our hospital with a clinical diagnosis of infected hip
prosthesis, focusing at results of diagnostic studies, management of
treatment and ultimately functional outcome of the various treat-
ment categories.
4.2. Materials and Methods
We reviewed 47 patients who were treated because of a deep
infection of a hip arthroplasty at our hospital between 1988 and
1998. All patients, in whom a clinical diagnosis of prosthetic hip
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infection was made, were included in the study. The parameters
analysed were: primary preoperative diagnosis, previous surgical
procedures, risk factors for infection, clinical presentation and diag-
nostic work-up, the infecting micro-organism, surgical and antibi-
otic therapy, and outcome of therapy. The treatment modalities
were divided in three groups: (1) debridement, (2) one- or two-
stage exchange procedure and (3) resection of the prosthesis even-
tually followed by one or more debridement procedures. In addi-
tion to these modalities, all patients were treated with antibiotics.
The choice of antibiotics was guided preferably by the results of
pre- and perioperative cultures. Outcome of therapy was assessed
by evaluating recurrent signs of infection and functional clinical
studies. Thirty-four out of 35 patients alive at the time the study
was initiated, answered 5 items of a questionnaire developed by
Dawson et al., evaluating level of hip pain, walking time, limping,
work interference due to pain and use of walking aids (Dawson
1996). In addition, they were asked to score their pain on a visual
analogue scale (VAS) (Huskisson 1974). Because of neurological
problems the answers of 3 patients were excluded.
4.3. Results 
The patient characteristics are presented in Table 4.1. Of the
47 patients included in the study, 35 were female and 12 were male.
In 25 cases the right hip was infected and in 22 cases the left hip.
The series included 39 total hip arthroplasties and 8 hemi-arthro-
plasties. Twenty-nine total hip arthroplasties were cemented, 5
were cementless and 5 were hybrid. The hemi-arthroplasties were
all cemented. The primary preoperative diagnosis was osteoarthritis
in 22 hips, rheumatoid arthritis and subcapital hip fractures in 7,
avascular necrosis in 5 and congenital dysplasia of the hip, M.
Perthes, septic coxitis, psoriatic coxitis or M. Bechterew in 6 hips.
The mean age at the time of infection was 68 (range: 40-88) years.
The mean interval from the implantation of the hip arthroplasty to
infection was 43 (0.1-263.9) months. In 12 patients the infection
was diagnosed within 6 weeks; in 2 patients within 3 months and in
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7 patients within one year. In 26 patients the infected prosthesis was
inserted more than one year prior to infection. The follow-up after
onset of treatment for infection was 39.4 (6.3-119.5) months.
Eighteen patients were suffering from rheumatoid arthritis (n=7),
diabetic mellitus (n=7) or renal insufficiency (n=1), or were using
corticosteroids (n=9). Twelve patients had been operated on the
same hip once before; 5 patients had been operated more than one
time before. 
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Table 4.1.
Overview of patient 
characteristics of the 47
patients involved in the
study.
Sex
males 12
females 35
Age
years 68
Side
left 22
right 25
Primary diagnosis
osteoarthritis 22
fracture 7
rheumatoid arthritis 7
osteonecrosis 5
congenital hip dysplasia 2
M. Perthes 1
M. Bechterew 1
coxitis 1
psoriatic arthritis 1
Implant
hemi-arthroplasty 8
total hip replacement 39
Cemented vs. cementless
cemented 37
hybride 5
cementless 5
First symptoms of infection
<6 wks 12
<3 mth 2
<1 yr 7
>1 yr 26
Signs
none 2
pain 44
fever 12
pus 31
sinus 8
Risk factors
none 16
diabetes mellitus 7
rheumatoid arthritis 7
renal insufficiency 1
use of steroids 9
previous operations 16
Previously operated 
before THP
no. 17
Haematogenous infection
yes 5
possible 9
unlikely 20
direct infection 13
Died
yes 12
no 35
Follow-up
mean (mth) 39
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Table 4.2. 
Laboratory data obtained
at time of presentation of
the patients. 
ESR = erythrocyte sedi-
mentation rate (mm/hr),
CRP = C-reactive pro-
tein (mg/l) and 
WBC = white blood-cell
count (x109/l).
ESR CRP WBC
n=41 n=18 n=32
mean 59.3 86.1 10.3
range 7-140 3.5-305.0 5.1-25.6
stdev 34.6 90.1 4.5
Table 4.3. 
Micro-organisms cultured
pre- and peroperatively of
45 patients. Of two
patients the cultures
remained negative.
Micro-organism No. % 
Gram positive
Coagulase-negative staphylococci 15 25.9
Staphylococcus aureus 14 24.1
Beta-haemolytic streptococci 3 5.2
- group B streptococci (n=2)
- group G streptococci (n=1)
Viridans streptococci 3 5.2
- Streptococcus oralis (n=1)
- Streptococcus bovis (n=1)
- non-typable (n=1)
Pepto-streptococcus sp. 1 1.7
Enterococcus sp. 10 17.2
Micrococcus sp. 1 1.7
Gram negative
Proteus mirabilis 1 1.7
Pseudomonas aeruginosa 1 1.7
Escherichia coli 3 5.2
Moraxella catarrhalis 1 1.7
Enterobacter cloacae 1 1.7
Anaerobes
Propionibacterium sp. 1 1.7
Clostridium perfringens 1 1.7
Bacteroides fragilis 1 1.7
Other
Mycobacterium tuberculosis 1 1.7
Negative 2
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Pain was the presenting symptom in the great majority of patients
(44 out of 47, i.e. 94%). Twelve patients (26%) had fever and from
31 patients (66%) pus was obtained from the hip joint. Eight
patients had a draining sinus tract. The laboratory parameters (Table
4.2) showed a mean erythrocyte sedimentation rate (ESR) of 59.3
mm/hr and a mean C-reactive protein value (CRP) of 86.1 mg/l.
The mean white blood-cell count (WBC) was 10.3x109/l.From 18
patients the radiographs showed abnormalities, such as radiolucency
around the prosthesis or periosteal reaction. Twelve of the 13
scintigraphic investigations (93%) performed were abnormal. In 8
cases these scintigraphic abnormalities were compatible with an
infection of the prosthesis.
Specimens for microbiological analysis were obtained prior to
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Table 4.4. 
Suggestive and probable haematogenous infections. In 5 patients a distant infectious focus with identical bacterial species was
detected. In 9 patients a haematogenous contamination was probable, but could not be proven by culturing identical micro-
organisms from both foci. DM = diabetes mellitus, RA = rheumatoid arthritis, S = use of steroids.
DM/RA/S Micro-organism
Suggestive S ulcer (ankle) S. aureus
RA, S ulcer (cruris) CNS
DM ulcer (foot) S. aureus
DM ulcer (foot) S. aureus
- cholecystitis Cl. perfringens
Probably - operation abd. aneurysm, pos. blood cult. S. aureus, E. coli
RA renal insufficiency, dialysis S. aureus, group G streptococcus
- M. tuberculosis cultured M. tuberculosis, E. coli
- necrotising fasciitis Pepto-streptococcus  sp.
- pulmonary infection unknown
DM paraplegia Enterococcus faecalis
DM decubitus Enterococcus spp.
- urinary tract infection. E. coli
- suprapubic catheter Group B streptococcus
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surgery by aspiration and/or at the time of operation (Table 4.3).
The majority of the isolated micro-organisms (47 out of 58, i.e.
81%) were Gram-positive, while Gram-negative bacilli were isolat-
ed 7 times (12%) and anaerobic micro-organisms 3 times (5%). In
one case Mycobacterium tuberculosis was isolated. Thirty-three out of
47 arthroplasties (70%) were infected with a single micro-organism
and 12 (26%) with two or more different micro-organisms. Two
cultures remained negative, although the hip was clinically infected
in both cases.
In 13 patients the prosthesis was infected by direct contamination.
In five patients a distant infectious focus with the same bacterial
species was detected, suggesting a haematogenous spread of infec-
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Table 4.5. 
Overview of therapy and final outcome of all patients. Thirty-five patients were still alive at the time of the study. Two
patients died because of the infection of the hip prosthesis.
debridement resection one-stage two-stage
arthroplasty revision revision
n=9 n=22 n=4 n=12
Infection remaining after 
initial therapy
no 5 16 4 12
yes 4 4 - -
unknown - 1 - -
n.a - 1 - -
Final outcome
THP 6 - 4 11
girdlestone 2 20 - 1
arthrodesis - 1 - -
died because of infection 1 1 - -
Draining sinus
no 6 16 4 12
yes 2 4 - -
unknown - 1 - -
n.a. 1 1 - -
Died
no 8 14 4 9
yes 1 8 - 3
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tion. In 9 patients a haematogenous contamination was probable,
but could not be proven by same micro-organisms cultured from
both foci (Table 4.4). In 20 patients a haematogenous contamina-
tion of the prosthesis could be possible, but no signs of a
haematogenous infection could be found.
Treatment choice and outcome of the initial treatment are
described in Table 4.5. Of the 47 infected hips, 9 were initially
treated by debridement (group 1). The average follow-up period of
these patients was 28 (15-46) months. The mean age at treatment of
the infection was 66 (55-84) years. In 4 patients the infection was
not eradicated. One patient died as a result of the infection.
Removal of the prosthesis was not performed initially, because of
the already bad health of the patient. Although in a second stage the
prosthesis was removed, the patient became septic after the opera-
tion and died. Because of a persistent infection in 2 patients a resec-
tion arthroplasty was performed at a later stage. Two patients still
have a draining sinus tract: 1 patient without and 1 patient with a
prosthesis in situ. 
Sixteen infected hips were treated by an exchange procedure
(group 2). Four patients underwent a one-stage, and 12 patients a
two-stage procedure. The average follow-up period of these
patients was 37 (28-47) and 50 (8-119) months, respectively. The
average age at the beginning of the treatment was 75 (61-88) and 65
(41-79) years, respectively. The average time until reimplantation of
a new prosthesis in the patients who underwent a two-stage
exchange procedure was 6 months (7-866 days). Seven out of 16
reimplanted hips were cemented, 3 cementless and 6 hybrid total
hip arthroplasties. At the time of reimplantation gentamicin-
impregnated cement was used in all cases. In 1 patient the infection
could not be eradicated by the exchange procedure and removal of
the prosthesis was performed successfully. At the time of the inves-
tigation 13 patients were still alive.
In 22 patients, a prosthesis was not reimplanted after removal of the
infected hip prosthesis (Girdlestone procedure; group 3). The aver-
age follow-up period in this group was 38 (6-113) months and the
average age was 69 (40-88) years. One patient died; it is not known
if this patient died because of infection. One patient died of an
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adult respiratory distress syndrome because of a sepsis after removal
of the infected prosthesis. This patient was already in a poor physi-
cal condition as a result of major surgery (aneurysm of abdominal
aorta) some weeks before removal of the prosthesis. Because of
pain, in one patient an arthrodesis was performed at a later stage. In
4 patients a draining sinus tract remained. Only 14 out of 22
patients were still alive at the time of the evaluation.
A total of 132 operations requiring anaesthesia were necessary
(Table 4.6). On average, for patients in group 1 2.3 operations, in
group 2 2.8 operations and in group 3 3.1 operations were neces-
sary. Patients treated by a one-stage revision underwent 1.3 opera-
tions; those treated by a two-stage revision procedure 3.7 opera-
tions. The average hospital stay in group 1 was 75 days. In group 2
the average hospital stay was 75 days, and in group 3 89 days.
Hospitalisation of the patients who underwent a one-stage revision
was 75 days and those who underwent a two-stage procedure 94
days.
In general, intravenous broad-spectrum antibiotics were started as
soon as preoperative cultures yielded micro-organisms, or when
these cultures remained negative, after collection of specimens for
culture during operation. Antibiotic therapy was changed according
to the susceptibility of the isolates. Subsequently, therapy was
switched to oral antibiotics whenever possible.
The results of the questionnaire from 31 patients are shown in
Table 4.7. From these patients, 18 had a total hip arthroplasty, 12 a
resection arthroplasty and 1 an arthrodesis of the hip. Thirty-three
per cent of the Girdlestone patients had severe pain against only 6
per cent of the arthroplasty patients. Thirty-three per cent of the
HIP PROSTHESIS INFECTIONS. A RETROSPECTIVE STUDY
Table 4.6. 
Hospitalisation and
number of operations
(mean and range). In
total, 132 operations were
performed.
Treatment No. of Hospital stay No. of
patients (days) operations
debridement 9 75 (25-186) 2.3 (1-5)
resection arthroplasty 22 75   (8-231) 2.8 (1-6)
one-stage revision 4 75 (51-122) 1.3 (1-2)
two-stage revision 12 94 (23-303) 3.7 (2-7)
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Table 4.7. 
Functional outcome of 31
out of 35 still living
patients at the time of
study. VAS = Visual
Analogue Scale from 0
(no pain) to 10 (intolera-
ble pain).
THP girdlestone arthrodesis
n=18 n=12 n=1
Initial therapy
debridement 6 1 -
girdlestone - 11 1
revision, 1 tempo 4 - -
revision, 2 tempi 8 - -
Residual sinus
no 17 11 1
yes 1 1 -
Rheumatoid arthritis
no 16 10 -
yes 2 2 -
Usual level of hip pain
none 4 3 -
very mild 6 1 -
mild 4 3 1
moderate 3 1 -
severe 1 4 -
Pain (VAS 0-10)
score±stdev 3.0±3.0 4.4±3.5 7.8
Work interference due to pain
not at all 4 2 -
a little bit 10 - 1
moderately 1 1 -
greatly 2 3 -
totally 1 6 -
Walking without severe hip pain
>30 minutes 4 - -
16-30 minutes 4 - 1
5-15 minutes 1 - -
around the house only 6 7 -
not at all 3 5 -
Limping when walking
rarely/never 2 - -
sometimes 6 1 1
often 4 - -
most of the time 2 - -
all of the time 4 11 -
Use of walking aids
never 7 - -
sometimes - - -
often 1 - -
most of the time - - -
all of the time 10 12 1
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Girdlestone patients had none or very mild pain, while of the
patients with an arthroplasty 56 per cent had none or very mild
pain. The patients with a Girdlestone scored their pain as 4.4 on a
scale of 0 (no pain) to 10 (intolerable pain), whereas patients with
an arthroplasty scored their pain as 3.0. Fifty per cent of the patients
with a Girdlestone said that pain of the hip interfered totally their
usual daily activities, in contrast to only 1 (i.e. 6%) of the arthro-
plasty patients. Pain interfered only slightly or not at all with daily
activities in 78 per cent of the patients with a hip arthroplasty. All
patients with a Girdlestone could not walk at all or only around the
house without severe pain. In the patients with an arthroplasty this
percentage was 33 per cent, while 44 per cent could walk more
then 15 minutes. Ninety-two per cent of the Girdlestone patients
were limping all of the time when walking. All these patients used
walking aids. Thirty-three per cent of the patients with an arthro-
plasty were limping most or all over the time, while 44 per cent
were limping sometimes or never. Of this group 56 per cent used
walking aids all of the time.
4.4. Discussion
This study retrospectively reviewed patients with infected
total hip arthroplasties, in an attempt to evaluate the results of diag-
nostic procedures and the outcome of the various management
strategies. In a period of 10 years 47 patients were treated by either
debridement only, removal of the prosthesis and debridement, or a
one- or two-stage exchange procedure. Beside surgical intervention
antibiotic therapy was given to all patients.
Infection of an arthroplasty is diagnosed by clinical symptoms, labo-
ratory parameters, radiological investigations and cultures taken
pre- and/or peroperatively. In accordance with the literature pain is
the major presenting symptom in patients with a deep infection
(Fitzgerald 1985). This was in concordance with this study, in
which almost all patients had pain. Other symptoms observed less
frequently were fever and a draining sinus tract. Laboratory para-
meters suggestive of an infection, like a raised ESR and/or raised
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CRP were found in the majority of patients.
Changes on plain X-rays are of limited value as an investigative tool
for the diagnosis of infection. Besides that diagnostic findings such
as loosening, osteolysis or endostal scalloping are common in both
septic and aseptic failure (Tigges 1994b), they are not always present
(Tigges 1994a). The findings of the present study agree with these
data from the literature, because only a limited number of patients
showed radiological changes compatible with infection. 
Additional nuclide imaging proved to be only of limited value in
diagnosing deep implant infection in the present study. Eight out of
13 nuclear investigations showed signs compatible with infection,
whereas 4 investigations showed signs of loosening without infec-
tion. These findings are in accordance with the literature. Spangehl
et al. already mentioned the limited role of scintigraphy by the
inability of the scans to yield consistently acceptable levels of sensi-
tivity and specificity (Spangehl 1998).
Gram-positive micro-organisms were isolated from the majority of
patients. Coagulase negative staphylococci (CNS) and Staphylococcus
aureus were isolated in 26 respectively 24 per cent of the cultured
micro-organisms. This is in agreement with other reports which
described staphylococci as the most common causative agents of
prosthetic joint infections (Fitzgerald 1973; Fitzgerald 1985;
Fitzgerald 1989; Ostendorf 1998).
A higher rate of deep infection of a prosthesis after previous opera-
tions has been reported (Fitzgerald 1977; Poss 1984; Wilson 1990;
Hanssen 1999). Other published risk factors for a deep infection are
rheumatoid arthritis (Charnley 1972; Ahlberg 1978; Stinchfield
1980; Glynn 1983; Ainscow 1984; Poss 1984; Bengtson 1987;
Maderazo 1988; Wilson 1990), diabetes mellitus (England 1990;
Papagelopoulos 1996) and use of steroids (Wilson 1990). In this
study 66 per cent had one or more of these risk factors for a deep
prosthetic infection.
Although it is difficult to link a preceding bacteremia to a prosthe-
sis-related infection, late postoperative infections are usually consid-
ered to result from haematogenous spread of bacteria from a distant
focus, which sometimes may become manifest weeks or months
later. It has been postulated that the most common sources for
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haematogenous total joint infection are skin and soft tissue. Other
important sources are mouth, respiratory tract and urinary tract
(Ainscow 1984; Maderazo 1988; Deacon 1996). The percentage
“suggestive” (i.e. those infections in which a distant focus was pre-
sent with the same bacterial species) haematogenous infections
(11%) is in agreement with the literature (Salvati 1982b; Ainscow
1984). Another 19 per cent of the infections in this study were con-
sidered as probably haematogenous. According to Ainscow and
Denham transient bacteremia is not likely to infect a replaced joint
in otherwise healthy patients. Patients with rheumatoid arthritis are
at greater risk than those with osteoarthritis (Ainscow 1984). Four
out of 5 patients with a proven haematogenous infection in this
study were suffering from diabetes mellitus, rheumatoid arthritis or
used steroids.
Depending on the time of onset of infection, the condition of the
patient as well as the local condition around the hip, several meth-
ods of treatment are described (Carlsson 1980; Härle 1989; Gillespie
1990; Garvin 1995; Hanssen 1999). Debridement without removal
of the prosthesis can be performed within 6 weeks of insertion of
the infected prosthesis or in the case of an acute haematogenous
infection. As reported previously by Crockarell et al. (Crockarell
1998) and confirmed in the present study, the success of debride-
ment is limited: in 4 out of 9 of our patients the infection was not
eradicated. One patient died as a result of the infection. Because of
a persistent infection, in 2 patients an excision arthroplasty was per-
formed at a later stage. In 3 patients, a debridement was performed
despite the fact that the prosthesis was inserted longer than 6 weeks
ago. In 2 out of these 3 patients the infection was never eradicated.
An resection or Girdlestone arthroplasty is proposed as the most
appropriate treatment for patients who are psychologically or med-
ically unfit to have an additional reconstructive procedure and
those who are mentally impaired or may be unable to cooperate
with the postoperative restrictions and rehabilitation protocols after
a complex reconstruction. Also a severe deficiency of bone stock
and poor quality of local soft tissue is an indication for a resection
arthroplasty (Ahlgren 1980; Bourne 1984; Forgon 1990; de Laat
1991; Lieberman 1994). According to the literature the infection is
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brought under control in a high percentage of cases (Grauer 1989;
Castellanos 1998). Pain is less compared with the situation before
the operation, but most of the time pain remains to some extent
(Ahlgren 1980; Bittar 1982; Bourne 1984; Grauer 1989; de Laat
1991; Castellanos 1998). The functional outcome is poor. After
resection there is a shortening of the leg on the operated side, vary-
ing from 3 to 11 cm (Ahlgren 1980; Bourne 1984; Grauer 1989;
Castellanos 1998). Almost in every case, patients use some type of
walking aids (Ahlgren 1980; Bourne 1984; Grauer 1989; de Laat
1991; Castellanos 1998) and walking distance is diminished (Grauer
1989; de Laat 1991). The results of the present study in this catego-
ry of patients with resection arthroplasty were in accordance with
the literature. All these patients were medically or psychologically
unfit to undergo a procedure for a new prosthesis. Only 14 out of
these 22 patients were alive at the time of the present study was ini-
tiated. In only 1 of these 14 patients the infection was not eradicat-
ed; this patient still has a draining sinus tract. Although in this cate-
gory of patients the hip was less painful than prior to removal, pain
was reported frequently. Pain scores were higher as compared to
patients where the prosthesis was left in place or was revised. In
addition, walking distance was diminished in this group, however
the ability to walk varied also with the in general diminished health
of the patients. Walking aids were used to some extent by all
patients who were able to walk. 
A one- or two-stage exchange arthroplasty gives a better functional
result and remains a better alternative in some cases (Carlsson 1980;
Bittar 1982). Usually, and especially in the Anglo-Saxon countries,
a two-stage exchange procedure is performed (Härle 1989; Antti-
Poika 1990). As was also the case in our patients, sometimes when
preoperative cultures were negative and the prosthesis was revised,
cultures obtained during surgery appeared to be positive. Thus, the
revision can be considered as a one-stage procedure. However,
there are groups which perform a one-stage exchange procedure
even when an infection of the prosthesis is evident (Buchholz 1972;
Elson 1994).
In conclusion, the eradication of an infected arthroplasty of the hip
by only surgical debridement and antibiotics is poor. Removal of
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the prosthesis gives better results with regard to eradication of the
infection. In case the prosthesis cannot be replaced, the functional
outcome of the so-called Girdlestone situation is poor. For better
functional results, an exchange of the prosthesis, when medically
and psychologically possible, is advised. In the current study, several
prosthesis infections were likely to be haematogenous infections. It
is therefore of great importance to get a better insight into the
mechanisms of these infections and to improve the prophylactic
and therapeutic options.
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5.1. Introduction
In orthopaedic surgery, an infection of a prosthesis is a very
serious, sometimes life-threatening, complication. In the majority
of cases the prosthesis has to be removed, followed by prolonged
treatment with intravenous antibiotics. In some situations a new
prosthesis can be inserted at once, but mostly it is inserted later in a
second stage.
A three-stage classification system of hip prosthesis infection is
described by Coventry (Coventry 1975) and later Fitzgerald et al
(Fitzgerald 1977). This system is based on the time of the presenta-
tion of infection. First stage infections occur in the immediate post-
operative period. These early post-operative infections are usually
caused by direct peroperative contamination. Second stage infec-
tions are also believed to originate at the time of the operation, but
because of a small inoculum or low virulence of the organism, the
onset of the symptoms is usually delayed until 6 to 24 months after
the operative procedure. Stage three infections are caused by
haematogenous or lymphatic spread to a previous asymptomatic
hip. These type of infections start usually 2 years or more after the
operative procedure. Early diagnosis may allow salvage of the joint
by means of complete debridement. A delay in the diagnosis may
necessitate a one or two-stage exchange procedure. The prevalence
of haematogenous prosthesis infections is estimated at 0.3 to 1 per
cent (Charnley 1969; Ahlberg 1978; Gristina 1983; Jaspers 1985;
Schutzer 1988; Nelson 1990), and the most common foci are skin
and soft tissue (46%), dental (15%) and urinary tract (13%) infections
(Maderazo 1988). For the skin, soft tissue and dental region,
Staphylococcus aureus and Staphylococcus epidermidis are the most com-
mon pathogens, while for the urinary tract, Escherichia coli is the
most common pathogen. The relationship between a staphylococ-
cal bacteremia and a distant prosthesis infection has also been
demonstrated in animal experiments by Blomgren (Blomgren 1981)
and Vogely (Vogely 1996).
This report describes for the first time an unusual presentation of a
late haematogenous infection of a total hip prosthesis with
Clostridium perfringens following an acute cholecystitis.
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5.2. Case report
A female patient (52 years old) with primary osteoarthritis of
the hip joint underwent in 1982 an intertrochanter osteotomy.
Because of persisting pain in 1983, a TARA prosthesis (Total
Articular Replacement Arthroplasty) was inserted. Eleven years
later, in 1994, the TARA prosthesis was removed because of aseptic
loosening and was replaced by a cemented (gentamycin containing
bone cement) Müller total hip prosthesis. Antibiotic prophylaxis
with cephalothin was given during five days. Before and during this
exchange procedure there were no signs of infection. Cultures of
aspiration before the operation and samples taken peroperatively
were negative. The patient recovered well from surgery and had no
postoperative complaints. Ten months later, she was admitted to
our hospital because of abdominal pain with high temperature and
shaking chills for several days. At examination she had signs of an
acute cholecystitis. Blood tests revealed an elevation of white
blood-cell count (WBC) and erythrocyte sedimentation rate
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Figure 5.1. 
X-ray of total hip pros-
thesis, six months after
the cholecystectomy.
There are no signs of
loosening or of gas accu-
mulation around the hip.
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(ESR). A sonography showed a thickened wall of the gallbladder.
Under the diagnosis of an acute cholecystitis, an open cholecystec-
tomy was done. Because of the infection, the wound was not
closed. Postoperatively, the patient was treated with intravenous
and later with oral amoxicillin and clavulanic acid. Cultures of the
gallbladder yielded Clostridium perfringens. The postoperative period
was uncomplicated. Eleven days after admission the patient was dis-
charged. The wound closed spontaneously. After six months, the
patient developed a progressive tenderness of the right groin. At
investigation she had a right limp. ESR and WBC were 55 mm/hr
and 9.9x109/l, respectively. X-ray examination showed no signs of
loosening of the prosthesis or signs of gas around the hip (Figure
5.1). However, a technetium bone scan was suggestive for an infec-
tion of the prosthesis (Figure 5.2). 
At aspiration of the joint, pus was obtained and Clostridium perfrin-
gens was cultured. Because of fear of a clostridial sepsis, the patient
was treated with oral penicillin several days before the prosthesis
was removed. At removal of the implant, the bacteriological cul-
tures were negative. Postoperatively, the patient was treated with
intravenous penicillin and subsequently with oral clindamycin. Ten
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Figure 5.2. 
Technetium bone scinti-
gram. An increased
uptake is shown around
the implant, suggestive
for an infection of the
prosthesis.
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days after removing of the prosthesis a surgical debridement was
done. Bacteriological cultures obtained at this last procedure
remained negative. Five weeks after removal of the implant the
patient was temporarily discharged from our hospital and nine
weeks later she was admitted to our hospital again for a new total
hip prosthesis. A Müller total hip prosthesis was inserted with gen-
tamicin containing bone cement. Antibiotic prophylaxis with intra-
venous cephalothin was given. Again, samples obtained peropera-
tively for bacteriological culture remained negative. The patient
recovered well and 26 days after she received the new prosthesis she
was discharged in good condition. One year after the operation she
has only slight complaints of pain and she walks with only one
crutch outside. Clinically there are no signs of infection. X-ray
examinations show no signs of loosening and blood tests remain
normal.
5.3. Discussion
Clostridia are spore forming bacilli and normal inhabitants of
the gastrointestinal tract, the biliary system and the genitourinary
tract. Clostridium perfringens is an anaerobic Gram-positive bacillus
that produces toxic proteolytic enzymes. It produces a haemolytic
and necrotising alpha-toxin and also lecithinases which can lyse
erythrocytes, leukocytes and platelets. In addition to the well-
known clostridial myonecrosis of open compound fractures, gas
gangrene has been documented without open contamination
(Finegold 1985).
Clostridial infections must be treated aggressively. Extensive surgi-
cal debridement combined with antibiotic therapy is essential for
adequate treatment (Finegold 1996). The antibiotic mostly used is
penicillin G. However resistance to beta-lactam antibiotics by
Clostridium perfringens has been reported (Nord 1990). Other report-
ed antibiotics for treatment of Clostridium perfringens infections are
metronidazole (Finegold 1996), imipenem (Finegold 1996), clin-
damycin (Finegold 1996), cefoxitin (Finegold 1996), chlorampheni-
col (Moehring 1988; Finegold 1996), tetracycline (Chetta 1982) and
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erythromycin (Darke 1977). Hyperbaric oxygen therapy may be of
value only in selected circumstances, such as in cases of gas gangrene.
However, there has never been clear-cut clinical evidence that hyper-
baric oxygen therapy is significantly beneficial and one should never
delay necessary surgical therapy to administer hyperbaric oxygen ther-
apy (Finegold 1996).
In orthopaedic surgery, infections with Clostridium perfringens have
been described incidentally.  For patients without a prosthesis, several
authors described a septic arthritis with Clostridium perfringens (Fauser
1988; Lluberas-Acosta 1989; McAllister 1989). For patients with a
total joint prosthesis, Stern (Stern 1988) and Rush (Rush 1976)
describe the possibility of a direct infection through a disturbed
wound healing or local contamination with Clostridium perfringens. 
An early (stage I) infection of a total knee prosthesis after an acute
cholecystitis was described by Wilde (Wilde 1988). This supports the
postulation of Blomgren that bacteremia poses a greater risk of infec-
tion of an implant in the early postoperative period than it does in the
late postoperative period (Blomgren 1980). 
Two previous cases were described of a late prosthesis infection with
Clostridium perfringens, for which a haematogenous spread of bacteria
from a distant focus might have been the cause. Kibbler (Kibbler
1991) reported a prosthesis infection in a patient after a period of diar-
rhoea and vomiting, and Maniloff described a late infection of a total
knee prosthesis in a patient with a common bile duct with stones
(Maniloff 1987). However, since no positive cultures from the possi-
ble primary focus were available in these studies, a direct relationship
between focus and prosthesis infection could yet not be made.
The patient in the current paper developed a so-called “stage three”
infection of her hip prosthesis, according to the previously mentioned
classification (Coventry 1975; Fitzgerald 1977). To our knowledge,
this is the first case that confirms how a relative common gastrointesti-
nal infection followed by surgical intervention, results in an infection
of a hip prosthesis with Clostridium perfringens through a haematoge-
nous pathway. This paper demonstrates that patients with an
orthopaedic endoprosthesis in situ are at risk to develop a late infection
of this implant with Clostridium perfringens after a gallbladder infec-
tion.
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The investigations in this thesis were initiated by the convic-
tion that infections in orthopaedics, in particular prosthesis-related
infections, are difficult to understand, to treat and to prevent.
Clinical studies are performed with the aim of getting a better
insight of the management of infection. Experimental studies focus-
ing at the underlying mechanisms of infection in orthopaedics are
important. It is hoped that these studies give us better tools for reli-
able diagnosis, the optimal therapy and more effective prophylactic
measurements. First, in Chapter 2, the current literature of hip
prosthesis-related infections has been summarised, and in the subse-
quent Chapters 3, 4, and 5, various clinical studies of orthopaedic
infections were described.
In Chapter 2, the current knowledge of prosthesis-related
infections was summarised based upon the present literature. The
epidemiology and classification of these infections was described, as
well as diagnostic examinations and treatment options. In addition,
current understanding of the underlying pathogenesis of implant-
related infections was presented.
In Chapter 3, the haematogenous route as an important path-
way for orthopaedic infections was described through a retrospec-
tive analysis of 28 children with a diagnosis of osteomyelitis. After
surgical intervention, it appeared that six weeks of antibiotic thera-
py was sufficient to eradicate acute as well as chronic osteomyelitis
in children. However, there is a great variability in managing
osteomyelitis between different treating physicians. No controlled
studies of the type and duration of antibiotic treatment of
osteomyelitis exist.
Chapters 4 and 5 refer to various clinical aspects of prosthe-
sis-related infections. In Chapter 4, the results of a retrospective
analysis of 47 patients with a prosthetic hip infection were
described. The specific goals of the analysis were how diagnosis was
reached, the results of the cultures, the management, and the infec-
tious and functional outcome of treatment. The conclusion was
that the eradication of an infected arthroplasty of the hip by only
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surgical debridement and antibiotics is insufficient. Removal of the
prosthesis clearly results in more complete eradication of the infec-
tion. In case the prosthesis cannot be replaced, the functional out-
come of the so-called Girdlestone procedure is unsatisfactory. The
population described in this chapter were all patients treated at one
hospital over a period of 9 years. Still this population showed that
management was far from uniform and contained many variables.
This emphasises the need for studies in an experimental, and there-
fore much better controlled setting.
In Chapter 5, an insidious complication of an abdominal
infectious process was described, emphasising the significance of the
haematogenous route for prosthesis infections. It was postulated
that if patients with joint prosthesis develop bacterial infections at
distant sites, they should be treated immediately and aggressively
with appropriate antibiotics to prevent haematogenous spread to
the prosthetic joint.
From the previous chapters it can be concluded that there is
a great lack in knowledge related to the pathogenesis of
orthopaedic infections, their course and treatment. Further research
is necessary, especially since the problem is extremely complex, but
also since the problem is growing as a result of the rapid increase of
the use of biomaterials in medicine, in particular in orthopaedics.
For instance, questions can be raised that are related to the use of
more biocompatible materials, such as hydroxyapatite coated
implants, and how these may affect the infection susceptibility of an
implant. The so-called “race for the surface” theory as postulated
by Gristina (see Chapter 2) implies that when cells arrive first at a
material surface after implantation, the implant will not be accessi-
ble for bacterial adhesion any more, while when bacteria arrive first
at the surface, tissue integration cannot take place. In addition, will
a local infection influence osseointegration of a bioactive implant or
not? Therefore, in Chapter 7, we address our aim to determine whether
there is a difference in infection susceptibility of two common orthopaedic
implant surfaces with a different biocompatibility (hydroxyapatite coated and
noncoated titanium), and how the response of the bone surrounding these
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implants is characterised in case of infection. Another question relates to
haematogenous infections in orthopaedics, that form a substantial
part of all infections. However, the pathogenesis of these infections
is not very well understood. This lack in basic and clinical knowl-
edge on the pathogenesis of haematogenous orthopaedic implant
infections is one of the motives for further study, and as a first step,
in Chapter 8, we address our aim to develop an experimental animal
model to study haematogenous implant infections. 
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7.1. Introduction
Implant infections in orthopaedic surgery are a serious clini-
cal problem leading to an increase in complicated and costly revi-
sion arthroplasties with a high mortality. To date, this infection rate
is about 1 to 2 per cent for a total hip arthroplasty and 4 per cent
for a total knee arthroplasty (Walenkamp 1990; Sanderson 1991).
Since the number of patients receiving an arthroplasty is still
increasing (Okhuijsen 1998), it is obvious that the problem of
implant-related infections will further increase in the future. Most
infections are caused by Staphylococcus aureus and Staphylococcus epi-
dermidis (Ostendorf 1998). Other frequently seen micro-organisms
are the Gram-negative bacilli, such as Escherichia coli, Proteus,
Pseudomonas and Klebsiella (Maderazo 1988).
Many new biomaterials, coatings and surfaces were developed in
the last decade to improve noncemented fixation of an implant.
Noncemented implants are especially indicated in younger patients
with severe osteoarthritis (Engh 1987; D’Antonio 1992; Malchau
1993; Geesink 1995; Tonino 1995). Noncemented fixation poten-
tially leads to a permanent bond between prosthesis and bone
(Engh 1987; Geesink 1987; Geesink 1988; Soballe 1990; Hardy
1991; Soballe 1993; Ang 1997; Overgaard 1997; Dhert 1998;
Tonino 1999). One of the most widely used materials for nonce-
mented joint prostheses is titanium, a biocompatible material that
permits bone to grow in close proximity to the implant surface
(contact osteogenesis) (Engh 1989; Mulliken 1996). To promote
implant-bone contact even more, bioactive materials such as
hydroxyapatite, a calcium phosphate ceramic, have been applied to
implant surfaces as a coating. Several prosthetic designs using
hydroxyapatite coated titanium have proven to be successful after
medium term follow-up and are subject of constant evaluation
(D’Antonio 1992; Geesink 1995; Tonino 1995; Vedantam 1996;
Tonino 2000). Thus, noncemented implants derive their success
from direct bone-to-implant contact, bone ingrowth into pores, or
from biological bonding between bone and a bioactive prosthesis
surface. A long lasting fixation will then be achieved by functional
integration of the prosthesis with the surrounding bone. For the
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process of bony integration, the early healing phase (days-weeks
after implantation) is especially of importance, and is characterised
by a cascade of various cellular events at the implant surface (Dhert
1998). Since the functionality of these implants is material or sur-
face dependent, a logical question would be how the (optimal)
characteristics for tissue integration relate to the susceptibility for
bacterial colonisation and infection. Is a highly bioactive implant
also more susceptible to infection, or is bacterial adhesion and
colonisation prevented by a rapid tissue integration, as described in
the “race for the surface” theory of Gristina (Gristina 1987a)?
Although a bioactive implant surface does not necessarily mean that
such a surface is also highly susceptible for bacterial adhesion and
colonisation, the relationship between implant bioactivity and
infection susceptibility has not yet been investigated.
The purpose of the present study was to investigate the infection
susceptibility and osseointegration related to peri-implant infection,
of two commonly used surfaces for noncemented fixation of
orthopaedic implants: grit-blasted Ti6Al4V as a biocompatible sur-
face and hydroxyapatite plasma sprayed Ti6Al4V as a bioactive sur-
face. We hypothesise that the microbiological and histological
behaviour of these two surfaces is different in the presence of bacte-
ria.
7.2. Materials and methods
7.2.1. Design
The evaluation of infection susceptibility of titanium (Ti)
and hydroxyapatite (HA) coated titanium implants was carried out
in a contaminated implant bed model in the proximal left tibia of
the rabbit. A total of 32 rabbits received in both tibiae either HA
coated (n=16) or non-coated Ti6Al4V (n=16) implants. Each
group was divided into 4 subgroups (n=4) that received different
concentrations of bacterial inoculi of Staphylococcus aureus. Each
right tibia served as control with an identical implant, but without
contamination. After 28 days, the animals were killed and both tibi-
ae were excised. Samples of surrounding bone were cultured and
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bacteria were counted. The remaining part of bone with implant
was prepared for histological and histomorphometrical (semiquanti-
tative scoring of bone response, bone-implant contact, bone area
next to implant) analysis. In Figure 7.1, the main steps in the animal
experiment are summarised.
7.2.2. Preparation of implants
Cylindrical non-coated, grit-blasted titanium-aluminium
(6%) vanadium (4%) (Ti6Al4V) implants and cylindrical
hydroxyapatite coated Ti6Al4V implants (length 20 mm and final
diameter 3.9 mm) were used in the present experiment (Figure
7.2). The thickness of the hydroxyapatite coating was approximate-
ly 60 microns. The coating was applied onto the surface by a vacu-
um plasma-spray technique and had a mean crystallinity of 75% and
a porosity of less than 10%. The implants were sterilised in an auto-
clave prior to use. The surface roughness of the two implant types
was established by a UBM laser profilometer (UBM, Etlingen,
Germany). Scanning electron micrographs (Philips 525M, Philips,
Eindhoven, The Netherlands) of carbon-coated Ti and HA
implants were made to determine the surface morphology of the
two implant surfaces.
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Figure 7.1. 
Artist’s impression of the
two steps in the experi-
mental animal model. In
step I, an inoculum S.
aureus or saline (control)
is injected into the
medullary canal.
Subsequently, a Ti or
HA implant is press-fit
inserted. In step II, four
weeks after surgery, the
animal is sacrificed, and
samples for bacteriologi-
cal, histological and his-
tomorphometrical exami-
nation are obtained.
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7.2.3. Bacteria
Staphylococcus aureus, strain Wood-46 (ATCC 10832) was
used throughout the experiment. This strain was described in detail
by Delmi and Zimmerli (Zimmerli 1982; Delmi 1994). For prepa-
ration of the stock, a colony was grown overnight in tryptic soy
broth at 37°C. Overnight cultures were centrifuged and resuspend-
ed in sterile saline. Standardised suspensions were frozen with liquid
N2 and held at -70°C until an inoculum was used. At regular inter-
vals a vial was thawed, opened and cultured; the bacteria were
counted to verify that the vial still contained the same amount of
bacteria as at the time the original suspension was prepared. On the
day of use, for preparation of an inoculum, the suspension was
thawed and diluted with sterile saline up to concentrations of 103,
104, 105 or 106 colony forming units per millilitre (CFU/ml).
During surgery the rabbits were inoculated with 0.1 ml of bacterial
suspension, resulting in inoculum sizes of 102, 103, 104, and 105
CFU. Previous pilot experiments revealed that higher inoculum
sizes resulted in severe systemic reactions, such as septicaemia.
7.2.4. Animals and surgery
The experimental design was approved by the institutional
review board (Animal Care and Use Committee, Faculty of
Medicine, Utrecht University). Female New Zealand White rab-
bits, weighing from 2.9-3.6 kg (mean 3.4 kg), were obtained from a
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Figure 7.2. 
Photograph of Ti6Al4V
(left) and HA coated
Ti6Al4V (right)
implant. Final dimen-
sions of the implants were
20 mm (length) and 3.9
mm (diameter).
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professional stock breeder (Ico:NZW, Broekman Instituut B.V.,
Someren, The Netherlands). In earlier studies this animal proved to
be suitable to study arthritis and osteomyelitis (Marks 1980;
Blomgren 1981; Eerenberg 1994; Belmatoug 1996; Cordero 1996a;
Vogely 1996; Nijhof 1997a). The rabbits were housed individually
in cages and fed with 80-100 g daily Hope Farms rabbit diet LKK-
20 (Hope Farms Standard Laboratory Diet LKK-20, Hope Farms
B.V., Woerden, The Netherlands). Water was given ad libitum.
After contamination of the implant, the animals were cared under
the same conditions in an infection unit, which is a barrier-separat-
ed wing of the animal laboratory.
Surgery was performed under general inhalation anaesthesia and
aseptic conditions. The rabbits were premedicated by an intramus-
cular injection with 4 mg acepromazinemaleate (Vetranquil®,
Sanofi Sante B.V., Maassluis, The Netherlands) and 4 mg
methadone (methadoneHCl). The anaesthesia was initiated by an
intravenous injection of 8-12 mg etomadate (Hypnomidate® ,
Janssen Pharmaceutica BV, Tilburg, The Netherlands). After intu-
bation, inhalation anaesthesia was followed by a mixture with O2
and N2O in a ratio of 1 to 1 and halothane 1% (Albic BV,
Maassluis, The Netherlands). Pain-relief was provided by 3 mg nal-
bufine (Nubain®, Lamepro B.V., Raamsdonkveer, The
Netherlands) i.m. immediately postoperative, and subsequently 0.1
mg buprenorphine (Temgesic®, Reckitt and Colman Products,
Kingston-upon-Hull, United Kingdom) i.m. if necessary.
After both legs of the rabbit were shaved, the animal was placed in
supine position on the operation table. After disinfection with 10%
povidone-iodine (Betadine® solution, Dagra, Diemen, The
Netherlands) and sterile draping, first the right knee was operated.
After a medial parapatellar incision of approximately 3 cm length,
the knee joint was opened. Anterior to the insertion of the anterior
crucial ligament on the tibia, the medullary canal was opened with
an awl, and reamed by hand until a depth of about 25 mm and a
diameter of 3.9 mm was obtained. Then, an inoculum of 0.1 ml of
saline was injected into the cavity with a small pipette.
Subsequently, a Ti or HA implant was press-fit inserted in the
medullary canal. The joint capsule was closed with Vicryl 3-0
CHAPTER 7
87
(Vicryl®, Ethicon GmbH & Co, Norderstedt, Germany) and the
skin with steel 4-0 (Ethicon GmbH & Co, Norderstedt, Germany).
The same procedure was performed on the left knee, but prior to
implant insertion, an inoculum of 0.1 ml of saline containing 102,
103, 104 or 105 CFU bacteria was injected into the cavity.
Postoperatively, X-rays were made to check the position of the
implants, and the animals were examined daily for activity, eating
and wound healing. Weight and body temperature were measured.
Blood samples were taken for erythrocyte sedimentation rate (ESR)
and white blood-cell count (WBC) preoperatively and 1, 2, 3 and 4
weeks postoperatively. The rabbits were sacrificed four weeks after
the operation with 5 ml pentobarbital N2 (200 mg/ml)
(Euthesate®, Apharmo B.V., Arnhem, The Netherlands) intra-
venously.
7.2.5. Post mortem sample acquisition and evaluation
procedures
Immediately after sacrifice, X-rays were made. The X-rays
were blindly examined by two investigators and compared with X-
rays made immediately after implantation for gross signs of infection
of the tibiae, such as periosteal reaction and osteolysis around the
implant.
Excision of the tibiae was performed under aseptic conditions.
After shaving of the skin, the operative area was disinfected with
10% povidone-iodine and isolated with sterile drapes. Subsequently,
the right tibia was excised. Using a high-speed dental drill with a
circular metal saw (Minitech electronic, Zeist, The Netherlands),
the proximal tibia was divided into an anterior half of bone and a
posterior half containing the implant. Hereafter, the same proce-
dure was performed for the left tibia. The bone fragments of the
anterior half of each tibia were weighed and ground in a sterile
metal mortar. Subsequently, the bone was homogenised in 10.0 ml
phosphate buffered saline (PBS, pH 7.4) using a Polytron PT 3100
tissue grinder (Kinetica Benelux B.V., Best, The Netherlands), 3
minutes at 2500 rpm and 5 minutes at 6000 rpm. Serial 10-fold
dilutions from these homogenates were then plated on blood agar
plates. After an overnight incubation at 37°C the samples were
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counted for viable bacteria. For each tibia, the number of viable
bacteria per gram of bone was calculated (colony forming units per
gram of bone, CFU/g). 
The implants with the remaining surrounding bone of the posterior
half of the tibiae were fixed in a 4% buffered formaldehyde solu-
tion, washed in PBS, and dehydrated by graded series of ethanol.
These samples were embedded in a mixture of methylmethacry-
late/dibuthylphthalate (Merck-Schuchardt, Hohenbrunn,
Germany) in a ratio of 4 to 1. Bis(4-tertiairbutylcyclohexyl)
peroxydicarbonate (Perkadox 16®, AKZO NOBEL, Arnhem, The
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Table 7.1. 
Semiquantitative grading
system used for histologi-
cal scoring of infection.
Eleven items were scored
and a value was assigned
to the severity of inflam-
mation.
Medullary Canal:
leukocytes no less moderate many
0 0 2 4
microabscesses no  less moderate many
0 2 4 6
granulation tissue no light moderate much
0 2 4 6
fibrosis no slight moderate much
0 0 2 4
Cortex:
destruction cortex no slight moderate much
0 2 4 6
enlarged Haversian canals no slight moderate much
0 0 2 4
leukocytes no less moderate many
0 0 2 4
microabscesses no less moderate many
0 2 4 6
granulation tissue no slight moderate much
0 2 4 6
fibrosis no slight moderate much
0 0 2 4
Periosteal Reaction:
quantity no slight moderate much
0 2 4 6
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Netherlands) was suspended as a catalyst. After polymerisation,
nondecalcified sections of approximately 10 µm thick were sawn
perpendicular to the length axis of the implant, using a sawing
microtome (van der Lubbe 1988; Klein 1994). The sections were
stained with basic fuchsin and methylene blue. 
For the histological evaluation, proximal and distal sections of each
tibia with implant were examined for signs of infection using a light
microscope. Semiquantitative scoring of infection was performed
on blinded sections, together with a pathologist, according to the
scoring system described in Table 7.1. This system was derived
from Petty (Petty 1985) and adapted to the current situation of
infection around a noncemented implant. Each sign of histological
abnormality was scored according to severity in none, slight, mod-
erate and many/much. A value was assigned to the items according
to the severity of damage. The sum of values of the proximal and
distal section of each tibia was calculated and averaged for each
infected and non-infected implant subgroup.
Histomorphometry included semiquantitative scoring of the bone
response next to the implants by measurements of bone-implant
contact and bone area next to implants. The percentage of bone-
implant contact and bone area next to the implants was also mea-
sured on blinded sections, using a light microscope (bone-implant
contact) or a macroscope (bone area), coupled to an IBAS image
analysis system (Carl Zeiss, Eching, Germany). Images of the sec-
tions were digitised in a resolution of 768 x 512 pixels. From the
proximal and distal sections of each tibia, the percentage of bone
apposition at the implant surface was measured (Figure 7.3). This
was defined as the percentage of implant length with direct bone-
implant contact (microscope with objective 1.0 x Optovar 1.6
resulting in a pixel size of 6.1 x 6.5 microns). From the proximal
sections only (distal sections were not used for bone area measure-
ments), the percentage of bone area within a radius of 1 mm next
to the implant was measured (Figure 7.4). Bone area measurements
were performed using a macroscope equipped with a Carl Zeiss
Luminar 40 mm objective (Carl Zeiss, Germany) resulting in a
pixel size of 10.1 x 10.6 microns.
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Figure 7.3. 
Histomorphometrical
measurement of bone
apposition at the implant
surface. On a digitised
micrograph in a specific
area (a) the percentage at
which there was direct
bone-implant contact was
measured (b).
Figure 7.4. 
Histomorphometrical
measurement of bone
area. On a digitised
macrograph the percent-
age of bone area within a
radius of 1 mm next to
the implant (a) was mea-
sured (b).
a
b
a
b
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7.2.6. Statistical analysis
The study consisted of two treatment groups (HA and Ti),
with 16 rabbits in each group, receiving 102, 103, 104, or 105 CFU.
In general, statistics was performed using an analysis of variance
with various dependent and independent variables (p ≤ 0.05). We
investigated the effect of implant type and dosage group upon the
severity of infection (log(CFU) or histopathological score) and
upon the bone-implant contact or bone area measurements, for the
left and right tibiae separately. In addition, to obtain further insight
into the relationship between actual infection and bone response,
we performed an analysis of variance on the effect of the presence
or absence of infection at sacrifice upon the bone contact and bone
area data. Furthermore, we calculated the correlation between
log(CFU) with the bone-implant contact and bone area measure-
ments. Statistical calculations were performed using Statview for
Macintosh and SPSS/PC.
7.3. Results
7.3.1. General
Two rabbits died due to a septicaemia after several days and
were replaced. The first few days after the operation, all animals
showed a decrease in appetite, which was more prominent in the
animals that had received a higher dose of bacteria. After 28 days
the mean loss of body weight was 12.2 per cent and 11.0 per cent
for the HA and Ti rabbits respectively. The rabbits that received a
higher inoculum dose lost more in body weight. After one week
postoperatively, an increase in ESR followed the same pattern:
ESR was more elevated in rabbits which received a HA implant.
After 4 weeks there was no difference of ESR in relation to implant
or inoculum (Table 7.2). With respect to the WBC, after one week
only a slight difference was seen between the two different implants
after receiving 105 CFU Staphylococcus aureus: rabbits with a HA
implant had higher WBC than rabbits with a Ti implant. Rabbits
receiving a lower inoculum had no difference of WBC. After four
weeks, the difference of WBC in those two different implant
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groups had decreased (Table 7.2).
Because of technical reasons, X-rays of 5 rabbits could not be made
after 28 days. In the left tibia of 8 out of 27 rabbits radiological signs
of infection, such as periosteal reaction, were seen: in 6 rabbits
which received a HA implant and in 2 rabbits which received a Ti
implant (see Figure 7.5). Six out of these 8 rabbits received a 104 or
105 CFU Staphylococcus aureus. No radiological signs of infection
were seen in the right tibiae. All animals with radiological signs of
infection had a positive culture after 28 days.
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Table 7.2. 
Erythrocyte sedimentation rate (ESR) and white blood cell counts (WBC) (mean ± standard error) before surgery, and at
1, 2, 3 and 4 weeks postoperative.
ESR (mm/hr)
wk  0 wk 1 wk 2 wk 3 wk 4
HA Ti HA Ti HA Ti HA Ti HA Ti
102 1.5 ± 0.5 1.3 ± 0.3 5.5 ± 2.9 1.5 ± 0.3 1.0 ± 0.0 1.3 ± 0.3 1.3 ± 0.3 1.0 ± 0.0 1.0 ± 0.0 1.8  ± 0.8
103 2.0 ± 0.6 2.0 ± 0.7 11.8 ± 9.4 2.0 ± 0.4 1.3 ± 0.3 4.3 ± 3.3 1.5 ± 0.3 1.8 ± 0.5 1.0 ± 0.0 1.0 ± 0.0
104 1.3 ± 0.3 1.0 ± 0.0 24.8 ± 8.8 13.3 ± 9.6 5.3 ± 2.8 4.3 ± 2.6 2.3 ± 0.9 1.5 ± 0.3 2.3 ± 0.6 1.5 ± 0.3
105 1.0 ± 0.0 1.3 ± 0.3 34.5 ± 5.7 29.0 ± 10.0 5.0 ± 3.3 4.5 ± 1.0 2.3 ± 1.3 2.0 ± 0.7 1.5 ± 0.3 2.0 ± 0.0
all 1.4 ± 0.2 1.4 ± 0.2 19.1 ± 4.3 11.4 ± 4.2 3.3 ± 1.2 3.6 ± 1.0 1.8 ± 0.4 1.6 ± 0.2 1.4 ± 0.2 1.6 ± 0.2
WBC (x109/l)
wk  0 wk 1 wk 2 wk 3 wk 4
HA Ti HA Ti HA Ti HA Ti HA Ti
102 4.3 ± 1.3 4.3 ± 0.6 9.2 ± 2.5 7.0 ± 1.3 5.1 ± 1.2 4.8 ± 0.4 3.9 ± 1.3 4.2 ± 0.7 4.4 ± 1.0 4.3 ± 0.9
103 5.0 ± 0.6 4.9 ± 0.6 6.8 ± 0.8 9.0 ± 3.0 5.8 ± 1.4 6.1 ± 1.7 4.7 ± 0.9 6.1 ± 0.8 4.2 ± 0.7 4.7 ± 1.3
104 4.3 ± 0.9 4.3 ± 1.1 8.5 ± 0.7 9.0 ± 0.7 7.6 ± 0.4 7.5 ± 1.6 6.3 ± 0.7 7.4 ± 2.1 5.3 ± 0.3 6.9 ± 0.8
105 3.5 ± 0.6 4.0 ± 0.6 12.8 ± 3.9 8.0 ± 1.3 10.4 ± 1.6 7.5 ± 0.6 8.0 ± 0.6 6.4 ± 0.5 6.8 ± 0.8 5.3 ± 0.3
all 4.3 ± 0.4 4.4 ± 0.4 9.3 ± 1.2 8.2 ± 0.8 7.4 ± 0.8 6.5 ± 0.6 5.7 ± 0.6 6.0 ± 0.6 5.2 ± 0.4 5.3 ± 0.5
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Figure 7.5. 
X-ray of left tibia at day
0 (left) and 28 (right).
After 28 days a peripros-
thetic reaction was visible
(arrows).
Figure 7.6. 
Laser profilometer surface
scans of the HA coated
(a) and non-coated (b)
Ti6Al4V implants. The
roughness of the HA
implant was some what
higher (Ra = 3.74) than
the Ti6Al4V implant
(Ra = 2.96).
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7.3.2. Implant surface characteristics
The surface roughness, as determined by the Ra values, was
2.96 for the Ti implant and 3.74 for the HA implant (Figure 7.6).
Scanning electron micrographs of the Ti and HA implants show
that there is an actual difference in surface morphology between
the two implants (Figure 7.7): the HA implants show a more 
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Figure 7.7. 
Scanning electron micro-
graphs, showing the sur-
face morphology of the
HA coated (a) and non-
coated (b) Ti6Al4V
implants. Bar = 0.1mm.
B
a
b
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“rounded/smooth”-like surface as a result of the vacuum plasma-
spraying, while on the surface of the Ti implants clearly the sharp
edges, as a result of the grit blasting procedure, are visible.
7.3.3. Bacteriology
The results from the bacteriological studies are summarised
in Figure 7.8. In 9 out of 16 rabbits with HA implants, and 6 out of
16 rabbits with Ti implants, bacteriological cultures from samples of
the left tibiae were positive. The number of colony forming units
per gram (CFU/g) increased with higher inoculum doses, as there
was a significant effect of inoculum dosage on bacterial counts (p ≤
0.025). From the left tibiae with a Ti implant contaminated with an
inoculum of 102, 103, 104, and 105 CFU on average none, 1.3±1.3,
2.1±1.2 and 3.7±1.3 log CFU/g (mean ± SEM) Staphylococcus
aureus were retrieved respectively. In the left contaminated tibiae
with a HA implant on average 1.6±1.6, 2.0±2.0, 5.6±1.9 and
6.3±0.7 log CFU/g (mean ± SEM) were retrieved respectively.
The analysis of variance revealed significantly more bacteria in the
HA group than in the Ti group (p ≤ 0.05). In two rabbits, we also
found positive cultures in the right, control tibia (one Ti and one
HA implanted rabbit).
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Figure 7.8. 
Graphical representation
of the results of bacterio-
logical cultures for the
various inoculi and
implant types. Data are
presented as mean (log
CFU) ± standard error.
At high inoculum
dosages, more CFU had
grown in the bone next
to the HA implants than
in the bone next to the
Ti implants.
96
7.3.4. Histology
Histological evaluation of sections of implants not contami-
nated with bacteria (right tibiae) showed a normal cortex without
periosteal reaction and small Haversian canals. Microabscesses,
granulation tissue or fibrosis were not seen and only occasionally a
few leukocytes were observed in the medullary canal. Especially in
sections from left tibiae, which were contaminated with a high
inoculum dosage, we saw severe loss of cortical bone. The remain-
ing cortex showed enlarged Haversian canals and an extensive
periosteal reaction. Around the implant in the medulla and the cor-
tex many leukocytes were found, sometimes accompanied by the
formation of microabscesses and granulation tissue. In some tibiae
extensive fibrosis was observed (Figure 7.9).
The results from the histopathological semiquantitative scoring are
summarised in Figure 7.10. From the left HA tibiae, contaminated
with 102, 103, 104, or 105 CFU, scores (mean ± SEM) were
4.5±1.0, 16.5±9.2, 33.5±8.5 and 49.0±8.7 respectively. In the left
Ti tibiae, scores (mean ± SEM) were 4.5±1.0, 11.0±4.0, 21.5±7.3
and 24.0±3.6 respectively. For the right, not contaminated tibiae
with a Ti or HA implant, scores were below 5.5. With increasing
inoculum dosage, both the infected left tibiae of the HA and Ti
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Figure 7.9. 
Photomicrograph typically
representing a HA coated
Ti6Al4V implant with a
severe infection: remain-
ing destructed cortical
bone (c), debris and pus
characterised by polymor-
phonucleair granolocytes,
nuclear dust and bacteria
(d), and periosteal reac-
tion (p). Bar = 0.5 mm.
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showed an increase in score, as compared to their contralateral con-
trol, and for the left, contaminated tibiae, there was a significant
effect of inoculum dosage on the histopathological scores (p ≤
0.0005). In addition, with increasing inoculum dosage, there was an
increasing difference between the HA and Ti implants, resulting in
higher scores for the HA implants (p ≤ 0.05). This indicates that
with increasing inoculum concentration, HA implants developed a
more severe infection as compared to the Ti implants.
7.3.5. Histomorphometry
In Table 7.3 and 7.4, the results of the bone contact mea-
surements for the proximal and distal sections are presented for the
separate inoculum concentrations. The overall mean percentage of
bone contact with the proximal part of the implants in the right
tibiae was 67.0 for the HA-coated implants and 66.0 for the Ti
implants. In the left, contaminated tibiae, these data were 67.6 per
cent and 60.0 per cent respectively. In the distal sections, the overall
mean percentage of bone contact in the right tibiae was 51.6 for the
HA-coated implants and 38.8 for the non-coated titanium. In the
left, contaminated tibiae these data were 33.4 per cent and 41.4 per
cent respectively. In table 7.5, the results of the bone area measure-
ments for the proximal sections are presented. The overall mean 
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Figure 7.10. 
Graphical representation
of results from semiquan-
titative scoring of the his-
tology for the various ino-
culi and implant types.
Data are presented as
mean of the total histo-
logical score ± standard
error. In the bone with
HA implants, after a
higher inoculum dosage a
higher score was seen as
compared to the Ti
implants.
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percentage of bone area in the right, i.e. not contaminated tibiae
was 38.9 for the HA-coated implants and 37.6 for the non-coated
implants. For the left, contaminated tibiae, these percentages were
42.6 and 35.4, respectively. Statistical analysis revealed for the HA
implants a significant effect of the inoculum concentration (dosage
group) on the bone contact in the distal sections (p ≤ 0.05) and on
the bone area next to the proximal part of the implant (p ≤ 0.05),
suggesting a decrease as a result of increasing inoculum concentra-
tion. For both the left and right sides separately, there were no sig-
nificant differences in bone contact or bone area between the two
implant types. In order to obtain further insight into the relation-
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HA Ti
contaminated control contaminated control
102 75.3 ± 7.9 68.4 ± 5.7 64.5 ± 8.1 58.0 ± 8.3
103 65.6 ± 10.0 76.6 ± 6.4 70.9 ± 6.9 75.9 ± 10.9
104 50.5 ± 11.2 69.5 ± 11.5 56.4 ± 5.0 67.3 ± 18.9
105 82.7 ± 5.4 54.2 ± 7.6 48.2 ± 8.4 62.7 ± 0.8
Table 7.4. 
Mean percentage of bone
contact ± standard error
in the distal sections, as
related to dosegroups for
each implant type and
each side.
Table 7.3. 
Mean percentage of bone
contact ± standard error
in the proximal sections,
as related to dosegroups
for each implant type and
each side.
HA Ti
contaminated control contaminated control
102 59.5 ± 13.0 65.3 ± 12.7 66.8 ± 14.4 55.8 ± 14.3
103 50.0 ± 14.7 68.2 ± 3.1 36.2 ± 9.3 21.2 ± 12.4
104 21.5 ± 10.8 45.7 ± 5.8 41.4 ± 17.4 36.4 ± 13.6
105 2.5 ± 0.0 25.9 ± 9.7 21.3 ± 9.3 41.6 ± 11.0
Table 7.5. 
Mean percentage of bone
area ± standard error in
the proximal sections, as
related to dosegroups for
each implant type and
each side.
HA Ti
contaminated control contaminated control
102 44.1 ± 2.2 43.2 ± 9.1 36.2 ± 4.4 37.8 ± 8.2
103 48.7 ± 3.0 40.6 ± 8.4 41.4 ± 6.3 41.4 ± 5.3
104 35.1 ± 3.3 35.1 ± 2.3 31.6 ± 7.5 37.2 ± 10.7
105 42.4 ± 3.9 35.8 ± 7.4 32.4 ± 7.5 34.1 ± 8.4
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ship between actual infection and bone response, we present in
Figures 7.11 - 7.13 the bone contact and bone area as a function of
the presence or absence of infection (i.e. positive or negative cul-
ture at sacrifice). In the proximal sections (Figure 7.11), the mean
percentage of bone-implant contact was 63.2 for HA implants and
58.5 for Ti implants, when cultures were positive, and 69.1 and
64.2 respectively, when cultures were negative (no significant dif-
ferences). For the distal sections (Figure 7.12), the mean percentage
of bone-implant contact was 13.0 for HA implants and 20.6 for Ti
implants in positive cultures, and 56.6 and 45.0 respectively in neg-
ative cultures. This difference in bone contact between positive and
negative cultures was significant for the HA implants (p ≤ 0.0001),
but not for the Ti implants, although the effect of infection
approached significance (p = 0.0524). With respect to the bone area
(Figure 7.13), we measured in case of an infection mean percent-
ages of 40.2 around the HA implants, and 35.0 around the Ti
implants. When the cultures were negative, these data were 41.0
and 36.9 respectively (no significant differences). With respect to
the correlation between log(CFU) and the bone contact and bone
area measurements, we found a negative relationship for the bone
contact in the distal sections (correlation coefficient -0.69; p ≤
0.0001). No significant correlations were found for the bone con-
tact and the bone area data in the proximal sections.
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Figure 7.11. 
Graphical representation
of the bone-implant con-
tact (mean ± standard
error) for the infected and
not infected HA and Ti
implants in the proximal
sections. No significant
differences in bone
implant contact were
measured between the
infected and not infected
HA and Ti implants.
not infected
infected
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7.4. Discussion
In the present study, we demonstrated that infections of bio-
compatible, noncemented implants can develop after direct conta-
mination of the local implant bed, and are related to the dose of the
original inoculum. Surprisingly, we also found that bacteria were
more likely to grow onto or next to the HA coated implants than
on non-coated Ti implants, and resulted in a more severe
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Figure 7.13.
Graphical representation
of the bone area (mean ±
standard error) around
the infected and not
infected HA and Ti
implants in the proximal
sections. No significant
differences of bone area
were measured between
the infected and not
infected HA and Ti
implants.
Figure 7.12. 
Graphical representation
of the bone-implant con-
tact (mean ± standard
error) for the infected and
not infected HA and Ti
implants in the distal sec-
tions. A significant differ-
ence in bone implant con-
tact was measured between
the infected and not infect-
ed HA implants (* p ≤
0.0001). The difference
between the infected and
not infected Ti implants
was not significant.
not infected
infected
not infected
infected
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histopathological characterisation of peri-implant inflammation and
infection. These results are especially of interest, since the outcome
of clinical studies on HA coated implants are successful and do not
report a higher infection rate (Geesink 1995; Tonino 1995). The
histomorphometrical results on bone contact and bone area can be
considered as a representation of implant fixation (Dhert 2000).
Our results show, in particular for the HA implants, a significant
effect of the inoculum concentration and/or the presence or
absence of infection on the bone contact (distal implant side) or
bone area. These data, in combination with the negative correla-
tion between the number of colony forming units at sacrifice with
the distal bone contact, confirm a relationship between implant
loosening and infection. We speculate that this was probably not
related directly to the implant type, but related to the severity of
infection. Since the HA implants revealed more severe infections,
as we demonstrated with the semiquantitative scores, this can
explain the histomorphometrical results. Wilke et al. demonstrated
for HA coated implants good osseous ingrowth behaviour in spite
of local infection (Wilke 1993). In our study, in case of infection,
the percentage of bone contact around the HA implants in the dis-
tal sections had decreased. This can also be explained by the fact
that infections were more severe around the distal part of the HA
implants (bacteriological cultures could not be differentiated
between proximal and distal side).
Various other groups have studied implant-related infections.
Cordero demonstrated that the presence of PMMA bone cement
required less bacteria to produce an infection in rabbit femora com-
pared to femora without an implant (Cordero 1996a). In another
study, he found that PMMA usually appears to be more prone to
cause an infection in relation to titanium and cobalt-chromium
(Cordero 1996b). Hauke described in a rabbit tibial model for tita-
nium, a lower susceptibility to Staphylococcus aureus infection as
compared with stainless steel (Hauke 1997). Petty demonstrated in a
dog model an early infection of stainless steel and cobalt-chromium
alloys, high-density polyethylene, prepolymerised PMMA, and
PMMA polymerised in vivo. The implants were inserted in the
femoral canal after a suspension of bacteria had been injected.
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Bacteriological and histological evaluation demonstrated that all
implants were more likely to be associated with infection with
Staphylococcus aureus than without an implant. He concluded that
efforts expended in reduction of bacterial contamination when
implants are used are justified (Petty 1985).
A point for discussion in all these studies is how to define implant
infection and cope with negative cultures. In these as well as in our
studies, bacteriological results were applied by counting the direct
culture of bone homogenate, obtained by grinding. This method
has a minimal detectable level of ± 1000 CFU/g. Therefore, a neg-
ative culture does not necessarily mean that no bacteria were pre-
sent. This problem is dealt with in most studies by counting the
number of infected implants (= positive culture) for each treatment.
In the current study, we quantified the number of bacteria that
were cultured from the tibiae, as a function of inoculum dose and
implant type (“dose-response curve”). Therefore, for our statistical
calculations, we assigned an absolute value of 0 CFU/g to each
negative culture, which increased the variation of the data and
reduced the possibility of demonstrating significant differences.
Despite this, we still found significant differences between HA and
Ti. To increase the readability the graph that demonstrates this
dose-response curve (Figure 7.8), we however assigned the absolute
value of 1000 CFU/g (= the minimal detectable level) to each neg-
ative culture. The reader should realise that in reality, this value will
be somewhere in-between 0 and 1000 CFU/g. Since we also stud-
ied the peri-implant regions histologically, we could correspond
negative cultures with histopathological signs of infection. In case
of a negative culture, in the majority of cases the histopathological
scores did not indicate a local inflammatory reaction. 
In 1987, Gristina described the “race for the surface” theory
(Gristina 1987a): “The competition between host tissue cells and bacteria
to adhere onto an implanted surface is “won” by the organisms that arrive
first at the implant surface”. So a fast tissue integration of a bioactive
material (HA coating) could result in less bacteriological colonisa-
tion, as compared to a slower tissue integration of a biocompatible
surface (Ti6Al4V). HA coatings are bioactive and well known for
their favourable bone-bonding properties, as compared to non-
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coated Ti6Al4V (Geesink 1987; Geesink 1988; Soballe 1990; Dhert
1991; Dhert 1993). Biocompatibility could be a determining factor
in infection susceptibility or in the development of an infection
after contamination of different materials. On the other hand, phys-
ical parameters such as surface morphology, porosity, charge, or
total surface area could also influence bacterial colonisation.
Since our aim was to use the materials as they are applied in the
clinical situation, the implant surfaces were not standardised with
respect to surface area and porosity. It was previously mentioned
that surface roughness may influence bacterial adhesion (McAllister
1993; Quirynen 1993). In addition, according to Naylor et al., the
effect of implant surface roughness on infection is also related to
differences in colonisation velocity (Naylor 1989a). The HA coat-
ing had a porosity of less then 10%, and as seen on Figure 7.7, there
are actual differences in surface architecture between the two
implant types. The presence of pores can increase the absolute sur-
face area, despite comparable roughnesses. It can also be hypothe-
sised that bacteria (in a liquid milieu) can more easily migrate into
the pores than the tissue cells after implantation, and that once the
bacteria adhered to the coating surface in the pores, they can be
difficult to access by the host defence system (Cordero 1994). These
factors should be taken into consideration when interpreting the
differences that were found between the HA and Ti implants in the
current study.
In the current study, we used concentrations of Staphylococcus
aureus, ranging from very low (102) until relatively high (105). It
should be realised that especially the higher concentrations are most
likely not to occur perioperatively under uncomplicated, standard
circumstances. However, the results from our study do indicate that
HA coated implants can, in the presence of bacteria (e.g. periopera-
tive contamination) more easily develop a more severe infection
than non-coated Ti implants. This suggests that precautions to pre-
vent contamination (sterility) or infection (perioperative antibiotics)
are even more important for the highly biocompatible HA coated
implant. This is in particular the case for patients with a higher sus-
ceptibility to infection.
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8.1. Introduction
An infection of a prosthesis in orthopaedic surgery is a very
serious, sometimes life-threatening, complication. In the majority
of the cases the prosthesis has to be removed, followed by intra-
venous antibiotic therapy. In some situations a new prosthesis can
be inserted, usually at least 6 weeks after removal of the infected
prosthesis. However, more than once it is decided to do a
Girdlestone resection arthroplasty. Thirty years ago, the first total
hip replacements showed infection rates of 7 to 11 per cent
(Charnley 1969; Wilson 1972). Improvements in prosthesis design
and surgical technique, the recognition of the high-risk patient and
the peri-operative use of antibiotic prophylaxis are responsible for a
decrease of infection rate as a result of peroperative contamination.
Today this infection rate is about 1 to 2 per cent for a total hip
arthroplasty and 4 per cent for a total knee arthroplasty
(Walenkamp 1990; Sanderson 1991). Nevertheless, this is still a
considerable group of patients when realised that in the
Netherlands in 1992 more than 20,000 total hip and knee prostheses
were implanted and that in the United States up by now almost 2
million patients have been treated with a total hip implant. It is
expected that the number of revisions of the implants because of an
infection will further increase in the future.
Prosthesis related infections can be split in two groups, based upon
their pathogenesis. Firstly, the early postoperative infections, which
can be caused peroperatively by direct contamination due to conta-
minated dust particles in the air, gloves or surgical instruments, or
by a disturbed wound healing (wound haematoma and wound
necrosis). Secondly, the late postoperative infections, of which the
first symptoms appear more than one year after operation. The late
postoperative infections are usually a result from haematogenous
spread of bacteria from a distant focus. Various authors have esti-
mated the prevalence of haematogenous implant infections to be
approximately 0.3 to 1.0 per cent (Charnley 1969; Ahlberg 1978;
Gristina 1983; Jaspers 1985; Schutzer 1988; Nelson 1990).
However, it is difficult to link a preceding bacteremia to a prosthe-
sis-related infection, which may become manifest weeks or months
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later. It has been postulated that the most common sources for
haematogenous total joint infection are skin and soft tissue (46%),
dental (15%), and urinary tract (13%) infections (Maderazo 1988).
Still, the mechanisms, prevention and therapy of late haematoge-
nous infections continue to be a source of discussion (Blackburn
1991). It is therefore of great importance to get a better insight into
the pathogenesis of such infections to improve the prophylactic and
therapeutic options. In addition, the relationship between loosening
of the prosthesis and (low-grade) infection is still unclear. It can
even be speculated that interface phenomena such as fibrous encap-
sulation and micro-motion are not only related with loosening, but
also with a lower resistance against infection.
Since no reliable and reproducible animal models are available to
study late implant infections, the aim of the current study was to
develop an experimental animal model that allows us to study
haematogenous implant infections.
8.2. Materials and Methods
A total of 10 New Zealand White rabbits, weighting 3.0-3.5
kgs, were used in the present study. The rabbits were housed indi-
vidually in cages and fed with 80-100 g Hope Farms rabbit diet
LKK-20 (Hope Farms Standard Laboratory Diet LKK-20, Hope
Farms B.V., Woerden, The Netherlands). Water was given ad libi-
tum. After contamination of the implant, the animals were cared
under the same conditions behind a barrier.
Five cylindrical non-coated, grit-blasted Ti6Al4V implants and 5
cylindrical hydroxyapatite coated Ti6Al4V implants (length 50 mm
and final diameter 3.9 mm) were used in the present experiment.
The thickness of the hydroxyapatite coating was approximately 50
microns. The coating was applied onto the surface by the plasma-
spray technique (HC Implants B.V., Leiden, The Netherlands).
The implants were sterilised in an autoclave prior to use.
In Figure 8.1, the various steps in the animal experiment are sum-
marised. In a first surgical procedure, the implants were placed in
the medullary canal of the proximal right tibia. The surgery was
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performed under general anaesthesia. The rabbits were premedicat-
ed with 4 mg acepromazinemaleaat (Vetranquil®, Sanofi Sante
B.V., Maassluis, The Netherlands), 4 g methadone and 0.5 mg
atropine (Atropinesulfaat, Kombivet, Etten-Leur, The
Netherlands). The anaesthesia was initiated by an intravenous injec-
tion of 8-12 mg etomadaat (Hypnomidate®, Janssen Pharmaceutica
B.V., Tilburg, The Netherlands). After intubation, inhalation
anaesthesia was followed by a mixture with O2 and N2O in a ratio
of 1 to 1 and halothane 1%. Peroperatively, 200 mg amoxycilline
(Clamoxyl®, SmithKline Beecham, Rijswijk, The Netherlands)
was given as infection prophylaxis. The right leg was shaved and
prepared for surgical procedure with 10% povidone-iodine
(Betadine® solution, Dagra, Diemen, The Netherlands). After a
CHAPTER 8
Figure 8.1. 
Artist’s impression of the
various steps in the
experimental animal
model. In step I, the
implant is placed in the
medullary canal of the
proximal right tibia of a
NZW rabbit. In step II,
four weeks after the first
operation, Staphylococcus
aureus bacteria are inject-
ed into the local blood-
stream through a catheter
which is brought in the
right carotid artery and
moved down until in the
right femoral artery.
Finally, in step III, the
animal is sacrificed, and
samples for bacteriological
and histological examina-
tion are obtained.
I
III
II
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parapatellar incision the knee joint was opened. Anterior to the
insertion of the anterior cruciate ligament on the tibia, the
medullary canal was opened with an awl, and reamed up by hand
until a length of at least 50 mm and a diameter of 3.9 mm.
Subsequently the implant was press-fit inserted in the tibial
medullary canal. The joint capsule and skin were closed in layers
with Vicryl (Ethicon, Norderstedt, Germany). Postoperatively, X-
rays were made to check the implant position (Figure 8.2). Post-
operative pain-relief was reached by a single dose of 0.1 mg
buprenorfin (Temgesic®, Reckitt and Colman Products, Kingston-
upon-Hull, United Kingdom) i.m. If necessary, a second dose was
administered to the animal.
A second surgical procedure was performed at least 4 weeks after
the first operation under comparable anaesthesiological circum-
stances, but now without antibiotic prophylaxis. The neck of the
rabbit was shaved and prepared with 10% povidone-iodine. Then a
longitudinal incision over the right carotid artery was made. The
artery was identified and mobilised. Next a catheter was brought in
and under fluoroscopy moved up until in the right femoral artery
(Figures 8.3 and 8.4). This artery supplies the local implant bed.
Through this catheter the animals subsequently received 1 ml of
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Figure 8.2. 
Radiograph showing an
implant in the right tibia
of a NZW rabbit.
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saline containing a varying concentration of Staphylococcus aureus,
strain Wood 46. Since the purpose of the study was to develop the
animal model, the number of bacteria was varied between 108 and
109 to find the optimal challenge dose. This dose range is higher
than used for the experiments described in Chapter 7, but in the
present experiment, the bacteria are expected to flow through the
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Figure 8.3. 
Photograph of the right
carotic artery, which is
catheterised under general
anaesthesia. The catheter
is moved up until in the
right femoral artery.
Figure 8.4. 
Fluoroscopy of the right
hind limb after injection
of contrast fluid in the
right femoral artery to
show the blood supply of
the implant bed.
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bloodstream in the implant bed, several weeks after implantation,
instead that bacteria are introduced simultaneously with the implant
(direct infection). After injection of the bacteria in the local blood-
stream, the catheter was removed and the carotid artery was ligated
with Vicryl. The skin was also closed with Vicryl. Subsequently,
the animals were examined daily. Body temperature was measured
and blood samples were taken for erythrocyte sedimentation rate
(ESR) and white blood-cell count (WBC).
The rabbits were sacrificed at least one week after the second oper-
ation with 5 ml Pentobarbital N2 (Euthesate
®, Apharmo B.V.,
Arnhem, The Netherlands) (200 mg/ml). After sacrifice, sterile
bone and marrow biopsies were taken next to the implant and cul-
tured. Also cultures of liver, spleen, lung and kidney were obtained.
The specimens were cultured by rolling them onto blood agar
plates. In addition, specimens were suspended in Mueler-Hinton
broth (Mueller-Hinton broth, Difco, Detroit, Michigan, USA).
Plates and broth were incubated for 48 hours at 37°C and inspected
for growth of Staphylococcus aureus and possible contamination after
24 and 48 hours. Identification of the bacteria occurred by standard
bacteriological dilution and counting methods. The implants with
the remaining surrounding bone were fixed in a formaldehyde
solution, dehydrated and embedded in PMMA. Thin (10 micron)
sections were cut using a sawing microtome and stained with basic
fuchsine and methylene blue (van der Lubbe 1988). These sections
were examined under a light microscope.
8.3. Results
Most animals passed the first operation without complica-
tions. Two rabbits had a disturbed wound healing as a result of bit-
ing at the stitches. These wounds healed secondary without addi-
tional complications. One rabbit had a spiral fracture of the tibia
after inserting the implant. This fracture consolidated without a
problem during the first postoperative weeks.
Our first goal was to find an optimal challenge dose, which resulted
in a contaminated implant, without serious systemic reactions. The
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first rabbit received 109 colony-forming units (CFU) Staphylococcus
aureus, and died after one day due to a sepsis. A second rabbit
received 108 CFU and did not develop any clinical signs of infec-
tion. At sacrifice, after one week, all cultures were negative. The
third rabbit was challenged with a dose of 3.3x108 CFU. In this ani-
mal we saw no clinical signs of illness, but only a slight increase of
the WBC for a few days. It was decided not to sacrifice this animal
after one week, but to wait and follow the clinical course. When
this animal was sacrificed after 12 weeks, there was a positive cul-
ture of the bone samples with Staphylococcus aureus. All other rab-
bits (n=7) received a dose of 5x108 CFU Staphylococcus aureus. In
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Table 8.1. 
Summary of results showing dosages, results from blood tests and bacteriological analyses and complications.* = preliminary
death of animal; WBC = white blood cell counts; ESR = erythrocyte sedimentation rate; - = no change; ± slight increase
during first postoperative days; n.a. = not applicable.
Animal Dose Implant Follow-up Blood tests Bone Organ Remarks
culture culture
1 109 HA 1 day* WBC: n.a S. aureus S. aureus S. aureus sepsis
ESR: n.a.
2 108 HA 7 days WBC: - none none no infection
ESR: -
3 3.3 x 108 HA 12 days WBC: ± S. aureus none
ESR: -
4 5 x 108 HA 7 days WBC: ± S. aureus lung: S. aureus
ESR: ±
5 5 x 108 HA 7 days WBC: ± S. aureus none
ESR: ±
6 5 x 108 Ti6Al4V 7 days WBC: ± S. aureus none
ESR: ±
7 5 x 108 Ti6Al4V 7 days WBC: - S. aureus none
ESR: ±
8 5 x 108 Ti6Al4V 2 days* WBC: n.a. n.a. Proteus Proteus sepsis
ESR: n.a.
9 5 x 108 Ti6Al4V 2 days* WBC: n.a. S. aureus Proteus Proteus sepsis
ESR: n.a.
10 5 x 108 Ti6Al4V 28 days WBC: - S. aureus none
ESR: -
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these animals, signs of illness were present in the first few days after
surgery, as represented by refusal to eat, lethargy and an increase of
body temperature. Laboratory tests revealed a slight increase of
ESR and WBC during the first postoperative week. Two rabbits
died preliminary, after two and three days respectively, due to a
Proteus infection. Four of the remaining five animals were sacrificed
after one week, and one rabbit was sacrificed after four weeks. At
sacrifice, all animals showed that cultures of bone and/or marrow
along the interface were positive for Staphylococcus aureus. In one
rabbit there was a positive culture of lung tissue as well, but all
other organ tissue cultures were negative for Staphylococcus aureus.
In Table 8.1, these results are summarised. 
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Figure 8.5. 
Histological appearance of
a hydroxyapatite coated
implant. (a) Survey
micrograph showing bone
and marrow in contact
with the implant surface.
Bar = 0.25 mm
(b) Detail of bone-
hydroxyapatite coating
interface showing strings
of cocci between coating
and bone (arrows). 
Bar = 0.01 mm
a
b
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The histological analysis revealed that all implants were properly
incorporated in the surrounding bone and that especially the
hydroxyapatite coated implants showed an intimate bone-implant
contact (Figure 8.5a). There were no signs of bone resorption,
loosening or fibrous encapsulation. Incidentally a mild, focal
inflammation was present along the implant surface, as represented
by polymorphonucleair granulocytes and macrophages. Also Gram
positive cocci were detected occasionally in remodelling lacunae
and blood vessels near the implant surface (Figure 8.5b).
8.4. Discussion
To study implant related infections in orthopaedic surgery,
various experimental models have been applied. The relationship of
infection of metal implants with Staphylococcus aureus has been
demonstrated by Barth (Barth 1989). Regarding the implantation in
bone, only a few studies relate to implant infection. Petty demon-
strated in a dog model the early infection after peroperative conta-
mination of stainless steel and cobalt-chromium with Staphylococcus
aureus (Petty 1985). In another report on direct implant infection
and bony integration, Wilke showed that even under persistent
infection with Staphylococcus aureus, hydroxyapatite coated implants
were able to establish an intimate bone-coating contact (Wilke
1993). In Chapter 7, we described the susceptibility of HA coated
and non-coated Ti6Al4V implants to infection. However these
studies are based upon peroperative introduction of bacteria to the
implant bed and do not address the clinical problem of late
haematogenous implant infections. Several attempts have been
made to investigate haematogenous implant infections in experi-
mental models through intravenous inoculation of cemented knee
(Blomgren 1981) or hip (Southwood 1985) prostheses. However,
the systemic challenge with bacteria resulted in a mortality up to 50
per cent due to sepsis. In addition, these studies focused only at the
infection rate of cemented implants. Our study was a step-by-step
pilot experiment to develop an animal model to study late
haematogenous infections of cementless implants, without serious
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systemic complications. We chose the New Zealand White rabbit
for our model. In earlier studies this animal proved to be suitable to
study arthritis and osteomyelitis (Schurman 1978; Marks 1980;
Blomgren 1981), and as a model for direct infection of a tibial
implant (this thesis). In contrast with previous studies by other
investigators, we injected the bacteria through a catheter that was
brought in the femoral artery. An advantage of this method is that
the bacteria are injected into the local bloodstream, so the fraction
of bacteria not passing the implant bed (e.g. the right femoral
artery) is minimal. Thus, the dose will be more precise and locally a
relative high dose can be given. In our study, two animals died
because of a Proteus infection. Both animals were operated and
injected with Staphylococcus aureus on the same day. Since Proteus is a
commensal micro-organism in the rabbit, and any deterioration in
physical condition can cause a Proteus infection, we speculate that
this complication is a result of the surgical procedure or is related
with the infection with Staphylococcus aureus. 
Histological examination showed occasionally bacteria present near
the implant surface without signs of bone resorption and loosening
of the implant. According to Wilke (Wilke 1993), the incorpora-
tion of the implants in bone is also related with the infection sensi-
tivity of an implant. In the present study the relative short follow-
up of one week for most animals was sufficient for the evaluation of
the model, but to study the local processes of possible resorption of
bone and loosening of the implant after infection, longer follow-up
periods will be necessary. 
The present study demonstrated that injection of Staphylococcus
aureus into the local bloodstream of an intramedullary implant in
the rabbit tibia can result in a contamination of the implant bed, as
demonstrated by positive cultures for bone and/or marrow near the
implant. In our study, a dose of 5x108 CFU was successful in reach-
ing a local implant bed contamination, but it should be realised that
this dose was specific for the current study. Differences in strain,
breeder, age of rabbit and even individual differences in resistance
against staphylococci, for instance as a result of previous skin (feet)
infections that can occur in rabbits that are housed for a longer
period in metal cages of an animal lab, can exist. In subsequent
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studies, standardisation with respect to age and breeder is necessary,
and it is recommended again to vary the number of bacteria in a
specific dose range. In the current study, the optimal dose was
5x108 CFU, and by injecting these bacteria in the local blood-
stream, the incidence of systemic infection was low. It is concluded
that in rabbits, with catheterisation of a femoral artery and subse-
quent injection of bacteria, it is possible to create a haematogenous
infection of a tibial implant, located in the distal bloodstream of the
catheterised femoral artery. It is recommended to focus further
studies on haematogenous infections with this model at possible
effects of implant surface, osseointegration, follow-up, or at various
prevention measures such as antibiotic prophylaxis. This falls how-
ever beyond the scope of the current thesis.
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Infection in orthopaedic surgery is a serious and growing
problem with a considerable physical and social impact on the
patient. Especially the introduction of implants in orthopaedic
surgery has resulted in a new kind of infection, prosthetic joint-relat-
ed infection. Despite advances in diagnosis, more effective antibiotics
and refined surgical techniques infections remain a formidable chal-
lenge. Our understanding of the pathogenesis of infection is incom-
plete and both management and prevention far from optimal.
The author’s interest in orthopaedic infections was initiated
by the diagnostic difficulties, variability in outcome and above all,
the heterogeneity of the problem of orthopaedic infections. It stim-
ulated to a study of the literature (Chapter 2), and several clinical
studies (Chapters 3 to 5). The outcome of these investigations,
summarised in Chapter 6, led to several questions for experimental
studies. These studies are presented in Chapters 7 and 8.
Based upon the currently available literature, in Chapter 2 the
present knowledge of prosthesis-related infections is summarised. A
review is given from a clinical, practical as well as from pathogenet-
ical viewpoint. The epidemiology and classification of these infec-
tions in orthopaedics is described. Despite preventive measure-
ments, because of an ageing population and increase in the
frequency of total joint replacement operations, infection of an
orthopaedic implant still is a source of considerable morbidity, and
the problem is expected to increase in the years ahead. It can be
difficult to make the correct diagnosis of an infected arthroplasty.
Only the combination of clinical, laboratory and imaging investiga-
tions enables the clinician to reach the diagnosis with an acceptable
degree of certainty. In many cases, an infection can be diagnosed or
excluded on the basis of a carefully obtained clinical history and the
determination of the sedimentation rate and the C-reactive protein
level. Other preoperative investigations, such as radiography,
arthrography, radionuclide imaging, aspiration of the joint and per-
operative investigations, such as frozen sections, Gram stains and
cultures, may provide additional proof. Peroperative cultures are
most accurate. However, their usefulness is offset by false-positive
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and false-negative results. For treatment and prognosis, it is impor-
tant to know when and how an infection actually started to devel-
op, and in which patient with his or her specific profile. A classifi-
cation system of infection of orthopaedic implants was proposed by
Coventry and later amended by Fitzgerald et al. To facilitate the
management of the patients with an infected hip arthroplasty,
Estrada described a new classification (Table 2.1). This classification
system is based on the moment of diagnosis of infection, and on
how the implant was infected. Because also other patient-related
factors play an important role in treatment of prosthesis-related
infections, this classification has its limits and can therefore only be
used as a rough guideline for treatment. A direct infection that
appears within 4 weeks after implantation of a primary arthroplasty
can be treated by debridement in combination with antibiotics
only. Also an acute haematogenous infection can be treated in this
way. Longer existing infections are treated by antibiotics only, an
exchange arthroplasty (one- or two-stage) or a resection
(Girdlestone) arthroplasty. Less frequently used treatments are
arthrodesis or disarticulation. The choice of treatment is dependent
on the health of the patient, the available bone stock, the quality of
the soft tissues, the virulence of the infecting micro-organism and
the mental state of the patient. In addition, the underlying patho-
genesis of implant-related infections is described in this chapter.
The adhesion of bacteria to the surface of human tissue or an
implanted biomaterial surface is the step that precedes any
orthopaedic infection. At the moment of implantation, a biomateri-
al surface presents the available free energy sites, which await physi-
cal or chemical bonding, first from ambient protein molecules and
subsequently, or concomitantly, from available cells. The so-called
“race for the surface” theory, as postulated by Gristina, suggests
competition between tissue and bacterial cells for implant material
surfaces. Successful colonisation by one cell type favours dominance
of this cell and exclusion of later arrivals. According to this theory,
if tissue cells arrive first at a biomaterial surface and a secure bond is
established, bacteria will be confronted by living, integrated cells
and unable to colonise. If not traumatised or altered, an integrated
tissue is resistant to bacterial colonisation by virtue of its viability,
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intact cell membranes, extramembranous polysaccharides and host
defence mechanisms. If however, bacteria arrive first at the surface
and colonise the biomaterial, an infection will develop. Such bio-
material infections almost always prevent successful integration of
the implant. After adherence of some strains of bacteria to an
implant surface, a layer of slime is produced, which makes bacteria
less accessible to the host defence system and decreases antibiotic
susceptibility significantly. These bacteria can then remain “quiet”
on the surface of a material for a long period of time. However,
when environmental influences change, such as a decreased host
immune function or poor tissue ingrowth around a prosthesis, these
bacteria can induce a manifest clinical infection. Biomaterials are
susceptible to infection because for the most part they are not well
integrated. Well-integrated devices are infrequently infected unless
an unfavourable situation is created by perturbed host defences,
trauma or exposure to massive infecting inoculi.
In Chapter 3, the haematogenous route as an important path-
way for orthopaedic infections is described through a retrospective
analysis of 28 children with an osteomyelitis. The patients were
evaluated by chart review for history, clinical presentation, diagnos-
tic work-up, treatment and outcome. The patients had an acute or
a chronic osteomyelitis with an average follow-up of 3.7 and 2.7
years, respectively. All children were treated surgically: a cortical
window was made, pus was drained and necrotic tissue was excised.
Positive cultures were obtained in 9 out 12 and 7 out of 16 children
with respectively acute or chronic osteomyelitis. Subsequently, all
patients were treated with intravenous and oral antibiotics. After
treatment, all but one patients were clinically well and the infection
parameters had returned to normal values. Three patients had resid-
ual signs (ankylosis, decreased function). In addition to surgical
intervention, six weeks of antibiotic therapy appears to be sufficient
to eradicate acute as well as chronic osteomyelitis in children.
In Chapter 4, the results of a retrospective analysis of 47
patients with a prosthetic hip infection are described. The specific
goals of the analysis were how diagnosis was reached, the results of
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the cultures, the management of treatment, and the infectious and
functional outcome of treatment. Diagnosis was based upon clinical
presentation, laboratory investigations and radiological and eventu-
ally nuclear imaging studies. Two patients died because of the
infection. Most prostheses were infected by direct contamination.
In addition, in 5 prostheses (11%) a haematogenous source of infec-
tion could be ascertained. On the basis of treatment, the patients
were divided into three groups. Group I comprised 9 patients who
were managed with debridement and retention of the original
components. Group II comprised 22 patients who were managed
with resection arthroplasty and group III comprised 16 patients
who had removal of the prosthesis and debridement followed by
immediate (n = 4) or staged reimplantation (n = 12). The infection
was successfully eradicated initially in 35 patients (group I 44%,
Group II 73%, Group III 94%). At follow-up, 31 out of 35 patients
still being alive answered a questionnaire about pain and functional
outcome. Patients with a prosthesis in situ had less pain and a better
ability to walk. Despite the small population, relative short follow-
up and variability of treatment in this population, it is concluded
that the eradication of an infected arthroplasty of the hip by only
surgical debridement and antibiotics is suboptimal therapy.
Removal of the prosthesis is superior for eradication of the infec-
tion. In case the prosthesis cannot be replaced, the functional out-
come of the so-called Girdlestone situation is poor. For better func-
tional results, an exchange of the prosthesis, when medically and
psychologically possible, is advised.
In Chapter 5, a treacherous complication of an abdominal
infectious process is described, emphasising the significance of the
haematogenous route for prosthesis infections. In this chapter, a
clinical lesson is presented describing the development and course
of a haematogenous hip prosthesis infection after an abdominal
infection. A 66-year-old woman, with a total hip prosthesis in situ,
developed an acute cholecystitis. She was treated by a cholecystec-
tomy and Clostridium perfringens was isolated. After several months
she developed complaints suggesting an infection of the prosthesis.
At aspiration of the hip joint, the same Clostridium perfringens was
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isolated. She was successfully treated by a two-stage revision proce-
dure of the prosthesis and antibiotic therapy. This case demonstrates
that patients with an orthopaedic endoprosthesis in situ are at risk to
develop a late infection of this implant with the causative agent of a
gallbladder infection. If patients with a total joint prosthesis develop
bacterial infections at distant sites, they should be treated immedi-
ately and aggressively with appropriate antibiotics to prevent
haematogenous spread to the prosthetic joint
The review of the literature and clinical investigations as
described in chapters 2 to 5 led to several questions, which were
the basis for the experimental studies. In Chapter 6, the aims for
these studies were defined. The basis for further studies in general
was the lack in knowledge of the pathogenesis of implant-related
infections. One of the questions concerned the relationship
between infection susceptibility and biocompatibility of common
implant surfaces. The “race for the surface” theory implies that
when cells arrive first at a material surface after implantation, the
implant will not be accessible for bacterial adhesion any more,
while when bacteria arrive first at the surface, tissue integration
cannot take place. This was further discussed in Chapter 7. Another
problem relates to haematogenous infections in orthopaedics,
which form a substantial part of all infections. To gain a better basic
and clinical knowledge of the pathogenesis of haematogenous
orthopaedic implant infections, appropriate animal models are nec-
essary, but not yet available. Therefore, an experimental animal
model to study haematogenous implant infections was developed as
a starting point for further studies. The development of this model
was described in Chapter 8, as final chapter on experimental studies
in this thesis.
In Chapter 7, the question of infection susceptibility in rela-
tion with implant surface characteristics and biocompatibility is
addressed. The main question here was whether there is a differ-
ence in infection susceptibility of two common orthopaedic
implant surfaces with a different biocompatibility. Will a more bio-
compatible surface indeed be in favour of the tissue cells, as postu-
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lated by Gristina’s “race for the surface” theory? This was addressed
by studying two clinically used implant surfaces: grit-blasted
Ti6Al4V and hydroxyapatite coated Ti6Al4V. Thirty-two New
Zealand White (NZW) rabbits were operated on. A hydroxyapatite
coated (HA) or non-coated (Ti) Ti6Al4V implant was inserted into
both tibiae. Prior to implantation the left tibia was contaminated
with increasing concentrations of Staphylococcus aureus (102-105
CFU). Four weeks after implantation, half of the tibial bone adja-
cent to the implant was harvested for bacteriological examination
and quantification. For the histological evaluation, sections of the
implant with the remaining tibia were examined by semiquantita-
tive scoring. Histomorphometrical data, which are a representation
of implant fixation, were obtained by measuring the part of the cir-
cumference of the implant that was in direct contact with bone and
by measuring the quantity of bone around the implants (within a
radius of 1 mm from the outer diameter of the implants).
Bacteriological data showed a significant effect of inoculum dose
and implant type on the culture outcome: more bacteria were
retrieved from the HA coated implants as compared to the non-
coated Ti implants. Histology showed more severe infections for
the HA implants as compared to the Ti implants.
Histomorphometry revealed in particular for the HA implants, a
relationship between the inoculum concentration and/or the pres-
ence or absence of infection with the bone contact or bone area.
This confirms a relationship between implant loosening and infec-
tion. We demonstrated that infections of biocompatible, nonce-
mented implants can occur and are related to the dose of the origi-
nal inoculum. In addition, the more biocompatible HA implant
showed in this study more severe infections as compared to the Ti
implants, which at least suggests that the “race for the surface” the-
ory should be reconsidered for the more complex in vivo situation.
The development of an experimental animal model to study
haematogenous infections of cementless implants is described in
Chapter 8. Ten New Zealand White rabbits were subjected to a
two-stage surgical procedure. A cylindrical Ti6Al4V or
hydroxyapatite coated Ti6Al4V implant was inserted into the right
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tibia. After a period of at least 4 weeks, the implants were selective-
ly contaminated with varying doses of Staphylococcus aureus, via the
right femoral artery. During the postoperative period, the animals
were examined daily and blood samples were taken. After at least 1
week, the animals were sacrificed and biopsies of bone, marrow,
liver, spleen, lung and kidney were cultured. The remaining
implant with surrounding bone was prepared for histological exam-
ination. Injection of 5x108 colony forming units caused positive
cultures in all cases and minimal systemic reactions. The histological
sections showed minimal numbers of bacteria and signs of only a
mild, focal inflammation were seen. It was concluded that this ani-
mal model was useful for further studies of haematogenous implant
infections on, for instance the effect of implant surface, osseointe-
gration, follow-up, and various prevention measures such as antibi-
otic prophylaxis.  
The investigations presented in this thesis do not provide all
the answers to the many questions related to pathogenesis of
orthopaedic infections, their course, and management. Further
research is necessary, especially since the problem is very complex,
but also since the problem is growing as a result of the rapid
increase in the use of biomaterials in orthopaedic surgery. Clinical
studies are necessary, but have their limitations. Many factors, such
as microbiological, patient and even emotional factors, play a role
in these infections. The number of patients in clinical studies is usu-
ally too small to permit sound conclusions. Therefore experimental
studies remain important for answering a number of specific ques-
tions in the field of orthopaedic infections. More knowledge is
required about the pathogenesis of these infections. Also more reli-
able and faster diagnostic tools (polymerase chain reaction, imaging)
is urgently needed and should be developed. And lastly, improve-
ments and standardisation of treatment modalities should be the
goals for the immediate future. The animal models described in this
thesis, and the results of the specific experiments we performed
using these models will hopefully be a small but significant step
towards a better understanding of these infections, and provide a
basis for new experimental studies.
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Infecties zijn binnen de orthopaedie een ernstig en groeiend
probleem met een belangrijke fysieke en sociale impact op de pa-
tiënt. Met name de introductie van implantaten heeft geresulteerd
in een nieuw soort infectie, de gewrichtsprothese gerelateerde
infectie. Ondanks de vooruitgang in diagnostiek, de beschikbaar-
heid van meer effectieve antibiotica en verbeterde chirurgische
technieken, blijven infecties een enorme uitdaging. Onze kennis
van de pathogenese van infecties schiet tekort; zowel therapie als
preventie zijn bij lange na optimaal.
De belangstelling van de auteur voor de infecties binnen de
orthopaedie werd gewekt door de diagnostische problemen, de
wisselende resultaten van behandeling en met name de heteroge-
niteit van het probleem van de orthopaedische infecties. Het leidde
tot een bestudering van de literatuur (Hoofdstuk 2) en een aantal
klinische studies (Hoofdstuk 3 t/m 5). De resultaten van deze stu-
dies, samengevat in Hoofdstuk 6, leidden tot een aantal vraagstellin-
gen voor experimentele studies. Deze studies worden gepresenteer
in Hoofdstuk 7 en 8.
Gebaseerd op de thans beschikbare literatuur wordt in
Hoofdstuk 2 een samenvatting gegeven van de huidige kennis over
de prothese gerelateerde infecties. Een overzicht wordt gegeven
vanuit zowel een klinisch, praktisch en pathogenetisch gezichts-
punt. Ook de epidemiologie en classificatie van deze infecties wor-
den beschreven. Ondanks preventieve maatregelen neemt, vanwe-
ge een ouder wordende populatie en een daarmee samengaande
stijging van het aantal totale heupprothese operaties, de morbiditeit
van infectie van orthopaedisch implantaten toe. Dit zal naar ver-
wachting de komende jaren nog verder toenemen. Het kan moei-
lijk zijn om tot de juiste diagnose van een geïnfecteerde gewrichts-
prothese te komen. Alleen de combinatie van klinisch,
laboratorium en beeldvormend onderzoek stelt de clinicus in staat
om tot de juiste diagnose te komen binnen acceptabele grenzen van
zekerheid. In veel gevallen kan een infectie al worden gediagnosti-
seerd of uitgesloten op basis van een zorgvuldig klinisch onderzoek
en bepaling van BSE en/of CRP. Radiologisch onderzoek, nucle-
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air geneeskundig onderzoek, aspiratie van vocht rondom het
gewricht, evenals peroperatief verrichte onderzoeken, zoals beoor-
deling van vriescoupes, Grampreparaten en kweken, kunnen aan-
vullende zekerheid geven. Peroperatief afgenomen kweken zijn het
meest nauwkeurig, hoewel ze soms ook fout-positieve of fout-
negatieve resultaten kunnen geven. Voor de behandeling en prog-
nose is het van belang te weten wanneer en hoe een infectie zich
openbaarde, en bij welke patiënt met zijn of haar specifieke ken-
merken. Een classificatiesysteem voor infecties van orthopaedische
implantaten werd opgesteld door Coventry en later verbeterd door
Fitzgerald. Om de behandeling van de patiënten met een geïnfec-
teerde heupprothese te vergemakkelijken, ontwikkelde Estrada een
nieuwe classificatie (Tabel 2.1). Dit classificatiesysteem is gebaseerd
op het tijdstip dat een infectie wordt gediagnostiseerd en hoe het
implantaat is geïnfecteerd. Omdat ook andere patiënt-gerelateerde
factoren een rol spelen bij de behandeling van infecties van prothe-
sen, heeft deze classificatie zijn beperkingen en moet daarom alleen
worden gezien als een grove richtlijn voor de behandeling. Een
directe infectie die zich binnen 4 weken na het inbrengen van een
primaire heupprothese openbaart, dient te worden behandeld met
nettoyage en antibiotica. Ook een acute hematogene infectie dient
op deze wijze te worden behandeld. Langer bestaande infecties
kunnen worden behandeld met alleen antibiotica, een wisseling van
de prothese (in een of twee tempi) of een resectie (Girdlestone)
arthroplastiek. Minder vaak gebruikte behandelingen zijn een
arthrodese of een disarticulatie. De keuze van behandeling is afhan-
kelijk van de gezondheid van de patiënt, de nog aanwezige “bone
stock”, de kwaliteit van de weke delen, de virulentie van het infec-
terende micro-organisme en de mentale toestand van de patiënt. In
dit hoofdstuk wordt eveneens de onderliggende pathogenese van
infecties van implantaten besproken. De adhesie van bacteriën aan
het oppervlak van humaan weefsel of aan het oppervlak van een
geïmplanteerd biomateriaal is een fase die aan elke orthopaedische
infectie vooraf gaat. Op het moment van implantatie zijn er op het
oppervlak van een biomateriaal vrije, energetisch geladen plaatsen
beschikbaar waar een fysische of chemische binding kan plaatsvin-
den met omringende eiwitmoleculen en vervolgens of tegelijkertijd
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met cellen. De zogenaamde “race for the surface” theorie, opge-
steld door Gristina, suggereert een competitie tussen weefselcellen
en bacteriën voor binding aan het oppervlak van een implantaat.
Succesvolle kolonisatie door een bepaald celtype leidt tot een
dominantie van dit celtype en tot uitsluiting van andere cellen.
Volgens deze theorie zou, als weefselcellen het eerst het oppervlak
van een biomateriaal bereiken en een stevige binding hiermee aan-
gaan, bacteriën worden geconfronteerd met levende geïntegreerde
cellen en niet meer in staat zijn om het implantaat te koloniseren.
Indien niet getraumatiseerd of veranderd, biedt dit geïntegreerde
weefsel een zekere weerstand tegen bacteriële kolonisatie. Als ech-
ter eerst bacteriën het oppervlak bereiken en het biomateriaal kolo-
niseren, dan zal er een infectie ontstaan. Een infectie van het bio-
materiaal voorkomt bijna altijd een succesvolle ingroei van het
implantaat. Sommige bacteriestammen produceren na adhesie aan
het oppervlak van een implantaat een slijmlaag, die hen minder
toegankelijk maakt voor de afweer van de gastheer en hun gevoe-
ligheid voor antibiotica aanzienlijk vermindert. Deze bacteriën
kunnen dan voor een lange tijd “slapend” blijven op het oppervlak
van een biomateriaal. Echter, wanneer omgevingsfactoren verande-
ren, zoals bij een verminderde weerstand, of bij een slechte ingroei
van weefsel rondom een prothese, dan kunnen deze bacteriën een
manifeste infectie veroorzaken. Biomaterialen zijn gevoelig voor
een infectie wanneer zij niet goed in het weefsel van de patiënt zijn
geïntegreerd. Goed geïntegreerde implantaten infecteren minder
frequent tenzij er een minder gunstige situatie ontstaat door een
verstoorde weerstand, trauma of blootstelling aan een grote hoe-
veelheid microorganismen.
In Hoofdstuk 3 wordt de hematogene verspreiding als een
belangrijk mechanisme voor orthopaedische infecties benadrukt
door een retrospectieve analyse van 28 kinderen met een osteomy-
elitis. De patiënten werden geëvalueerd door een analyse van sta-
tussen, waarbij werd gekeken naar de voorgeschiedenis, anamnese,
klinische presentatie, diagnostiek, behandeling en het resultaat. De
patiënten hadden een acute of chronische osteomyelitis met een
gemiddelde follow-up van respectievelijk 3,7 en 2,7 jaar. Alle kin-
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deren werden chirurgisch behandeld: een corticaal luik werd
gemaakt, pus werd gedraineerd en necrotisch weefsel werd verwij-
derd. Positieve kweken werden verkregen in 9 van de 12 en 7 van
de 16 kinderen met een acute, respectievelijk chronische osteomye-
litis. Na afname van de kweken werden alle patiënten behandeld
met intraveneuze, gevolgd door orale antibiotica. Na behandeling
waren op één na alle patiënten klinisch genezen en waren de infec-
tie parameters genormaliseerd. Drie patiënten hielden restverschijn-
selen (ankylose, verminderde functie). Naast chirurgische behande-
ling blijkt 6 weken antibiotische behandeling voldoende te zijn
voor het genezen van zowel een acute als een chronische infectie
bij kinderen.
In Hoofdstuk 4 worden de resultaten van een retrospectieve
analyse van 47 patiënten met een geïnfecteerde heupprothese
beschreven. De specifieke aandachtspunten van deze analyse waren
hoe men tot de diagnose kwam, de resultaten van de kweken, de
methode van behandeling en de infectieuze en functionele resulta-
ten van deze behandeling. De diagnose werd gesteld op basis van
de klinische presentatie, laboratorium onderzoek, radiologisch
onderzoek en eventueel nucleair geneeskundig onderzoek. Twee
patiënten overleden als direct gevolg van de infectie. De meeste
prothesen werden geïnfecteerd via een directe contaminatie. Bij 5
prothesen (11%) kon een hematogene bron van infectie worden
vastgesteld. Op basis van de behandeling werden de patiënten
onderverdeeld in 3 groepen. Groep I bevatte 9 patiënten die waren
behandeld met een nettoyage en waarbij de prothese niet werd ver-
wijderd. Groep II bevatte 22 patiënten die waren behandeld met
een resectiearthroplastiek en groep III bevatte 16 patiënten waarbij
de prothese was verwijderd, een nettoyage was verricht en waarbij
de behandeling direct (n = 4), dan wel in een latere fase (n = 12)
werd gevolgd door een reïmplantatie. Alle patiënten kregen antibi-
otica. De infectie werd primair succesvol behandeld bij 35 patiën-
ten (groep I 44%, Groep II 73%, Groep III 94%). Ten tijde van het
onderzoek beantwoordden 31 van de 35 nog levende patiënten een
vragenlijst over pijn en functie. Patiënten met een prothese in situ
hadden minder pijn en een grotere actieradius. Ondanks de kleine
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populatie, de relatieve korte follow-up en de verschillende wijzen
van behandeling van deze populatie, werd geconcludeerd dat de
behandeling van een geïnfecteerde heupprothese met uitsluitend
het debrideren en toedienen van antibiotica een niet optimale
behandeling is. Het verwijderen van de prothese heeft de voorkeur
in het kader van de behandeling van de infectie. In het geval dat
een nieuwe prothese niet kan worden ingebracht, is het functionele
resultaat van deze zogenaamde Girdlestone-situatie slecht. Voor een
beter functioneel resultaat is een wisseling van de prothese, indien
medisch en psychisch mogelijk, aan te raden.
Een verraderlijke complicatie van een abdominaal infectieus
proces, die het bestaan van een hematogeen mechanisme voor een
prothese infectie onderschrijft, wordt beschreven in Hoofdstuk 5. In
dit hoofdstuk wordt in een klinische les de ontwikkeling en het
beloop van een hematogeen geïnfecteerde heupprothese beschre-
ven na een abdomidale infectie. Bij een 66-jarige vrouw met een
totale heupprothese openbaarde zich een acute cholecystitis. Zij
werd behandeld door middel van een cholecystectomie waarbij een
Clostridium perfringens werd gekweekt. Na enkele maanden ontwik-
kelde zij klachten die een infectie van de heupprothese suggereer-
den. Uit geaspireerd vocht rondom de heup werd eveneens een
Clostridium perfringens geïsoleerd. Zij werd met succes behandeld
met een “two-stage” revisie procedure van de prothese en antibio-
tica. Deze casus demonstreerde dat een patiënt met een gewrichts-
prothese in situ het risico loopt op het ontwikkelen van een late
infectie van deze prothese met een micro-organisme vanuit een
geïnfecteerde galblaas. Wanneer patiënten met een gewrichtspro-
these een bacteriële infectie ontwikkelen in een op afstand gelegen
focus, dienen zij onverwijld behandeld te worden met de juiste
antibiotica ter voorkoming van een hematogene verspreiding van
bacteriën naar de gewrichtsprothese.
Het literatuuroverzicht en de klinische studies zoals beschre-
ven in de hoofdstukken 2 t/m 5, leidden tot een aantal vragen die
de basis vormden voor experimenteel onderzoek. In Hoofdstuk 6
worden de doelstellingen voor deze studies geformuleerd. De basis
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voor verder onderzoek in het algemeen was het gebrek aan funda-
mentele kennis over de pathogenese van implantaatinfecties. Zo is
het de vraag of er een verschil bestaat in infectiegevoeligheid tussen
de verschillende oppervlakken van gangbare implantaten en hoe
zich dat verhoudt tot de biocompatibiliteit. De “race for the surfa-
ce” theorie impliceert immers dat wanneer cellen het eerst het
oppervlak van een biomaterial bereiken na implantatie, het implan-
taat niet toegankelijk meer is voor bacteriën, terwijl wanneer bacte-
riën het oppervlak eerder bereiken, weefselintegratie niet meer kan
plaatsvinden. Dit werd verder onderzocht in Hoofdstuk 7. Een
ander probleem betrof de hematogene infecties, welke een substan-
tieel deel vormen van alle implantaatinfecties. Om meer basaal en
klinisch inzicht in de pathogenese van deze infecties te verkrijgen,
zijn diermodellen noodzakelijk. Derhalve werd in het onderzoek
zoals beschreven in Hoofdstuk 8, een experimenteel diermodel
ontwikkeld waarmee hematogene infecties van implantaten nader
kunnen worden bestudeerd.
In Hoofdstuk 7 wordt de vraag betreffende de infectiegevoe-
ligheid van een implantaat in relatie tot de specifieke karakteristie-
ken en biocompatibiliteit van het oppervlak bestudeerd. De belang-
rijkste vraag was of er een verschil is in infectiegevoeligheid tussen
twee gangbare oppervlakken van orthopaedische implantaten, bei-
den met een verschillende biocompatibiliteit. Is een meer biocom-
patibel oppervlak inderdaad minder gevoelig voor het ontwikkelen
van een infectie, zoals gepostuleerd in de “race for de surface” the-
orie van Gristina? Hiervoor werden twee klinisch veel gebruikte
materialen nader bestudeerd: het ongecoate gezandstraalde Ti6Al4V
en het met hydroxyapatiet gecoate Ti6Al4V. Tweeëndertig “New
Zealand White” konijnen werden geopereerd. Een met hydroxapa-
tiet gecoate (HA) of een ongecoat (Ti) Ti6Al4V implantaat werd in
beide tibiae van het konijn gebracht. Voor implantatie werd het
linker pootje gecontamineerd met een opklimmende concentratie
Staphylococcus aureus (102-105 “kolonie vormende eenheden”
(CFU)). Vier weken na implantatie werd de helft van het bot naast
het implantaat verwijderd voor bacteriologisch onderzoek en tel-
ling van het aantal bacteriën. Voor de histologische en histomorfo-
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metrische evaluatie werden preparaten van het implantaat met het
overblijvende omringende bot semi-kwantitatief histologisch beo-
rdeeld, en werd de hoeveelheid bot in contact met de implantaten,
alsmede de hoeveelheid bot rond de implantaten gemeten. De bac-
teriologische resultaten toonden een significant effect van de inocu-
lum dosis en het implantaattype op de hoeveelheid teruggekweekte
bacteriën: meer bacteriën werden teruggekweekt bij de HA
implantaten in vergelijking met de ongecoate Ti implantaten. De
histologie liet meer infectie zien bij de HA implantaten dan bij de
Ti implantaten. De metingen van botcontact en botoppervlak to-
nden verder aan, in het bijzonder voor de HA implantaten, dat er
een relatie bestaat tussen infectie en verlies van botcontact en bot-
oppervlak, dus een relatie tussen infectie en loslating van de prothe-
se. Infecties van biocompatibele, ongecementeerde implantaten zijn
gerelateerd aan de dosis van het ingebrachte inoculum. Voorts lie-
ten de meer biocompatibele HA implantaten in deze studie een
ernstiger infectie in vergelijking met de Ti implantaten zien. Dit
suggereert in ieder geval dat de “race for the surface” theorie her-
overwogen zou moeten worden voor de meer complexe in vivo
situatie.
De ontwikkeling van een experimenteel diermodel om
hematogene infecties van ongecementeerde implantaten te bestude-
ren wordt beschreven in Hoofdstuk 8. Tien “New Zealand White”
konijnen ondergingen een chirurgische procedure in 2 tempi. Een
cylindrisch Ti6Al4V of hydroxyapatiet gecoate Ti6Al4V implantaat
werd in de rechter tibia ingebracht. Na een periode van minimaal 4
weken werden de implantaten via de arteria femoralis selectief
gecontamineerd met een wisselende dosis Staphylococcus aureus.
Gedurende de postoperatieve periode werden de dieren dagelijks
gecontroleerd en werden er bloedmonsters afgenomen. Na mini-
maal 1 week werden de dieren opgeofferd en werden er biopten
van bot, beenmerg, lever, milt, long en nier gekweekt. Het over-
blijvende implantaat met omliggend bot werd bewerkt voor histo-
logisch onderzoek. Injectie van 5x108 CFU veroorzaakte in alle
gevallen positieve kweken, met minimale systemische reacties. De
histologische preparaten lieten alleen kleine hoeveelheden bacteriën
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zien met slechts een milde lokale ontsteking. Er werd geconclude-
rd dat dit diermodel bruikbaar is voor verdere bestudering van
hematogene infecties, bijvoorbeeld naar het effect van implantaat-
oppervlak, integratie in bot, follow-up, en verschillende preventie-
ve maatregelen, zoals antibioticaprofylaxe.
De in dit proefschrift beschreven studies leiden niet tot alle
antwoorden op de vele vragen over de pathogenese, het beloop en
de behandeling van orthopaedische infecties. Verder onderzoek is
noodzakelijk, met name omdat dit probleem zo complex is, maar
ook omdat het een groeiend probleem is als gevolg van een toene-
mend gebruik van biomaterialen binnen de orthopaedie. Klinische
studies zijn noodzakelijk, maar hebben hun beperkingen. Vele fac-
toren, zoals microbiologische, patiënt gebonden en zelfs emotione-
le factoren, spelen een rol bij deze infecties. Het aantal patiënten in
de klinische studies is vaak te klein om tot betrouwbare conclusies
te komen. Daarom blijven experimentele studies belangrijk om een
antwoord te kunnen geven op een aantal specifieke vragen binnen
het gebied van de orthopaedische infecties. Meer kennis van de
pathogenese van de infecties is noodzakelijk. Ook snellere en meer
betrouwbare diagnostische instrumenten (“polymerase chain reacti-
on”, beeldvormende instrumenten) zijn nodig en zullen moeten
worden ontwikkeld. Tenslotte zal het ontwikkelen van verbeterde
en meer gestandaardiseerde behandelingsmodaliteiten het doel
moeten zijn voor de directe toekomst. De diermodellen die in dit
proefschrift werden beschreven en de specifieke experimenten die
wij met deze modellen verrichtten zullen een kleine maar hopelijk
belangrijke bijdrage leveren aan een beter begrip van deze infecties
en de basis zijn voor nieuwe experimentele studies.
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Voor het schrijven van een proefschrift is een heel team
nodig. Ook aan dit proefschrift hebben in de afgelopen jaren veel
mensen in meer of mindere mate, op zijn of haar wijze bijgedragen.
Een aantal personen wil ik hier in het bijzonder bedanken.
Prof.dr. A.J. Verbout. Beste Ab, jij hebt mij opgeleid tot
orthopaedisch chirurg, en bent nu ook mijn promotor. Jij bent
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Dr. W.J.A. Dhert. Beste Wouter, dit is het uiteindelijke resultaat
van wat eens begon op de zolderkamer bij mij thuis. Infecties bin-
nen de orthopaedie zou het onderwerp worden. Je hebt het
geweten! Zonder jouw steun als co-promotor en vriend zou het
voor mij een stuk moeilijker zijn geweest. 
Dr. A. Fleer. Beste André, jouw kennis vanuit de microbiologie
van infecties bij biomaterialen was een must voor het slagen van dit
proefschrift. Het was voor mij dan ook vanzelfsprekend dat ook jij
mijn co-promotor werd.
Drs. M.W. Nijhof. Beste Marc, je aanwezigheid binnen de "infec-
tiegroep" heeft geleid tot zinvolle en kritische discussies. Jij bent nu
de volgende. Zet hem op!
Drs. E.W.A. Puts. Beste Noortje, jouw hulp bij de experimenten,
en niet te vergeten het maken  van de coupes, was groot. Ik wens
je veel succes in je verdere loopbaan.
Drs. Oosterbos. Beste Kees, wij hadden een gemeenschappelijke
belangstelling en vulden elkaar prima aan. De samenwerking ver-
liep telkenmale weer prettig.
Dr. P.G.J. Nikkels. Beste Peter, jouw specialistische kennis bij het
beoordelen van de preparaten was onontbeerlijk.
Dr. M. Terlou. Beste Maarten, zonder ook jouw hulp en kennis
van de histomorfometrische technieken had dit allemaal niet kun-
nen worden volbracht.
Dr. ir. J.A.J. Faber. Beste Joop, mijn hiaten in de statistiek heb je
steeds weer weten op te vullen.
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De mensen van het Gemeenschappelijk Dieren Laboratorium.
Beste Kees Brandt, Nico Atteveld, Hans Vosmaer, Gerard Geelen
en alle anderen voor en achter "de barrière", zonder jullie
vakkundige verzorging van de dieren was dit allemaal niet mogelijk
geweest.
De mensen van het microbiologisch laboratorium, Piet Aerts en
Cor Pot. Jullie dank ik voor jullie toegewijdheid en geduld bij het
overbrengen van de kennis van de microbiologische technieken.
Harry Wisse van het klinisch chemisch laboratorium was steeds
behulpzaam bij het bepalen van de bloedmonsters.
Ria Matthijssen, op jou kon ik altijd weer een beroep doen als de
computer weer eens vast liep. Annet en Monique, na Öner gaat nu
ook Vogely promoveren. Ik voorspel jullie: de lucht klaart weer op.
De promotie commissie bestaande uit prof. dr. I.M. Hoepelman,
prof. dr. P.J. Slootweg, prof. dr. M. Kon en prof. dr. J. Verhoef
bedank ik voor het beoordelen van het manuscript.
Beste collegae, familie en vrienden. Jullie belangstelling was altijd
hartverwarmend en stimuleerde mij om het onderzoek verder af te
maken.
Lieve ouders, jullie bedank ik voor alles wat ik van jullie heb
meegekregen. Belangstellend hebben jullie van de zijkant dit proef-
schrift zien ontwikkelen. Lieve schoonouders, jullie toonden con-
tinu je interesse.
Een speciale dank gaat uit naar mijn paranimfen, Cumhur Öner en
Daniël Saris. Ik ben blij met jullie als collegae en hoop nog lang
met jullie samen te werken.
Tenslotte het thuisfront. Lieve Marilous, jij bent mijn maatje in het
leven en de spil in ons gezin. Je ontkent het, maar zonder jou was
dit proefschrift zeker niet mogelijk geweest. Lieve Frédérique,
Clementine en Claire, de laatste woorden zijn voor jullie: het is
eindelijk zover, het boekje is nu klaar!!
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Curriculum vitae
Henri Charles Vogely werd op 12 mei 1957 in Utrecht
geboren. In 1976 behaalde hij het diploma Atheneum-B op het
College Blaucapel te Utrecht. Na een jaar biologie gestudeerd te
hebben, werd vervolgens aangevangen met de studie geneeskunde.
In 1985 werd het artsexamen behaald. Na een periode werkzaam te
zijn geweest als consultatiebureau-arts voor kleuters en zuigelingen,
was hij enkele jaren werkzaam als AGNIO in de vakgebieden
chirurgie, urologie en orthopaedie. In 1990 werd begonnen met de
opleiding tot orthopaedisch chirurg. De vooropleiding algemene
heelkunde werd gedaan in het Medisch Spectrum Twente te
Enschede (opleider Dr. I.J. Hoogendam). Na een korte periode
weer als AGNIO orthopaedie te hebben gewerkt, kon de opleiding
in het Academisch Ziekenhuis Utrecht worden voortgezet (oplei-
der Prof. Dr. A.J. Verbout). De perifere stages werden gedaan in
het Medisch Centrum Alkmaar (opleider Dr. W.J. Willems) en het
Onze Lieve Vrouwe Gasthuis te Amsterdam (opleider Prof. Dr.
J.W. van der Eyken). Op 4 juni 1997 volgde de inschrijving in het
specialisten register als Orthopaedisch Chirurg. Sindsdien is hij
werkzaam in het huidige Universitair Medisch Centrum en het
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